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Summary 
The class III PI3-kinase VPS34 is a mediator of endocytosis, trafficking of intracellular 
membranes and vesicles, and autophagy in various cell types. Given its central role in key cell-
biological processes, we explored whether VPS34 is critical for immune cells by generating 
conditional knockout mice where exon 21 of Pik3c3 (the VPS34 gene) is deleted specifically in 
regulatory T (Treg) cells or activated CD8+ T cells, respectively. 
We found that mice with VPS34-deficient Treg cells died within 6 weeks of birth from 
an autoimmune lymphoproliferative disease, similar to mice lacking Treg cells. However, 
VPS34-deficient Treg cells developed normally and populated the peripheral lymphoid 
organs, demonstrating a critical role for VPS34 in Treg cell suppressive functions rather than 
survival. However, none of the known Treg cell suppressive mechanisms were impaired by 
the loss of VPS34. Nonetheless, VPS34-deficient Treg cells had a competitive disadvantage 
and impaired activation compared to VPS34-sufficient Treg cells, suggesting that VPS34 is 
required for Treg cells maturation or the survival of mature Treg cells. In an attempt to 
determine which cellular processes are affected by the loss of VPS34, we performed 
proteomic profiling, and while the results could not provide a definite clue about the 
mechanism leading to the observed phenotype in mice with VPS34-deficient Treg cells, they 
suggested that loss of VPS34 induces a state of heightened metabolic activity in Treg cells. 
Autophagy is critical for the formation of memory CD8+ T cells, while it is dispensable 
during the effector phase. Since VPS34 is required for the induction of autophagy, it was 
striking to observe that deletion of VPS34 in activated CD8+ T cells did not result in a 
phenotype similar to mice with autophagy (ATG7)-deficient CD8+ T cells. Rather, mice with 
VPS34-deficient, activated CD8+ T cells displayed reduced proportions of antigen-specific CD8+ 
T cells and reduced effector functions at the peak of expansion after infection with Listeria 
monocytogenes, while memory formation seemed intact. Results from in vitro data suggested 
that while proliferation was intact, the transition through the cell cycle was impaired in 
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1.1 The immune system 
The immune system represents a complex network of cells, tissues, molecules, and organs 
working together to protect the host from foreign pathogens and malignant cells. This 
protection is accomplished by the inherent ability of the immune system to distinguish ’self’ 
from ’non-self’ and to eliminate potentially harmful molecules and non-self cells. The immune 
system has also the capacity to recognize and eliminate cells that display an ’altered self’, e.g. 
virally infected and transformed cells that are derived from the host’s tissue, or self-reactive 
cells, such as auto-reactive T cells.  
 
Cells of the immune system originate in the bone marrow and arise from hematopoietic stem 
cells which further differentiate to either common myeloid progenitor cells or common 
lymphoid progenitor cells  [1]. The former give rise to granulocytes, macrophages, dendritic 
cells and mast cells, while the latter are the precursors of lymphocytes, i.e. Natural Killer (NK) 
cells, B cells, and T cells. Based on antigen specificity and timing of activation, the immune 
system can be, broadly speaking, divided into two distinct immune compartments - the innate 
and the adaptive immune system. The innate immune system is an evolutionary ancient 
defence mechanism that serves as an early mechanism of host-defence against tumour cells 
and invading pathogens [2]. Innate immune cells play a crucial role in the initiation and the 
subsequent direction of the adaptive immune response and participate in the removal of 
pathogens targeted by cells of the adaptive immune system. The adaptive immunity 
represents the second phase of an immune response. It is defined by a high degree of 
specificity in recognising foreign antigens and the ability to form an immunological memory, 
which is faster, stronger and generally more effective at neutralising pathogens in the event 
of renewed exposure to the same antigen [1]. In contrast to the innate immune response, the 
initial adaptive immune response does not act immediately and only reaches the peak of cell 
expansion and functional activity by four to seven days, a period during which the innate 
immune response is critical for controlling the infection. Both arms of the immune system 
regulate each other in many different ways and act in concert to eliminate foreign antigen 
and malignant cells [3]. The interplay between the innate and the adaptive immune system is 
an important basis for the effective protection of the host. 




In the following chapters, I will concentrate on two cell subsets belonging to the adaptive 
immunity, CD8+ T cells and regulatory T cells, as those cell types are the focus of this thesis. 
Since both arise from the T cell compartment, the next sub-chapter will describe in general 
the development of T cells, before subsequently focusing on either CD8+ T cells or regulatory 
T cells.  
 
1.1.1 T cell development – from being born to being educated 
T cells derive from haematopoietic stem cells found in the bone marrow. T cell progenitors 
migrate to the thymus where they undergo a series of maturation steps that can be discern 
from each other based on the expression of different cell surface markers. The majority of the 
T cells gives rise to αβ T cells, with only ~ 5% bearing the γδ T cell receptor (TCR). When 
entering the thymus, T cells lack the expression of both co-receptors CD4 and CD8 and are 
therefore termed double negative (DN) cells. This DN population can be further sub-divided 
by the expression of the adhesion molecule CD44 and the interleukin-2 receptor α chain (IL-
2Rα, also referred to as CD25). Cells expressing CD25 but lacking CD44 undergo beta-selection 
– a process selecting for cells that have successfully rearranged their TCR-β chain locus.  The 
β chain pairs with the surrogate pre-TCR-α chain to produce a pre-TCR. Successful pre-TCRs 
form a complex with CD3 molecules, leading to the survival, proliferation, arrest of further β 
chain loci rearrangement, and the up-regulation of CD4 and CD8. This stage is called the 
double positive (DP) stage. In the DP stage, T cells rearrange their TCR-α chain loci to produce 
an αβ-TCR.  
Next, T cells undergo positive selection in the cortex. DP cells are tested for the ability 
to interact with self-antigens in the context of major histocompatibility complex (MHC) class 
I or class II molecules. Depending on the affinity of the engagement between the antigen and 
the MHC, i.e. appropriate affinity versus weak affinity, T cells may survive or die by apoptosis, 
respectively. In the medulla, T cells undergo negative selection, i.e. they are presented to self-
antigens on antigen presenting cells (APCs), such as dendritic cells and macrophages. T cells 
that interact too strongly with an antigen undergo apoptosis, which is the case for the 
majority of the T cells. Surviving T cells down-regulation either co-receptor to produce either 
CD4 or CD8 single positive cells and exit the thymus to carry out their distinct roles.    




1.2 Regulatory T cells 
1.2.1 The Ying and the Yang of the immune system 
The adaptive immune system is a powerful and immensely versatile defence mechanism 
against both external and internal threats, including harmful microorganisms and malignant 
cells, respectively. However, inappropriate, overwhelming, and prolonged immune answers 
represent a potential risk to the host. The immune system is therefore endowed with a 
control mechanism to maintain tolerance against commensal microorganisms, harmless and 
self-antigens, and to control desirable immune response to limit tissue damage. 
Two types of control mechanisms have been described, i.e. ‘recessive’ and ‘dominant’ 
control mechanisms. Recessive mechanisms are cell intrinsic and include death by apoptosis 
or cell anergy of overly self-reactive T cells that are exposed to their cognate antigen in the 
thymus during negative selection [4]–[7]. In the periphery, anergy is being induced by 
prolonged exposure to a self-antigen. The requirement of CD28 to interact with the co-
stimulatory receptor CD80/86 expressed on APCs, in addition to TCR engagement, provides a 
further level of control in the periphery [8]. However, these mechanisms are not sufficient on 
their own to maintain immune homeostasis. A subset of T cells, characterised by the 
expression of CD4, IL-2Rα (CD25), and the transcription factor forkhead-box transcription 
factor (FoxP3) is critical for the maintenance of peripheral tolerance. This cell subset was first 
identified in experiments conducted on neo-nataly thymectomized mice that displayed 
autoimmunity until restored with adult thymocytes or splenocytes [9]–[12] and was therefore 
named regulatory T cells (Treg cells). Treg cells are essential for the control and the 
termination of ongoing immune responses, maintain peripheral tolerance to self-antigens, 
and prevent autoimmunity by suppressing or downregulating the activation and proliferation 
of effector T cells [13]. Lack of Treg cells or impairment in their suppressive functions results 
in autoimmune diseases and lymphoproliferative disorders. 
 
1.2.2 Treg cell development and activation 
Treg cells comprise between 5 to 10% of all peripheral CD4+ T cells [14] and arise from two 
distinct sources; thymic Treg (tTreg) cells develop in the thymus from CD4+ T precursor cells 
and have a diverse TCR repertoire which confers specificity for self and non-self antigens [15]–




[17]. Induced Treg (iTreg) cells arise from naïve peripheral CD4+ T cells following activation in 
the presence of transforming growth factor beta (TGF-β) [18]. Both Treg cell subsets can be 
distinguished by their expression of neuropilin-1, which is expressed on tTreg cells but not 
iTreg cells [19], [20]. In mice, FoxP3 is unique to and required for the identity of Treg cells 
[21], [22], and depletion of the FoxP3 gene leads to the so-called Scurfy phenotype, a fatal 
lymphoproliferative disease associated with the massive activation and proliferation of 
effector CD4+ T cells and the production of pro-inflammatory cytokines [23]. Similarly, in 
human, dysfunction of the transcription factor FoxP3 results in a disease termed 
immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome [24], [25], 
resulting in autoimmunity with a lethal outcome for the patient.   
FoxP3 controls the differentiation and the function of Treg cells by controlling their 
transcriptional signature, i.e. by repressing the expression of genes that promote immune 
responses while reinforcing the expression of genes that intrinsically limit the activation of 
effector T cells, i.e. CTLA-4, IL-10, and IL-10Rα [26]. Around 700 genes are thought to be 
regulated by FoxP3, and 20-30% are directly bound by FoxP3 [27], [28], such as genes 
encoding transduction molecules, transcription factors, cytokines, cell-surface molecules, and 
metabolic enzymes [14]. FoxP3 also interact with chromatin remodelling factors, such as the 
acetyl transferase TIP60, histone deacetylases, and the transcription factors nuclear factor of 
activated T cells (NFAT) and Runx1 [26]. TIP60 and HDAC7 regulate the activity of FoxP3 [29], 
[30] and its interaction with Runx1 suppresses the transcription of IL-2, a key cytokine for the 
survival and proliferation of effector T cells.   
NFAT binding to the activator protein 1 (AP-1) and NFκB induce the expression of IL-2, 
IL-4, and CTLA-4 in conventional T cells, and their differentiation into effector T cells. The 
replacement of AP-1 by FoxP3 represses the expression of IL-2 while increasing the expression 
of CD25 and CTLA-4 [31].  
FoxP3 also regulates the expression of micro-RNAs (miRNAs) [14], [26] that are critical 
for the fitness of Treg cells: miR-155 is required for Treg cell development [32] and to increase 
the response to IL-2 [33], while miR-146a expression prevents the differentiation of Treg cells 
into a Th1-phenotype [34]. Hence, mice deficient for Dicer or Drosha, two components of the 
miRNA maturation machinery, fail to generate Treg cells and display a Scurfy phenotype [35]–
[37]. In summary, the continuous expression of FoxP3 is required to maintain the 




transcriptional programme in mature Treg cells, making FoxP3 the master regulator of Treg 
cell differentiation, survival and suppressive functions [38]. 
 
1.2.3 Mechanisms of Treg cell suppression 
Treg cells employ diverse mechanisms to maintain a balanced response to exogenous and 
self-antigens, involving the production of secreted immunosuppressive cytokines, directly 
suppressing effector T cells or indirectly by suppressing dendritic cells [39]. The relative 
contribution of each mechanism is still a matter of investigation, and so far no mechanism 
has been identified as being absolutely indispensable for the function of Treg cells.  
Treg cells secrete immuno-suppressive cytokines such as IL-10, IL-35, and TGFβ-1 and can 
directly kill target cells. In mice, Treg cells express mainly granzyme B, and target cells are 
killed in a perforin-dependent manner [40]. 
Besides directly inhibiting effector T cells, Treg cells regulate the immune response by 
modulating the ability of APCs to prime naïve T cells. Cytotoxic T lymphocyte-associated 
protein 4 (CTLA-4), a member of the immunoglobulin superfamily, plays an important role in 
regulating the expression of co-stimulatory molecules required for the activation of naïve T 
cells on dendritic cells (DCs) by Treg cells. Similar to CD28, CTLA-4 binds CD80 and CD86, but 
with a much higher affinity and is intrinsically inhibitory rather than activating [41]. Treg cells 
sequester CD80/CD86 from the cell surface of DCs through a process called transendocytosis 
[42], thereby indirectly preventing naïve T cell activation. Furthermore, the binding of CTLA-
4 to CD80/CD86 induces the production of indolamine-2,3-dioxygenase (IDO), an enzyme 
which catabolises tryptophan [41], [43]. Tryptophan is an amino acid required for the 
proliferation of T cells [44], and its breakdown results in kynurenines that have a pro-
apoptotic influence on T cells [45]. Hence, CTLA-4 deficiency or blockade has detrimental 
effects: CTLA-4 – deficient mice develop multi-organ inflammation leading to death at three 
to four weeks of age [46], [47], Treg cell-specific depletion of CTLA-4 results in 
lymphadenopathy, splenomegaly, myocarditis, gastritis, and death at seven weeks of age 
[48], while antibody blockade of CTLA-4 abrogates Treg cell suppressive functions [49]. In the 
absence of CTLA-4, CD80/CD86 levels are heightened on DCs, leading to an increased 
activation of naïve T cell through the interaction with CD28.  




Treg cells also mediate indirect inhibition of naïve T cells through their expression of the 
lymphocyte-activation gene 3 (LAG3), a CD4 homologue highly specific for MHC class II 
molecules. LAG3 binding to MHC class II on immature DCs inhibits the maturation and the 
immune-stimulatory capacity of DCs [50]. 
Expression of the IL-2 receptor on the cell surface is critical for Treg cell homeostasis 
and their suppressive functions [51]. Upon IL-2 binding, the IL-2R – IL-2 complex is rapidly 
endocytosed, IL-2 is degraded through the lysosomal pathways and the IL-2 receptor recycled 
to the cell surface [52]. This mechanism allows the consumption of extracellular IL-2, thereby 
depriving effector T cells of a key growth factor and leading to Bim-mediated apoptosis [53].  
Treg cells can also suppress the survival, the proliferation, and effector functions of 
target cells through the disruption of their metabolism. One of this mechanism involves the 
release of cyclic adenosine monophosphate (cAMP), which potently inhibits the proliferation 
of T cells and their production of IL-2 [54]. A further mechanism by which Treg cells disrupt 
the metabolism of target cells is through the expression of the ectoenzymes CD39 and CD73 
on their cell surface, which synergize to elevate the level of pericellular adenosine. Adenosine 
binds to the adenosine receptor A2 on target cells and thereby supresses T cell effector 
functions [55]. This mechanism also promotes the secretion of TGFβ-1 and supresses IL-6 








1.3 CD8+ T cells 
CD8+ T cells are critical for the elimination of intracellular bacteria- or virus-infected cells, and 
of transformed cells [57], [58]. Upon activation, naïve CD8+ T cells undergo many rounds of 
proliferation and differentiate into mature effector cells termed as cytotoxic T lymphocytes 
(CTLs). CTLs are specialized in the direct, contact-dependent cytolysis of target cells [59]. 
 
1.3.1 CD8+ T cell development and activation 
Naïve single positive CD8+ T cells circulate throughout the body, migrating through the blood 
system and secondary lymphoid organs (SLOs) (spleen and lymph nodes) via high endothelial 
venules (HEVs). HEVs are specialized post-capillary venous swellings which express ICAM1, 
CD34 as well as the CCR7 ligands CCL19 and CCL2 [60]–[62]. Their role is the constant search 
of pathogen-derived peptides presented in the context of the class I major histocompatibility 
complex (MHC) which is expressed on all nucleated cells [63] and recognised through their 
TCR and the CD8 co-receptor (consisting of a CD8α and a CD8β chain). The encounter of a 
naïve CD8+ T cell with its cognate antigen results into numerous molecular changes within the 
T cell, leading to cell activation and differentiation into distinct subpopulations. The activation 
of CD8+ T cells depends on three signals: 1) stimulation by the antigen through the TCR; 2) co-
stimulation through molecules such as CD28, CD40, 4-1BB, CD27, ICOS, and/or OX40; and 3) 
stimulation by inflammatory cytokines, especially IL-12 and type I interferon (IFN) [64]–[66]. 
Upon activation, antigen-specific CD8+ T cells undergo three distinct phases: 1) clonal 
expansion, during which effector functions are acquired; 2) contraction of the effector 
population through activation induced cell death (AICD), where only a small percentage of 
cells remaining to generate memory cells; and 3) maturation of memory cells. Memory 
formation is independent of the contraction phase, and is believed to be already programmed 
during the early stages of the priming phase [67].  
Once activated, CD8+ T cells loose the expression of the lymph node homing receptors 
L-selectin (CD62L) and the CC-chemokine receptor 7 (CCR7) [68]. Activated cells increase the 
expression of tissue-specific integrins and chemokines allowing them to transmigrate into the 
tissues following their expression [68]. The expression of the cell surface glycoprotein CD44 
mediates the primary adhesion of activated CD8+ T cells to endothelial cells through binding 




to the ligand HA [69] and the integrin α4β1 (VLA-4) [70]. CTLs also express CD11a/CD18 
(leukocyte functional antigen-1, LFA-1), which binds ICAMs on the endothelium and is 
expressed only during inflammation, CD49d, and chemokine receptors including CXC-
chemokine receptor 3 (CXCR3). 
 At the peak of the primary CD8+ T cell response, two distinct subsets of CD8+ T cells 
can be distinguished from each other based on the expression of two receptors, i.e. IL-7 
receptor alpha chain (IL-7Rα, also referred to as CD127) and killer-cell lectin-like receptor G1 
(KLRG1). Kaech et al. described how the expression of CD127 inversely correlates with 
effector CD8+ T cell survival [71]. They adoptively transferred CD127high or CD127low effector 
CD8+ T cells into naive mice, and found that CD8+ T cells expressing high levels of CD127 
preferentially survived and differentiated into long-lived memory cells [71]. Therefore, 
memory precursor effector cells (MPECs) can be defined by their high expression of CD127 
[71], and short lived effector cells (SLECs) by their low CD127 expression [71]–[73]. Voehringer 
et al. suggested KLRG1 as an early and unique marker for replicative senescence of CD8+ T 
cells [74]. Together with CD127, KLRG1 can therefore be used to distinguish effector CD8+ T 
cells (i.e. SLECs) from memory precursor cells (i.e. MPECs) [75], [76] - KLRG1high CD127low 
defining SLECs and KLRG1low CD127high defining MPECs. The ratio between these two 
populations is often taken as a measure to assess the ability of cells to react to an infection 
as well as to form a pool of memory cells.  
A multitude of mechanisms control the differentiation into either MPECs or SLECs, 
including the strength of antigen stimulation and the exposure to cytokines such as IL-2 and 
IL-12 [76]. SLEC differentiation is favoured by enhanced signal 1 (prolonged antigen exposure, 
TCR affinity/avidity/peptide concentration) and signal 3 (high levels of IFN-γ, IL-12), while 
brief TCR stimulation, defects in inflammatory cytokine signalling, enhanced anti-
inflammatory cytokine availability (TGF-β, IL-10) or the presence of regulatory T cells 
promotes the formation of MPECs [77]. The differentiation into SLECs is favoured by the 
expression of T-box transcription factor (T-bet), Blimp-1, XBP-1, ID2, whereas increase levels 
of Eomesodermin (Eomes), Bcl-6, ID3 and Mbd2 promotes MPEC differentiation  [76], [78]. 
 Joshi et al. proposed T-bet as a master regulator of cell-mediated immunity, able to 
control the expression of genes encoding a wide range of effector molecules [76]. For 
example, inhibition of T-bet favours the formation of memory T cells and the expression of 
CXCR3 (also known as CD183). The expression of CD183 affects the balance between the 




generation of effector and memory CD8+ T cell [79]. Consequently, fewer SLECs and more 
MPECs developed when CD8+ T cells lacked CD183 expression due to reduced co-localisation 
of effector CD8+ T cells with antigen in the spleen. Eomes has also been shown to be key for 
the function of CD8+ T cells, and it has been established that Eomes and T-bet have both 
overlapping and separate functions in the regulation of CD8+ T cell effector functions.  One 
example is that the abrogation of IFN-γ production requires both T-bet and Eomes to be 
knocked-out [80]. 
 
1.3.2 Effector mechanisms of activated CD8+ T cells  
Activated effector CD8+ T cells differentiate into cytotoxic T lymphocytes (CTLs), in reference 
to their specialisation in the direct, contact-dependent lysis of target cells [81]. CTLs display 
several effector functions with both direct and indirect effects on target cells.  
Through the release of pro-inflammatory cytokines such as tumour necrosis factor-α 
(TNF-α) and interferon-γ (IFN-γ), CTLs shape the ongoing immune response by indirectly 
inhibiting intracellular pathogens [82], [83], upregulating antigen presentation on MHCs [84] 
and shaping the immune response of several immune cell subsets, including CD8+ T cells 
themselves [85]–[87]. IFN-γ directly interferes with viral replication, leads to the recruitment 
of macrophages to the site of infection, and activate those to kill pathogens and present 
antigens. Furthermore, IFN-γ stimulates the expression of MHC class I, rendering it more likely 
for any infected cells to be recognised and killed, as most cells express the IFN-γ receptor. 
CD8+ T cells rapidly and directly kill target cells, either by the release of cytotoxic 
granules, or ligation of receptors that initiate apoptosis [88]–[90]. Both mechanisms of 
targeted cell lysis require direct contact between the effector and  the target cell [91], an 
interaction termed as the immunological synapse (IS) [92]–[94]. Binding of the Fas ligand 
(FasL) on the surface of the CD8+ T cells to death receptor Fas (CD95) on the target cell induces 
classical caspase-dependent apoptosis [95]. 
CTLs also contain special granules, or modified lysosomes, containing perforin, 
granzymes and granulysin [96]–[98], which are released in a regulated manner when the CTL 
is in direct contact with the target cell. When a T cell is activated through its TCR, microtubule-
associated granules migrate towards the plasma membrane along microtubules that direct 
the release of these granules [91]. The microtubules emerge from the microtubule organising 




centre (MTOC) located at the IS upon cellular activation [99]. The amplitude of the 
degranulation is controlled by the avidity of the TCR and peptide ligands interactions within 
the IS [100].  
Perforin forms transmembrane pores in the target cells, allowing water and salts to enter the 
cell and cause osmotic lysis. Perforin is absolutely required for granule-mediated killing [101], 
as shown by genetic knock-out studies. Perforin knock-out mice are susceptible to viruses and 
intracellular pathogens, such as Listeria [102].   
Granzymes are serine proteases and to date, five granzymes (A, B, G, H and K) have 
been described in humans, while ten in mice [103]. Granzyme B is the most studied granzyme 
and is expressed both in mice and humans. It cleaves and activates caspase-3, leading to the 
activation of caspase-activated deoxyribonuclease (CAD), resulting in the degradation of DNA 
and the induction of apoptosis [104], [105]. Granzyme B can also initiate apoptosis 
independently of caspase through the activation of the Bcl-2-family, pro-apoptotic protein 
Bid [106]–[108]. While it is widely believed that Granzyme B enters the target cell via perforin 
pores [109], it has also been suggested that Granzyme B enters the cell in the absence of 
perforin [110].  
 
1.3.3 CD8+ T cell memory formation 
Memory T cells are present in relatively large numbers and located at multiple sites in the 
body [111]; in the case of re-infection, they are at the front line of potential pathogen entry 
sites. Once a pathogen has breached the first line of defence, memory cells are able to rapidly 
re-express effector molecules, such as cytokines and lytic proteins [112]. The ability to quickly 
respond is a result of the hyper-responsive state of memory T cells compared to naïve T cells 
[113], [114]. Antigen-specific naïve CD8+ T cells represent an operational army of effector cells 
that can protect the host from the present infection, as well as a pool of memory cells poised 
to quickly and efficiently react to future infections with the same pathogens.  
After the rapid expansion, the population of CD8+ effector cells undergoes a rapid contraction 
phase whereby approximately 95% of the cells die by apoptosis. This contraction phase is 
mediated mainly by the ratio between the expression of survival versus apoptotic factors, 
including Bcl-2, Bclx, and components of the Bim and Fas pathways [115]–[117]. The 
remaining antigen-specific CD8+ T cells eventually form a population of long-lived memory T 




cells that survive for a long time in the host in an antigen- and TCR-independent manner [118]. 
However, the long-term maintenance of the memory CD8+ T cell population depends on 
cytokines, especially from the γc-cytokine family. IL-7 and probably thymic stromal 
lymphopoietin (TSLP) enhance memory cell survival [73], [119], [120] while IL-15 is essential 
for the slow homeostatic turnover of memory cells [118], [121].  
Memory cells are a heterogeneous pool of cells, including T central memory (TCM) 
cells and T effector memory (TEM) cells. Both subsets express CD44 but can be distinguished 
based on the expression of cell surface markers determining their ability to migrate to 
peripheral tissues [122]. TCM cells express high levels of the lymph node homing receptors 
CD62L and CCR7, allowing them to circulate between bloodstream and secondary lymphoid 
organs [123]. They secrete IL-2, but not IFN-γ [124]–[126]. TEM cells, on the other hand, lack 
the expression of CD62L and CCR7, and circulate through the bloodstream, permissive non-
lymphoid tissues and secondary lymphoid organs. They quickly respond to reinfection with 




1.4 Metabolic regulation of immune cells 
Recent findings have increase our understanding on how intracellular metabolism can shape 
the development, trafficking, and function of Treg cells [127]–[129]. Indeed, the integration 
of multiples extrinsic and intrinsic signals are directly influencing cellular transcriptional 
programs and signalling pathways involved in cell proliferation, cytokine production, and 
energy metabolism [130].   
Glycolysis and fatty acid oxidation (FAO) are differentially used by conventional T cells 
(Tcons) and Treg cells. In vitro, mouse Treg cells display a low glycolytic rate and oxidize lipids 
at a higher rate than Tcons, doing so through activation of the AMP-activated protein kinase 
(AMPK) (5). In vivo, mouse Treg cells display a high glycolytic rate associated with 
hyperactivation of the “environmental” sensor mechanistic target of rapamycin (mTOR) 
[131]–[133].  In the last decade, a special emphasis has been placed on the mTOR complex as 
it can sense environmental nutrients and growth factors and thereby modulate Treg cell 




differentiation and functions [131], [132], [134], [135]. mTOR is an evolutionary conserved, 
289 kDa serine/threonine protein kinase found in two multi-protein complexes: mTOR 
complex 1 (mTORC1), which contains the regulatory-associated protein of mTOR (RAPTOR), 
and mTOR complex 2 (mTORC2), which contains the rapamycin-insensitive companion of 
mTOR (RICTOR) [136]. mTORC1 is an important regulator of cell growth and differentiation 
[137], [138], and plays bidirectional roles in Treg cell induction and functions. mTORC1 can 
act as a negative regulator of de novo differentiation of Treg cells, but is critical for Treg cell 
suppressive activity [131], [132], [139]. Mechanistically, mTORC1/Raptor couples TCR and IL-
2 signalling to Treg cell suppressive functions [132] and, metabolically, drives cholesterol and 
lipid biosynthesis through the induction of genes including 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGCR), squalene epoxidase (SQLE) and isopentyl-diphosphate δ isomerase 1 
(IDI1). Furthermore, it drives the induction of the mevalonate pathway which is required for 
the expression of suppressive Treg cell markers such as cytotoxic T-lymphocyte-associated 
protein 4 (CTLA-4) and inducible co-stimulator (ICOS) [132], [140]. Hence, Treg cell-specific 
deletion of mTORC1 impairs Treg cell suppressive function and homeostasis, resulting in the 
spontaneous activation of effector T cells and in the development of inflammation in barrier 
tissues [141]. In contrast, Toll-like receptor (TLR) signals enhance Treg cell proliferation 
through mTORC1 signalling pathway, glucose transporter 1 (Glut1) upregulation, and 
glycolysis. However, these signals decrease the suppressive ability of Treg cells [142]. It is 
likely that the TLR signal results in high levels of pro-inflammatory cytokines that decrease 
Treg cell functionality even as Treg cells maintain mTORC1 expression [136]. 
While Treg cells are highly dependent on mitochondrial metabolism with the flexibility 
to also oxidize lipid or glucose, Tcons  mainly convert glucose to lactate [143]–[145]. Treg cells 
appear to have a stronger respiratory capacity and preferentially oxidize glucose-derived 
pyruvate as compared to Tcons [146]. The high expression of carnitine palmitoyltransferase 
1a (CPT1a) - the rate-limiting enzyme of FAO that allows the entry of acyl groups into the 
mitochondria - supports the possibility that Treg cells can use multiple fuel sources [143], 
[144].  
By increasing the expression of glucose transporters, such as Glut1, on activated T cells, 
mTORC1 activation augments the intracellular concentration of glucose to support glycolysis 
[147]. mTORC1 signalling also induces glycolysis via the oncogene c-MYC, a crucial regulator 
of metabolic reprogramming in T cells [145]. The role of mTORC1 in lipogenesis is also 




supported by the findings that rapamycin blocks the expression of genes involved in lipid 
synthesis and alters nuclear localization of the master regulators of lipid homeostasis, sterol 
regulatory element-binding proteins (SREBPs) [148]. 
Freshly isolated Treg cells express high levels of mTORC1 and ATP due to their high 
proliferation rate in vivo [133], making them refractory to TCR stimulation in vitro and renders 
them therefore anergic. The over-activation of mTORC1 in Treg cells also depends on the 
capacity of Treg cells to secrete leptin, a cytokine that activates mTORC1 via its class I cytokine 
receptor [149]. Hence, leptin neutralisation or transient rapamycin treatment reverses Treg 
cell anergy, hence re-inducing Treg cell proliferation upon TCR stimulation [149]. Recent 
findings suggested that Treg cells need to reduce transiently their metabolic rate to enter the 
cell cycle and proliferate [131]. This implicates that although high mTORC1 activity renders 
Treg cells refractory to TCR stimulation, it is also necessary for Treg cells to proliferate over 
time once the cell cycle is engaged [143]. 
Modulation of PI3K signalling can also alter cellular metabolism and FoxP3 expression. 
Genetic ablation of phosphatase and tensin homolog on chromosome 10 (PTEN), the primary 
negative regulator of PI3K, results in an increase in glycolysis, loss of FoxP3 expression, and 
the induction of effector T cells [150], [151]. The observations by Wei et al.,  who showed that 
deletion of Atg7 or Atg5 leads to Treg cells loss, is due to the upregulation of the metabolic 
regulators mTORC1 and glycolysis in autophagy-deficient Treg cells, contributing to defective 
Treg function [152].  




1.5 The world of phosphoinositide 3-kinases 
Based on their structure, substrate specificity and function, phosphoinositide 3-kinases (PI3-
kinases) comprise eight members that are divided into three classes (class I, class II and class 
III), all of which phosphorylate the 3' hydroxy position of the inositol ring of 
phosphatidylinositol. PI3-kinase class I family members (that can be further divided into Class 
IA and Class IB based on their associated regulatory subunits) phosphorylate 
phosphatidylinositol-(4,5)-diphosphate (PIP2) to generate the lipid second messenger 
PI(3,4,5)P3 (PIP3). Class II (i.e. PI3KC2α, PI3KC2β, and PI3KC2γ) phosphorylate 
phosphatidylinositol-(4)-phosphate and Class III PI3K (VPS34) phosphorylate PI on the third 
position to generate PI(3,4)P2 and PI3P, respectively. 
PI3-kinases are intracellular signal transducer lipid kinases and regulate multiple 
intracellular pathways by integrating signals from growth factors, cytokines, and other 
environmental cues. Therefore, PI3-kinases regulate diverse physiological functions and 
cellular processes including cell growth, survival and proliferation, cellular motility and 
differentiation, as well as intracellular trafficking and nutrient metabolism [153], [154]. Given 
the importance of PI3-kinases in controlling versatile intracellular pathways, alterations in 
PI3-kinases are frequently found in various cancer types as well as pathological immune 
deficiencies, and an increase interest is emerging towards delineating the molecular 
mechanisms influenced by PI3-kinases [155].  
This work has solely been investigating the role of the class III PI3-kinase, with VPS34 
being its sole member. Hence, the following chapters will focus on the Class III PI3-kinase 
VPS34.  
 
1.5.1 The class III PI3-kinase VPS34 
VPS34 (vacuolar protein sorting 34) is encoded by Pik3c3 and is highly conserved from yeast 
to mammals. In yeast, where it was first identified, it is required for vacuole protein sorting 
[154], [156]–[159]. It is the catalytic subunit of the class III PI3-kinase family and it 
phosphorylates PI on the 3’ position of the inositol ring to generate the second messenger 
phosphatidylinositol 3-phosphate (PI3P) [156]. VPS34 is the main source of PI3P, and provides 
a platform for the recruitment of effector proteins containing phox homolog (PX) or FYVE 




domains (FYVE zinc finger domain is named after the four cysteine-rich proteins: Fab 1 (yeast 
orthologue of PIKfyve), YOTB, Vac 1 (vesicle transport protein), and early endosome antigen 
1E (EA1)) [160]–[162].  
VPS34 is closely associated with the serine threonine kinase VPS15, which is required 
for the activation of VPS34 [163]. In yeast and specific mammalian cell types, VPS34 plays an 
important role in autophagy and endocytosis, with two different protein complexes mediating 
these distinct processes (autophagy complex vs. endocytosis complex). Both complexes 
contain VPS34 and VPS15 as well as the functional adapter Beclin-1 (Atg6 in yeast) [164]. The 
forth unit of complex I (autophagy complex) is Atg14L (Atg14 in yeast) while UVRAG (UV 
radiation resistance-associated gene, Vps38 in yeast) is part of complex II (endocytosis 
complex) [156], [164]. Further distinct proteins interact with both complexes, such as Bcl-2 
[165] and Ambra [166] in the case of the autophagy complex, and Rubicon in the case of the 
endocytosis complex [167]. Meanwhile, Bif-1  is thought to interact with both complexes 
[166]–[168]. 
 
1.5.2 VPS34 in autophagy 
Autophagy is an evolutionary conserved and fundamental catabolic process required for 
cellular homeostasis. It plays an important role in the degradation of protein aggregates, 
damaged organelles, and the recycling of nutrients. Autophagy is upregulated by nutrient 
deprivation (starvation-induced autophagy) and various forms of stress, such as oxidative 
stress, accumulation of misfolded proteins, bacterial and viral infection, in order to adapt to 
energy demand.  
There are three forms of autophagy, referred to as macroautophagy, microautophagy 
and chaperone mediated autophagy (CMA). During microautophagy, autophagic substrates 
are directly engulfed by the lysosome; CMA consists in the degradation of tagged proteins 
with a specific sequence motif that binds to chaperone HSP70 which are then transported 
and internalised in the lysosome [169]. Macroautophagy is the most widely studied form of 
autophagy and will hereafter simply be referred to as autophagy. Autophagy is generally 
divided into three different steps: a) initiation, formation and closure of the autophagosome; 
b) maturation of the autophagosome and fusion with the lysosome, leading to lysosomal 
degradation; and c) autophagosome-lysosome reformation. The initiation of autophagy 




involves the formation of doubled membraned vesicles, so-called autophagosomes, from the 
phagophore (also referred to as isolation membrane) [170]. During the elongation step, the 
pagophore enlarges and closes around cytoplasmic proteins, damaged or excess organelles, 
or invading intracellular pathogens [171]. This process is mediated by two ubiquitin-like 
conjugation systems, Atg7-Atg10 and Atg7-Atg3. Analogous to ubiquitination, Atg12 is 
conjugated to Atg5 by Atg7—an E1-like protein—and Atg10—an E2-like protein [172]. The 
Atg7-Atg3 conjugation system catalyses the conjugation of the microtubule-associated 
protein L chain 3-I (LC3-I) to phosphatidylethanolamine to generate the membrane-bound 
lipid form, LC3-phosphatidylethanolamine, also called LC3-II [173]. This ultimately leads to 
membrane closure and fusion of the mature autophagosome with the lysosome, where the 
cargo is degraded by lysosomal hydrolases. A simplified scheme of the autophagy process is 
shown in Figure 1.1.  
Depending on the context and the cytoplasmic material engulfed, two form of 
autophagy can be distinguished - selective autophagy and non-selective autophagy. Selective 
autophagy described the degradation of particular organelles or content such as 
mitochondria, ER, aggregates, Golgi, etc. These processes have been named according to the 
organelle engulfed (mitophagy, ER-phagy, aggrephagy, Golgi-phagy etc).  
In budding yeast, flies and some mammalian cell lines, VPS34 is critical for autophagic 
processes by providing the main source of PI3P [174]. The level of PI3P is tightly controlled by 
VPS34 as well as Jumpy and MTMR3, two PI3P phosphatases, and determines the size and the 
production rate of autophagosomes, and inhibition of PI3P phosphatases enhances 
autophagy [175], [176]. During vesicle nucleation and autophagosome biogenesis, PI3P 
synthesis allows the recruitment of effector proteins harbouring PI3P-binding domains, such 
as DFCP1 (double FYVE-containing protein 1) or WIPI1-2 (WD-repeat protein interacting with 
phosphoinositide) [177], [178]. These proteins promote autophagosome maturation and 
serve as a scaffold for the recruitment of Atg proteins required for the downstream steps. 
PI3P is also continuously required during the maturation step, where it regulates the 
trafficking of autophagosomes and their fusion with the lysosome [179]. However, alternative 
pathways mediate this process as it has been reported that other lipids, in particular PtdInsI4P 
and PtdInsI5P, are also involved in autophagosome formation [180]–[183]. 
While the role of VPS34 is well documented for budding yeast, it is less straight 
forward to assess the role of VPS34 in mammalian cell types due to the redundancy of PI3P 




sources (PI3K class II has also been shown to contribute to PI3P production, however at a very 
low level); and the possible role(s) of VPS34 beyond autophagy and endocytosis. Genetic 
mouse models have brought insights into the in vivo role and function of mammalian VPS34: 
VPS34 null mutants are prenatally lethal (between E7.5 and E8.5) [184]; Tissue-specific 
deletions have shown that in heart and liver, VPS34 is essential for autophagy and the 
functioning of these organs [185]; VPS34 deletion in sensory neurons leads to neuron 
degeneration, due to a drastic defect in the endo-lysosomal pathways. However, sensory 
neurons lacking VPS34 were still able to form LC3-positive autophagosomes, due to an 
alternative pathway that requires Atg7 and the conventional conjugation system [186].  
 
 
Figure 1.1: Overview of the autophagy process.  
Autophagy is initiated by various conditions of stress, including starvation, hypoxia, oxidative stress, 
protein aggregation, and endoplasmic reticulum (ER) stress.  Recruitment of the Unc-51-like kinase 1 
(ULK1) complex (consisting of ULK1, autophagy- related protein 13 (ATG13), RB1-inducible coiled- coil 
protein 1 (FIP200) and ATG101, not displayed in the scheme), and Atg9 to the omegasome triggers the 
nucleation of the phagophore by phosphorylating components of VPS34 complex I (consisting of 
vacuolar protein sorting 34 (VPS34), VPS15, Beclin 1, and ATG14). Together with the activating 
molecule in Beclin 1-regulated autophagy protein 1 (AMBRA1)), VPS34 complex I activates the 
production of PI3P at the omegasome. PI3P then recruits the PI3P effector proteins WD repeat domain 
phosphoinositide- interacting proteins (WIPIs) and zinc-finger FYVE domain-containing protein 1 
(DFCP1) to the omegasome via interaction with their PI3P- binding domains. WIPI binds ATG16L1, 
which subsequently recruits the ATG12~ATG5–ATG16L1 complex that induces the conjugation of the 
microtubule- associated protein light chain 3 (LC3-I) protein to membrane- resident 




phosphatidylethanolamine (PE), thus forming the membrane-bound, lipidated form of LC3 (LC3-II).  
The cargo to be degraded is sequestered (e.g. malfunctioning mitochondria), and sealing of the 
autophagosomal membrane gives rise to a double-layered vesicle called the autophagosome, which 
matures and finally fuses with the lysosome, giving rise to the autolysosome were acidic hydrolases 
degrade the autophagic content, and nutrients are released back to the cytoplasm to be used again 
by the cell. Scheme based on Dikic and Elazar [187]. 
 
Autophagy is a tightly controlled process induced upon stress signals. The master regulators 
that integrate these signals to modulate autophagy activation are mTORC1 and AMPK. 
mTORC1 is critical to direct the balance of catabolic and anaerobic activities. In nutrient rich 
conditions, mTORC1 is activated and phosphorylates S6K1 and 4E-BP1, which in turn trigger 
the synthesis of proteins, lipids, and nucleotides. mTORC1 represses autophagy by 
phosphorylating UNC51-like Ser/Thr kinase (ULK1), responsible for autophagy initiation [188], 
and the transcription factor EB (TFEB), which triggers transcription of genes involved in 
lysosome biogenesis [189]. On the other side, AMPK positively regulates autophagy. AMPK is 
activated by cellular stress and an imbalance in the cell energy status, such as a low ATP/AMP 
ratio, and the depletion of glucose (which drops the ATP/AMP ratio) by phosphorylation via 
LKB1 (liver kinase B1) [190]. Once activated, AMPK phosphorylates and activates the TSC2 
complex, which inhibits mTORC1. Moreover, AMPK can directly phosphorylate Raptor, the 
regulatory subunit of mTORC1 complex, at S863, which has an inhibitory effect on the 
mTORC1 complex [191].In addition, it can directly activate ULK1 by phosphorylation [192], 
[193].  
After induction of autophagy, ULK1 complex (formed of ULK1, FIP200, Atg13 and 
Atg101) is activated and translocates from the cytoplasm to the omegasome until completion 
of the phagophore. ULK1 act as a platform for the recruitment of the machinery necessary for 
autophagosome formation. It recruits and positively regulates VPS34 activity by 
phosphorylating Beclin1 at S14 [194] and S30 [195], ATG14L at S29 [196], and by directly 
binding to VPS34 complex I [197]. ULK1 also phosphorylates Raptor at multiple sites, 
preventing the binding of Raptor to mTORC1 substrates [198].ULK1 also regulates Atg9 
trafficking, a transmembrane protein that travels from the Golgi, endosomes or Atg9 positive 
membranes to autophagic structures (omegasome, phagophores and autophagosomes). Atg9 
function is still unclear but has been suggested to deliver components to the recruited 
locations and to participate in membrane scaffolding [199]. 




ULK1 is indirectly recruited to the omegasome by the Golgi apparatus. WAC and 
GM130, two proteins located at the Golgi apparatus, regulate a pool of GABARAP (a member 
of the Atg8 family) that traffics to the centrosome. The non-lipidated centrosomal GABARAP 
binds then the omegasome, where it recruits ULK1 by its LIR (LC3 interacting region) domain 
[177]. Upon recruitment and activation by ULK1 at the omegasome, VPS34 produces PtdIns3P 
that serves as a platform for FYVE and PROPPIN domain – containing proteins, such as DFCP1 
or WIPI2. WIPI2 directly binds Atg16L1 [200], a critical step for the induction of the autophagic 
flux [201].   
The elongation of the phagophore relies on two ubiquitin-like conjugation systems. 
Cytosolic precursor Atg8 proteins (LC3/GABARAP) are cleaved by Atg4, a cysteine protease, 
exposing a Gly residue at the C-terminal region of Atg8. Cleaved Atg8 binds to Atg7 (an E1-
like enzyme), is then transferred to Atg3 (an E2-like enzyme) and conjugated to the 
membrane-bound form of phosphatidylethanolamine (PE) through the activity of Atg12-Atg5-
Atg16L1 system (which acts as an E3-like enzyme). The formation of the ATG16L1 complex 
start with the linking of Atg12 and Atg7 through a thioester bond, giving rise to an Atg12-Atg7 
intermediate complex. Atg12 is then transferred to Atg10 (an E2-like enzyme). Atg5 has an 
acceptor Lys, where Atg12 is finally conjugated via an isopeptide bond, and two sets of the 
Atg12-Atg5 complex bind to Atg16L1 for form one Atg16L1 complex [202], [203].  
The initiation, nucleation and expansion steps of autophagy are followed by the 
maturation of the autophagosome and fusion with the lysosome, critical for degradation of 
the engulfed materials. Lipidated members of the LC3 family are crucial for the expansion and 
the closure of the phagophore. They associate with protein membranes where they act as an 
anchor for cargo receptors (SARs) such as p62 as well as other proteins like ULK1, VPS34, 
ATG14L, Beclin-1, Atg4 or Atg12-Atg5 to autophagic membranes.  
The recruitment to and the fusion of the autophagosome with the lysosome requires 
changes in lysosomal pH, tethering factors such as the HOPS complex and RAB7, cytoskeleton 
motor proteins such as dynein, phospholipids including PtdIns3,5P2, the SNARE complex, and 
LC3 [177], [204], [205]. When the autophagosomal membrane fuses with the lysosome, giving 
rise to a so-called autolysosome, lysosomal hydrolyses degrade the engulfed 
material/organelles [177], [206] and export the obtained amino acid, nucleic acids, etc. to the 
cytoplasm [189]. 




To maintain their structure and identity, lysosomes undergo autophagosome-
lysosome reformation (ALR). PtdIns4P and PtdIns(4,5)P2 orchestrate the induction of the 
autolysosome tubulation [207], [208], and PtdIns4P provides the substrate for the PIP5K1A 
kinase, which drives tubule scission together with the VPS34 complex II. Microtubules are 
necessary for ALR [209], and Dynamin2, a GTPase that mediates scission of cellular 
membranes and that can be activated by PtdIns3P, PtdIns4P, or PtdIns(3,4)P2, is involved in 
the process of tubule scission [210]. 
 
1.5.3 The role of autophagy in T cell activation 
The first evidence that autophagy is taking place in T cells was provided by Li and colleagues 
who observed the formation of autophagosomes in Th1 and Th2 cells upon in vitro activation 
with αCD3/αCD28, leading to the conclusion that  TCR signalling induces autophagy in effector 
CD4+ T cells [211]. These observations were confirmed subsequently by several studies, as 
well as shown to hold true for human primary CD4+ T cells as well. Together with Pua et al., 
who demonstrated the presence of lipidated LC3 in primary mouse CD4+ T cells cultured in 
the presence of αCD3 [212], Li et al. reported that the key autophagy genes Atg5, Atg7, Beclin-
1, and LC3 are expressed in CD4+ T cells [211], [212]. Downregulation of these genes and 
inhibition of Jun amino-terminal kinase (JNK)/mitogen-activated protein (MAP) kinase 
pathways or PI3-kinase could inhibit autophagy in CD4+ T cells, while inhibition of mTOR led 
to autophagy induction [211]. TCR-activation induces the expression of Beclin-1 [213] and LC3 
protein levels and promotes TCR-driven proliferation of CD4+ T cells. Indeed, Atg5-deficient 
CD4+ T cells display impaired proliferation following in vitro TCR activation with αCD3/αCD28 
and IL-2. However, autophagy inhibition did not alter TCR-driven activation of CD4+ T cells, as 
cell surface expression of the activation markers CD25 and CD69 were not altered [212]. 
These observations were confirmed in other mouse models of Atg3, Atg5, Atg7 and VPS34 
deletion in CD4+ T cells [171], [214]–[217]. Published finding about how autophagy regulates 
effector and regulatory CD4+ T cell activation, differentiation and effector functions are 
summarized in Table 1. 1. 
 
 




Table 1.1: Summary of autophagy-related knock-out mouse models in T cells. 
Deletion strategy Phenotype Authors & Reference 
ATG3 
Lck-Cre Atg f/f   
or ER-Cre Atg3f/f 
 
- Reduced survival of naive CD4+ and CD8+ T 
cells 
- Expanded mitochondria and ER 
- In vitro: temporal accumulation of 
mitochondria and ER beginning 10 d after 
the deletion 
- cell death does not begin to increase until 
>3 week after deletion 
- proliferation defect 
 
Jia et al. [171] 
ATG5 






































- Enhanced CD8+ T cell apoptosis in the 
periphery 
- Inability of CD4+ and CD8+ T cells to 
undergo TCR-induced proliferation 
 
 
- Reduced survival of CD8+ T cells but no 
influence on CD4+ T cell numbers and 
short-term activation 
- Autophagy in CD4+ T cells is required to 
transfer humoral memory 
- Mitochondrial and lipid load defects in in 
vitro differentiated memory CD4+ T cells, 
compromised survival, without any 
collapse of energy production 
 
- Intact proliferation and function of 
effector cells 
- Reduced memory T cells 
 
 
- Decreased thymocyte and peripheral T cell 
numbers, and decrease in cell survival 
- Increased mitochondrial mass in 
peripheral T cells 
 
- Decreased peak effector response 
-  Reduced cell viability during effector 
phase 
- Impaired effector-to-memory cell survival 
- Upregulation of p53, resulting in high ROS 
levels and ROS-dependent apoptotic cell 
death 
 
- Same observations as for FoxP3-Cre Atg7f/f 
(published by the same authors) 
 


































Wei et al. [152] 
























































- Enhanced apoptotic death in mature CD4+ 
and CD8+ T cells 
- Increased mitochondrial content in 
autophagy-deficient CD4+ and CD8+ T 
cells, resulting in increased ROS 
accumulation and cell death 
 
- Increased ER content in mature T 
lymphocytes 
- Deregulated stimulation-induced calcium 
influx and efflux 
- Autophagy regulates calcium mobilization 
in T lymphocytes through controlling ER 
homeostasis 
- Failure of T cell proliferation in vitro 
- Failure of CD8+ T cells to enter into S-phase 
after TCR stimulation 
- Accumulation of the cell-cycle inhibitor 
CDKN1B (Cyclin-dependent kinase 
inhibitor 1B) 
 
- Reduced thymocytes and peripheral T cell 
numbers 
- Decreased IL-2 and IFN-γ production and 
defective activation-induced cell 
proliferation in vivo and in vitro 
- Macroautophagy activation is required to 
ensure sufficient energy production 
during T cell activation 
- Decreased proliferation in response to 
TCR stimulation 
 
- Similar observations to Lck-Cre Atg5f/f 
(published by the same authors) 
 
 
- Similar to GzmB-Cre Atg5f/f mice: intact 
proliferation and function of effector cells 
but reduced memory T cells 
- Dysregulated lipid metabolism, 
mitochondrial FAO, glucosamine 6-
phosphate, and glycan-biosynthesis 
pathways 
 
- Peripheral T cell lymphopenia, leading to 
proliferation and an activated phenotype 
- Failure to establish CD8+T cell memory to 
influenza and MCMV infection 
- Autophagy is highest in antigen-specific 
CD8+ T cells 
 




























































- Increased cell death at the time of 
memory formation, 
- Compromised mitochondrial health 
- Increased expression of GLUT1 
 
- Increased apoptosis of Treg cells 
- Lymphoid hyperplasia, increased 
cellularity of the spleen and peripheral 
lymph nodes, and increased 
effector/memory CD4+ and CD8+ T cells 
- Loss of Foxp3, Foxo, and Bach2 expression, 
especially after activation 
- Upregulation of the metabolic regulators 
mTORC1 and c-Myc and glycolysis, 
contributing to defective Treg function 
- Enhanced glycolytic metabolism results in 
lineage destabilization and loss of effector 
function 
- Normal proliferate upon in vitro TCR 
stimulation with αCD3/CD28 + IL-2 and 
after adoptive transfer into Rag1−/− mice, 
suggesting that Atg7 may be dispensable 















- Chronic intestinal inflammation 
accompanied by aberrant type 2 
responses toward commensal and dietary 
antigens 
- Loss of Foxp3+ Treg cells 
 
- Aberrant mucosal TH2 cell expansion 
- Reduced survival and impaired metabolic 
adaptation to the intestine 
- Enhanced glycolytic metabolism results in 
lineage destabilization and loss of effector 
function 
 
Kabat et al. [224] 
Beclin-1 
 
Rag1−/− blastocysts injected 
in Beclin-1−/− ESCs and 











- Reduction in thymic cellularity: impaired 
maintenance of lymphoid progenitors in 
vivo and in vitro 
- Normal in vitro proliferation of peripheral 
T cells  
-  Reduced autophagic activity (reduced LC3 
staining) 
 
- No differences in thymic development, 
but decrease in CD4+ and CD8+ T cells in 
the spleen and lymph nodes 










Kovacs et al. [226] 




- Increased apoptosis upon TCR stimulation 
due to increased cell death-related 
proteins (procaspase-3, caspase-8, 
capsase-9, and Bim) 
- Th1 more susceptible to cell death than 
Th17 
VPS34 





























CD4-Cre Pik3c3 Δ4 
 
 
- Increased T cell death and reduced 
proliferation 
- Impaired IL-7Rα trafficking, signalling, ad 
recycling 
- Mislocalized intracellular EEA1, HGF-
regulated tyrosine kinase substrate, and 
Vps36 
- Intact autophagy (TCR stimulated 
autophagy, starvation-induced, basal 
autophagy) 
 
- Reduced stability of Vps15 and Beclin-1 
- Dispensable for T cell development but 
important for the survival of naïve T cells 
- Impaired autophagy in T cells 
- increased mitochondrial mass and 
accumulation of ROS 
 
- inflammatory wasting syndrome 
characterized by weight loss, intestinal 
inflammation, and anemia 
- severe defects in autophagic flux and 
accumulation of cellular organelles 
- normal intrathymic development of 
CD4+ and CD8+ T cells but impaired 
development of iNKT cells 
- Impaired peripheral homeostasis and 
function of Treg cells 
 
- Impaired cellular metabolism 
- CD4+ T cells failed to differentiate into T 
helper 1 cells 
- reduced levels of active mitochondria 
upon T cell activation 
 
 








































1.5.4 VPS34 in endocytosis 
Endocytosis is a process by which eukaryotic cells take up macromolecules and particles from 
the surrounding medium [230]. During endocytosis, extracellular material is internalized by 
plasma membrane which buds off inside the cell and the cargo might be recycled to the cell 
surface, trafficked to the trans-Golgi network (TGN) through the retrograde system, or sorted 
to multivesicular bodies (MVBs)/late endosomes for lysosomal degradation [231]. Different 
lipid phosphatases and kinases contribute to the endocytic trafficking. For instance, 
PtdIns(4,5)P2 is enriched at the plasma membrane where it recruits proteins of the clathrin-
mediated endocytosis (CME) pathway; PtdIns3P is present at early endosomes and 
intraluminal vesicles (ILVs) and recruits proteins containing FYVE or PX domain (such as EEA1 
or HRS). 
The endosomal VPS34 complex (complex II) comprising VPS34, VPS15, Beclin-1 and 
UVRAG assembles at the early endosome by associating with Rab5-GTP to generate PI3P 
[154]. Rab5 interacts with VPS15 of the endocytosis complex, thereby increasing the synthesis 
of PI3P at this site. Endosomal PI3P recruits various downstream effector molecules such as 
EEA1, HRS, endosomal SNXs, and ESCRT proteins. These proteins directly bind to PI3P via their 
FYVE or PX domains, and regulate endosomal fusion, intralumenal vesicle formation, 
tubulation, and maturation [232], [233]. 
Endosomal maturation from early to late endosome depends on PI3P and is 
accompanied by the conversion from the early endosomal Rab5 to the late endosomal Rab7 
[234], and cargo sorting into intraluminal vesicles mediated by the ESCRT complex. This 
process is partially regulated by VPS34. As small GTPases, Rab5 and Rab7 need GAP and GEFs 
to modulate their activity [235]. VPS15 binds to the activated form of Rab5 [236], [237], which 
consequently recruits the VPS34 complex. VPS34 is also able to interact with Rab7 through 
VPS15 [238], and recruits Armus to repress Rab7 activation in mammals [239].  
Rab7 recruits RILP (Rab-interacting lysosomal protein) to mediate the fusion with the 
lysosome. PI3P also promotes translocation of late endosomes/lysosomes to the cell 
periphery by promoting the contact between late endosome and lysosomes to the 
endoplasmatic reticulum (ER) via the kinesin adaptors protrudin and FYCO1 [240]. Fusion of 
the late endosomes with lysosomes is depending on the conversion of PI3P to PI(3,5)P2 on 




the late endosome, a process dependent on the PI(3)P 5-kinase PIKFYVE. A simplified scheme 
of the endocytic process is shown in Figure 1.2. 
Lack of VPS34 protein or its kinase activity in yeast and flies results in defective 
endosomal sorting [241]. In mammalian cells, VPS34 inhibition results in impaired 
endolysosomal trafficking and recycling [238], [242] while VPS34 deletion in sensory neurons 
disrupts the endolysosomal pathway [186]. In the immune system, VPS34 is important for 
phagocytosis by generating PI3P at the phagosomal membrane [243]. While the initial step in 
phagosome formation is dependent in PI3K class Ia, maturation requires VPS34-generated 
PI3P [244]. PI3P is also important for the activation of the NOX2 NADPH oxidase, which 
generates reactive oxygen species (ROS) required for the destruction of the content of 
phagosomes [245]. More specifically, the PX-domain containing p40 subunit of NOX2 requires 




Figure 1.2: Overview of the endocytosis process.  
Extracellular material is trafficked into the cell by clathrin-mediated endocytosis (relying on plasma 
membrane PI(4,5)P2 and PI(3,4)P2 generated by the class II PI3K), and sorted into PI3P-enriched early 
endosomes. The majority of PI3P is generated by the class III PI3K VPS34 complex II (including VPS34, 
VPS15, Beclin-1, and UVRAG), which assembles at the early endosomes via association of VPS15 with 




Rab5-GTP. Endosomal PI3P recruits various downstream effectors, including early endosome 
autoantigen 1 (EEA1), the ESCRT component hepatocyte growth factor-regulated tyrosine kinase 
substrate (Hrs), endosomal SNXs, and ESCRT proteins. Endosomal maturation is accompanied by the 
conversion of the early endosomal Rab5 to late endosomal Rab7, and cargo sorting into intraluminal 
vesicles is mediated by the ESCRT complex, two processes critically depending on PI3P. ESCRT proteins 
mediate the inward vesicle budding to generate multivesicular bodies (MVBs) and PI3P promotes the 
contact between late endosomes/lysosomes and the endoplasmatic reticulum (ER) via the kinesin 
adaptors protrudin and FYCO1, enabling the microtubule-dependent translocation of late endosomes 
and lysosomes to the cell periphery. Rab7 recruits RILP (Rab-interacting lysosomal protein) to mediate 
the fusion with the lysosome. Fusion of the late endosome with lysosomes is depending on the 
conversion of PI3P to PI(3,5)P2 on the late endosome, a process mediated by the PI(3)P 5-kinase 
PIKFYVE. Fusion with the lysosome gives rise to the autolysosome, were acidic hydrolases degrade the 
endosomal content. Scheme based on Wallroth and Haucke [231].  




1.5.5 VPS34 in cytokinesis 
Cell division by mitosis ends in a very complex physical separation of the two daughter cells, 
a process referred to as cytokinesis. Cytokinesis starts in the anaphase, with the assembly and 
the activation of the actomyosin contractile ring, that leads to the formation and the cleavage 
of the furrow ingression. Furrow-associated membrane trafficking and phosphoinositides 
have been shown to be an essential feature of cytokinesis. PI3P was suggested to regulate 
cytokinesis based on the observations that PI3P-positive endosomes are present at the 
intercellular bridge (ICB) [247]. Although still not fully understood, PI3P might be required for 
the recruitment and assembly of the ESCRT-III complex during abscission [248]. PI3P also 
recruits several effector proteins to endosomes, such as FYVE-CENT, ensuring their delivery 
to the ICB [249]. In return, FYVE-CENT binds and recruits several other effector proteins, i.e. 
TTC19, Beclin-1, VPS15, and UVRAG, which are known to regulate protein degradation and 
the recruitment of the  ESCRT-III complex [250]. Interestingly, FYVE-CENT also can bind and 
directly recruit VPS34. Thus, the FYVE-CENT/VPS34 complex is probably involved in a positive-
feedback loop that is critical to maintain high concentrations of PI3P within the cleavage 
furrow. 
 
1.5.6 VPS34 in T cells 
In the immune system, autophagy is a process essential for the development and function of 
T lymphocytes. It is a mechanism required for the clearance of intracellular pathogens, 
presentation of exogenous antigens [251], and cross-presentation of endogenous antigens by 
MHC class II molecules [252], [253]. It regulates the calcium mobilization and energy 
metabolism in T cells, is critical for effector CD8+ T cell survival and memory formation, 
promotes the proliferation and survival of NKT cells, and downregulates T cell receptor (TCR) 
signalling through degradation of Bcl10. 
The role of VPS34 in T cell immunity has been investigated using mouse models with 
T cell specific deletion of VPS34 [227], [228], [254]. McLeod et al. used a mouse model where 
exons 17 and 18 of Pik3c3 was deleted in T cells through the activity of the Cre-recombinase 
expressed under the Lck promoter [227]. This led to a severely reduced numbers of CD4+ and 
CD8+ T cells in spleen and lymph nodes. Analysis of freshly-isolated T cells showed an increase 




in apoptosis, a phenotype already observed in autophagy-deficient T cells (Atg5- or Atg7-null 
mutants), along with impaired proliferation, increased apoptosis, and failure to clear 
defective mitochondria [255], [256]. 
TCR stimulation and starvation induced comparable levels of LC3 puncta in VPS34Δ17,18 
and wild-type T cells, suggesting that these forms of autophagy are intact in the absence of 
VPS34 activity [227]. Similarly, basal autophagy, determined by the presence of 
autophagosomes by electron microscopy, seemed to be intact in VPS34Δ17,18 T cells. The 
authors suggested that reduced T cell survival arises from a defect in endocytosis, as they 
observed a reduction in cell surface expression of IL-7Rα due to impaired receptor trafficking 
and recycling to the cell surface [227]. However, two other studies challenged these 
observations: Willinger and Flavell [228] and Parekh et al. [254] deleted VPS34 in T cells by 
using a system where the Cre-recombinase is expressed under the CD4 promoter and exon 4 
of Pik3c3 is flanked of LoxP sites. In VPS34Δ4 T cells, the authors observed a reduction in the 
autophagic flux [228], challenging the observed ‘normal’ formation of LC3 punctae in 
VPS34Δ17,18 T cells. The suggested role of VPS34 in IL-7Rα trafficking and recycling was 
challenged by a study showing that VPS34-deficient T cells from mixed bone marrow chimera 
expressed normal cell surface levels of IL-7Rα [228]. This implies that the observed reduction 
of IL-7Rα is caused by the lymphopenic environment rather a cell-intrinsic role for VPS34. 
Meanwhile, both studies reported a role of VPS34 in autophagy, as the autophagic flux was 
reduced in VPS34-deficient T cells [228], [254]. Intact autophagic flux is required for 
autophagosome production and removal of damaged or excessive mitochondria. When 
impaired, it results in increased ROS production eventually leading to cell death.  
Figure 1.3 displays the domain organization of VPS34, highlighting in red the exons 
floxed in the different mouse models used to investigate the role of VPS34. The differences 
in targeting strategies might explain the observed discrepancies between the different studies 
described above: impaired autophagy was reported in studies using a mouse model with Cre-
mediated deletion of exon 4 (VPS34Δ4) while defective endocytosis was observed in 
VPS34Δ17,18 T cells. Deletion of exon 4 could lead to a truncated protein unable to bind its 
protein partners. It has been show that the binding to VPS34 is necessary for the stability of 
Beclin-1, and lack of VPS34 lead to a reduction in Beclin-1 levels [257]. Beclin-1 is 
independently involved in autophagy, and Beclin-1 reduction might be a possible explanation 




for the observed defect. Meanwhile, deletion of exon 17 and 18 could lead to a mutated 
version of VPS34 that can still bind and stabilize Beclin-1.  
 
Figure 1.3: VPS34 structure and targeting strategies.  
a) Domain organization and 3D structure of VPS34. b) 3D structure of VPS34 highlighting in red the 
exons floxed in the different mouse models used to investigate the role of VPS34. DeepView 
/SwissPdbViewer (v4.1.0) was used to create the 3D models [258].   




1.6 Questions, Hypotheses and Objectives 
1.6.1 Role of VPS34 in Treg cells: What are the molecular mechanisms underlying the fatal 
lympho-proliferative disease observed in mice with VPS34-deficient Treg cells? 
While the biology and the functions of the class I PI3-kinases have been extensively studied 
and are well understood, less is known about class II and class III PI3-kinases, and even less in 
the context of the immune system.  
A previous study conducted in aged CD4Cre Pik3c3fl/fl mice suggested that VPS34 
controls T cell homeostasis, probably by regulating canonical autophagy, and has an effect on 
the number and effector functions of Treg cells, as these mice developed a wasting phenotype 
[254]. However, so far, no definite role for VPS34 in Treg cells has been proposed.  
The cell-intrinsic role of VPS34 in Treg cells was investigated by Elisabeth Slack, a previous 
PhD student in the laboratory of Klaus Okkenhaug. She used a mouse model in which exon 21 
of Pik3c3 is conditionally excised under the action of FoxP3-induced Cre recombinase. These 
mice suffered from an autoimmune lymphoproliferative disease and died within 6 weeks, 
similar to mice lacking Treg cells. However, VPS34-deficient Treg cells developed normally, 
populated the peripheral lymphoid organs. This suggested that VPS34 is intrinsically required 
for effective suppressive functions of Treg cells.  
 
My aim was to continue the work that Elisabeth Slack and Dr. Priya Schoenfelder (a postdoc 
that continued Elisabeth’s work) had started and further dissect the role of VPS34 in Treg 
cells, concentrating on the following questions: 
1) Which (novel) suppressive mechanism(s) of Treg cells is/are impaired by the deletion 
of VPS34? 
2) Which further proteins are involved in processes relying on VPS34? 
The approaches used to study these questions and the results obtained are presented in 









1.6.2 Role of VPS34 in activated CD8+ T cells: Is VPS34 required for CD8+ T cell function 
and/or memory formation? 
Upon clearance of pathogens or malignant cells, most effector CD8+ T cells undergo apoptosis 
and only a small pool of cells remains that survive and differentiate into memory cells [71], 
[76], [259]. During this naïve-to-effector-to-memory – differentiation process, CD8+ T cells 
undergo a cellular and metabolic reprogramming, i.e. a shift from anabolic processes and 
proliferation, to catabolic processes and contraction of the population size [219]. Using a 
mouse model where Atg5 or Atg7 is specifically depleted in antigen-specific CD8+ T cells, Xu 
et al. [219] reported that autophagy is required for the formation of memory CD8+ T cells, 
while it is dispensable for effector functions of cytotoxic T lymphocytes (CTLs). Therefore, I 
aimed to investigate the role of VPS34 in activated CD8+ T cells using a Granzyme B-Cre 
recombinase system, in which naïve T cells develop normally and exon 21 of Pik3c3 is deleted 
only after activation of CD8+ T cells. In order to explore the role of VPS34 during the 
recruitment, the expansion and the activation of CD8+ T cells in vivo, I used two different 
experimental strategies to analyse the numbers and phenotype of CTLs responding to an 
antigenic stimulus in vivo. First, I analysed antigen-specific CD8+ T cells that have undergone 
clonal expansion in response to infection with Listeria monocytogenes expressing Ovalbumin 
(Lm-OVA) using antigen-specific MHC-II tetramers. I investigated the primary and, upon re-
challenge, development of the secondary immune answer and immune memory formation. 
Secondly, I implanted GzmBYFP-Cre Pik3c3fl/fl mice subcutaneously with a syngeneic tumour cell 
line expressing the model antigen ovalbumin. CTLs infiltrate the tumour and become 
activated by cognate antigens expressed by the cancer cells. I used both models to assess 
whether VPS34-deficiency affects the activation, effector functions and/or memory 
formation of CD8+ T cells. Finally, I supplemented in vivo experiments with in vitro analyses of 
activated CD8+ T cells. 
 
Since, to the best of my knowledge, the role of VPS34 in activated CD8+ T cells has not been 
investigated yet, I had only one, but for the furthest broad, question: ‘What is the role of 









Material and Methods 
  





2.1.1 Deletion of VPS34 
Mice with a floxed version of the exon 21 of the Pik3c3 gene (Pik3c3fl/fl mice) were crossed to 
mouse strains expressing the Cre-recombinase under the promoter of a cell type-defining 
protein to achieve cell type-specific deletion of VPS34. Exon 21 encodes a critical stretch 
(Ala730 to Thr754) of the VPS34 kinase domain. The floxed region comprised 75 base pairs, 
resulting in the in-frame deletion of 25 amino acids. This strategy was designed to create a 
kinase-dead truncated mutant VPS34 protein that retains its scaffolding properties and thus 
its ability to bind to Beclin-1 and VPS15. These mice were kindly provided by Bart 
Vanhaesebroeck. 
 
2.1.2 Conditional depletion of VPS34 in regulatory T cells 
Pik3c3fl/fl mice were crossed to FoxP3Cre-YFP transgenic mice to generate FoxP3YFP-Cre Pik3c3fl/fl 
mice where VPS34 is deleted specifically in Treg cells. In FoxP3Cre-YFP transgenic mice, the 3’ 
UTR of the FoxP3 locus harbours a viral IRES followed by a yellow fluorescent protein (YFP)-
Cre recombinase fusion protein. The location of FoxP3 on the X chromosome enabled the 
breeding of heterozygous FoxP3YFP-Cre/wt female offspring with VPS34-deficient and VPS34-
sufficient Treg cells arising from a common environment.  
 
2.1.3 Conditional depletion of VPS34 in activated CD8+ T cells 
To generate mice with a conditional depletion of VPS34 in activated CD8+ T cells, Pik3c3fl/fl 
mice were crossed to a mouse strain expressing the transgene encoding the Cre recombinase 
under the Granzyme B promoter and a ROSA26-loxP-STOP cassette followed by the transgene 
for enhanced YFP (eYFP) to generate GzmBYFP-Cre Pik3c3fl/fl mice. 
 
2.1.4 Housing and husbandry 
FoxP3Cre-YFP Pik3c3fl/fl mice were used at 3.5–5.5 weeks old unless otherwise noted, with the 
age- and gender-matched wild-type mice containing the FoxP3Cre-YFP allele as control. Other 
mice were used at 8–12 weeks old unless otherwise noted. Breeding and in vivo procedures 
were carried out in accordance with the United Kingdom Home Office Regulation Office. Mice 




were maintained in pathogen-free conditions at the Biological Service Unit of the Babraham 
Institute, the Veterinary School (MIRA) facility, and the Gurdon Institute of the University of 
Cambridge. Mice were euthanized by exposure to carbon dioxide, followed by cervical 
dislocation, or cervical dislocation followed by destruction of the brain.  
 
2.1.5 Genotyping 
Genotyping was performed by Transnetyx (www.transnetyx.com) using real-time PCR. 
 
 
2.2. Isolation of cells 
Mice were euthanized according to a Schedule 1 method and spleen, thymus, lymph nodes 
(axillary, cervical, brachial, and inguinal) and were applicable tumours were harvested in PBS 
or RMPI-1640. Distinct population of cells were enriched for by magnetic-activated cell 
sorting (MACS) using cell-type specific kits from Miltenyi or StemCell. In both cases, 
manufacturers’ protocol was followed. To increase the purity of the isolated cell population, 
cell enrichment was followed by fluorescence-activated cell sorting (FACS) when required. 
 
2.2.1 Magnetic-activated cell sorting (MACS) using Miltenyi kits 
Following preparation of single cell suspensions, cells were resuspended at 1x108 cells/ml in 
MACS buffer and incubated with 1 µg/ml biotin-conjugated αCD8 or αCD4, αB220, αDX5 and 
αMHC-class II (Ia/b) (all from BioLegend) for 30 minutes at 4 ⁰C. Samples were washed, 
centrifuged for 5 minutes at 500 g and incubated with anti-Biotin MicroBeads (Miltenyi 
Biotech) for 30 mins at 4 ⁰C. Cells of interest were negatively selected using LS separation 
columns and MidiMACSTM Separator (Miltenyi Biotech) in accordance to the manufacturer’s 
instructions. 
 
2.2.2 Magnetic-activated cell sorting (MACS) using EasySep® (StemCell) kits 
Briefly, cells in single cell suspensions were resuspended at 1x108 cells/ml in FACS buffer, 
transferred to FACS tubes and 50µl/ml Rat Serum was added. 25µl/ml of the Isolation Cocktail 
was added and cells were incubated for 10mins at room temperature. RapidSheresTM were 




vortexed for 30 seconds, 37.50µl/ml added to the cells and incubated at room temperature 
for 2.5 minutes. Samples were topped-up with up to 2.5ml FACS buffer, tubes were placed in 
the magnet and incubated for 2.5 minutes at room temperature to allow separation. In a 
continuous motion, the magnet was inverted and the enriched cell suspension was 
transferred to a fresh tube. 
 
2.2.3  Fluorescence activated cell sorting (FACS) 
Following single cell preparation and immune-magnetic enrichment (where applicable), cells 
were stained with the appropriate surface antibodies for FACS sorting depending on the 
experiment. Cells were incubated for 45 minutes at 4°C, washed twice with FACS buffer, and 
passed through 30μm filters (Partec CellTrics) to remove cell clumps. Cells were resuspended 
in 500ul of FACS buffer containing 5% FCS and cell sorting was carried out on a BD Aria IIu (BD 
Biosciences) or MoFlo Astrios (Beckman Counter) cell sorter.  
For experiments using GzmBYFP-Cre Pik3c3fl/fl mice, viable CD8+ CD62Lhigh CD44low were FACS 
sorted for subsequent in vitro stimulation with αCD3/CD28. For Western blot analysis or DNA 
isolation, viable CD8+ CD44high YFP+ cells were FACS sorted.  
For in vitro Treg cell differentiation assays, viable CD4+ CD62Lhigh CD44low were FACs sorted. 
For proteomic profiling of Treg cells from mosaic FoxP3YFP-Cre/wt Pik3c3fl/fl mice, DNA isolation 
for PCR, metabolic analysis by SeaHorse or protein analysis by Western blot, viable CD4+ 
CD25+ YFP+ cells were FACs sorted. Cells were collected in Falcon tubes contained 1ml RPMI 
with 5% FCS.  
 
 
2.3 Staining and analysis by flow cytometry 
2.3.1 Staining for cell surface markers 
Single cell suspensions from spleen, thymus and lymph nodes was prepared by passing the 
organs through a 40µm cell strainer (BD Falcon) using the plunger from 2.5 ml syringes into 
FACS buffer (2% v/v foetal calf serum (FCS, heat inactivated, LabTech) in PBS). Red blood cells 
were lysed with 1 ml/spleen ACK buffer (Sigma-Aldrich) and stopped after 5 minutes by 
adding FACS buffer. Staining for flow cytometry was performed in 96 well plates (round 




bottom, Greiner). Samples were centrifuged for 3 minutes at 540 x g and supernatant 
discarded. The cell pellet was resuspended in 50 µl staining FACS buffer containing the 
appropriate fluorochrome-conjugated antibodies, αCD16/CD32 to block unspecific Fc 
receptor binding and a fixable viability dye. A complete list of fluorochrome-conjugated 
antibodies used in flow cytometric assays is given in Table 2.1. Samples were incubated for 
30 to 45 minutes at 4⁰C and then washed twice with FACS buffer. If required, samples were 
subsequently stained for intracellular antigens, cytokines, or Annexin V (as specified) (2.3.2 – 
2.3.3).  
The CD8+ T cells response to Lm-OVA infections was detected by staining with PE or APC 
labelled H-2Db MHC class I tetramer loaded with the OVA 257-264 (SIINFEKL) peptide (NIH 
tetramer core facility USA) at a dilution of 1 in 100.  
 
Table 2.1: List of fluorochrome-conjugated antibodies used for extracellular staining for 
flow cytometric analysis  
Specificity Clone Conjugation Concentration 
(µg/ml) 
Supplier 
CD4 RM4-5 BV510 0.5 BioLegend 
CD4 GK1.5 BUV805 0.5 BioLegend 
CD8α N418 BV785 0.5 BioLegend 
CD11c N418 Pacific Blue 1 BioLegend 
CD19 6D5 PE Dazzle594 0.5 BioLegend 
CD19 1D3 BUV395 0.5 BD Bioscience 
CD25 PC61 BV605 0.5 BioLegend 
CD25 PC61 BV785 0.5 BioLegend 
CD38 90 PE Dazzle594 1 BioLegend 
CD44 IM7 PerCP Cy5.5 0.5 eBiosciences 
CD44 IM7 AF700 0.5 BioLegend 
CD62L MEL-14 PE 1 BioLegend 
CD62L MEL-14 BV711 1 BioLegend 
CD69 H1.2F3 PE-Cy7 1 eBiosciences 
CD80 16-10A1 PerCP Cy5.5 1 BioLegend 




CD86 GL-1 PE-Cy7 1 BioLegend 
CD98 4F2 PE 1 BioLegend 
CD103 2E7 PE 1 eBiosciences 
CD107 (Lamp-1) 1D4B BV421 1 BioLegend 
CD127 A7R34 PE-Cy7 1 BioLegend 
CD183 (CXCR3) CXCR3-173 BV605 1 BioLegend 
CD223 (LAG-3) C9B7W APC 1 BioLegend 
CD278 (ICOS) 15F9 PE 1 BioLegend 
CD278 (ICOS) 7E.17G9 BV421 1 BD Bioscience 
CD279 (PD-1) 29F.1A12 PE-Cy7 1 BioLegend 
F4/80 BM8 PE 1 BioLegend 
GITR YGITR 765 PE-Cy7 1 BioLegend 
I-A/I-E (MHC-II) M5/114.15.2 PE-Cy7 1 BioLegend 
KLRG1 2F1/KLRG1 BV605 0.5 BioLegend 
NK1.1 PK136 BV650 0.5 BioLegend 
TCRβ H57-597 BUV737 0.5 BD Bioscience 
Tetramer SIINFEKL PE 2 NIH 
 
2.3.2 Staining for transcription factors and cytokines  
To assess cytokine production, 0.2 – 1 x106 cells per sample were incubated in 200µl T cell 
culture medium (TCM) (RPMI-1640 (Gibco) with 10% v/v FCS, 0.005% v/v β-mercaptoethanol 
(Sigma), 1% v/v Penicillin/Streptomycin (Gibco)) containing 50ng/ml PdBU (Tocris) and 1μM 
ionomycin (Sigma) for a total of 5-6 hours at 37 ⁰C, 5% CO2. Alternatively, 5x106 splenocytes 
were stimulated in the presence of 10nM OVA257-264 peptide (SIINFEKL) (ProImmune, UK) 
for to measure antigen specific cytokine release from mice infected with either Lm-OVA. To 
assess levels of LAMP-1 (CD107a), α-CD107a-BV421 (BioLegend) was added during the re-
stimulation phase.  
One hour after the start of the re-stimulation, 1x Brefeldin A (eBioscience) was added to each 
well. At the end of the re-stimulation, cells were washed once with FACS buffer and stained 
for cell surface antigens. For intracellular staining, samples were resuspended in 100µl/well 




Fixation Buffer (eBiosciences, FoxP3 Fix-Perm kit) and incubated for 15 minutes at room 
temperature. Subsequently, cells were washed with Permeabilization Buffer (eBiosciences) 
and resuspended in 50µl Permeabilization Buffer containing the appropriate fluorochrome-
conjugated antibodies. Table 2.2 provides a list of antibodies used for intracellular staining. 
Samples were incubated for 20 minutes at room temperature and washed twice with 
Permeabilization Buffer and resuspended in 50µl FACS buffer for FACS analysis.  
 
Table 2.2: List of fluorochrome-conjugated antibodies used for intracellular staining for flow 
cytometric analysis  
Specificity Clone Conjugation Concentration 
(µg/ml) 
Supplier 
CD152 (CTLA-4) UC10-4B9 BV421 1 BioLegend 
FoxP3 MF-14 AF488 1 BioLegend 
FoxP3 FJK-16s PE-Cy5.5 1 eBiosciences 
FoxP3 FJK-16s eFluor450 1 eBiosciences 
Granzyme B GB11 AF647 1 BioLegend 
IL-10 JES5-16E3 PE 1 eBiosciences 
IL-17A eBio17B7 APC 1 eBiosciences 
IFN-γ 4S.B3 PE-Cy7 1 BioLegend 
Ki-67 SolA15 eF405 1 eBiosciences 
TNF-α MP6-XT22 AF700 1 BioLegend 
 
2.3.3 Detection of apoptotic cells by Annexin V staining 
The Annexin V/Dead Cell Apoptosis Kit with PerCP-Cy7 Annexin V (BioLegend, Cat #640950) 
was used alongside Fixable Viability Dye eFluor 780 (eBioscience) to detect apoptotic cells. 
Following staining for cell surface markers, cells were washed twice with FACS and 
centrifuged at 540 x g for 3 minutes, and subsequently washed twice with Annexin-binding 
buffer. Cells were stained with Annexin V in 50µl Annexin-binding buffer for 20 minutes at 
room temperature in the dark. After the incubation period, 200µl Annexin-binding buffer 
were added and cells were analysed by flow cytometric analysis within 1 hour of staining. 
 




2.3.4 Staining for mitochondria 
Cells were stained with 0.25µM MitoTracker Orange Orange CM-H2-TMRos, staining for 
mitochondrial potential/active oxidative phosphorylation, or MitoTracker Orange CM-TMRos, 
staining for mitochondrial potential in RPMI-1640 medium containing 10% FCS and 1% 
Pen/Strep for 15 minutes at 37 ⁰C. Samples were washed twice with TCM and staining for 
flow cytometry was performed as described above. 
 
2.3.5 Flow cytometry and data analysis 
Flow cytometry analyses were performed on either a Becton Dickinson LSR Fortessa 5 
equipped with BD FACSDiva™software (BD Biosciences), an Attune NxT (Thermo Fisher 
Scientific), or a Cytek Aurora (Cytek Biosciences). Data were analysed using FlowJo software 
(Version vx.10.2 and 10.5.3, Tree Star Inc.) and results were plotted in and statistical analysis 
calculated using Prism version 7 and 8 (GraphPad, LaJolla, CA). 
 
 
2.4 Functional assays 
2.4.1 In vitro stimulation with anti-CD3 and anti-CD28  
For in vitro T cell stimulation assays, flat bottomed 96 well Nunclon delta surface plates 
(#167008, Thermo Scientific) were coated overnight at 37°C with plate bound anti-CD3 (1-
2μg/ml) (BioLegend, #100314) and anti-CD28 (2μg/ml) (#102112). On the following day, the 
preparation of cells (either total splenocytes, lymph nodes or sorted naïve CD4+ or CD8+ T 
cells) was carried out as described earlier in section 2.2.  
In order to assess in vitro proliferation, equal numbers of cells from each sample was 
resuspended in 1ml PBS and mixed with an equal volume of 10μM Cell Proliferation Dye 
eFluor 450 (eBioscience, #65-0842-85) in PBS and incubated for 10 minutes at 37°C. Cells were 
then washed twice in PBS by centrifuging at 500 x g for 5 minutes, before resuspending at 2 x 
106 cells/ml in RPMI complete medium (RPMI 1640 (Life Technologies #21875-034) + 5% heat-
inactivated FCS (Labtech) + 1% Pen/Strep (Invitrogen #15070-063) + 50 μM β-Mercapto-
ethanol (Sigma-Aldrich #M3701)). 2x105 cells/100μl were plated and 100μl of RPMI complete 
medium containing 1µM VPS34-IN1 or DMSO were added (these were made up at 2x final 




concentration in order to take in account the dilution within the wells). Plates were incubated 
for 3 days at 37°C (5% CO2). 
 
2.4.2 In vitro BrdU cell cycle analysis 
The BrdU phase flow kit (BioLegend# 3707040) was used to carry out in vitro cell cycle 
analysis. CD8+ T cells stimulated with anti-CD3/CD28 for 48h and expanded in IL-2 for five days 
were were pulsed with 1mM BrdU made up in complete RPMI medium and incubated at 37°C 
for 2 hours. Cells were centrifuged at 540g for 3 minutes at 4°C and washed twice with PBS. 
Cells were stained with appropriate surface antibodies in 50μl of FACS buffer and incubated 
for 45 minutes at 4°C. Cells were washed twice with FACS buffer, fixed by adding 100μl of 
Buffer A (provided in the kit) and incubated at 4°C for 20 minutes. Cells were washed twice in 
FACS buffer and left in FACS buffer overnight in the fridge. Following day, cells was washed 
with Buffer B (Buffer B was diluted 1:10 with MilliQ water). Cells were incubated with 100μl 
Buffer C and incubated at room temperature for 10 minutes. Cells were washed once with 
Buffer B and the fixation step was repeating by incubating the cells with 100μl Buffer at room 
temperature for 5 minutes, following by washes using Buffer B. Cells were centrifuged and 
treated with 30μl DNAse (Reconstituted DNAse by adding 1 ml of PBS (Ca/Mg2+) per vial, 
allowing for the DNAse to dissolve for 2-3 minutes). Cells were incubated for 1 hour at 37°C. 
Following this, cells were washed in 200μl of Buffer B and stained with anti-BrdU antibody for 
20 minutes at room temperature in the dark. Cells were washed first in Buffer B, then in FACS 
buffer. Cells were resuspended in 50μl FACS buffer containing 1:10 dilution of 7-AAD, 
incubated for 10 minutes in the dark at room temperature before acquisition.  
 
2.4.3 CD80 trans-endocytosis and degradation assay 
To test the capacity to deplete and digest CD80 from antigen presenting cells (APCs) through 
CTLA-4 – mediated trans-endocytosis, Treg cells were co-cultured with Chinese Hamster 
Ovary (CHO) cells expressing GFP-tagged CD80 (a kind gift from Professor David Sansom) in 
CHO cell medium (DMEM containing 25mM D-glucose (Sigma), 1mM sodium pyruvate (PAA), 
10% v/v FBS, 2mM glutamine, 1% v/v Pen/Strep, 5mM β-mercaptoethanol and 500ug/ml 
G418 sulphate (Invitrogen)). CHO cells were co-cultured in a 1:10 ratio with CD4+ T cells 
obtained by MACS purification in αCD3-coated (1 µg/ml) 48-well plates in CHO cell medium 




supplemented with rhIL-2 (20 ng/ml) and αCD28 (1 µg/ml). After 24h co-culture at 37°C, 5% 
CO2, Treg cells were separated from the CHO cells by FACS sorting, transferred to a new 48-
well plate and treated with the selective inhibitor VPS34 IN1 (1mM). The percentage and the 
MFI of GFP+ Treg cells was assessed by flow cytometry at the indicated time points.  
 
2.4.4 In vitro Treg cell differentiation 
Naïve CD4+ T cells were FACS sorted from FoxP3YFP-Cre Pik3c3fl/fl, mosaic FoxP3YFP-Cre/wt Pik3c3fl/fl 
and corresponding control mice were obtained by FACS sorting as previously described (). 
Following FACS, cells were resuspended at 2x106 cell/ml in complete IMDM media (IMDM 
with GlutaMAX supplement (GIBCO) containing 5% FCS (LabTech), 100 U/ml 
penicillin/streptomycin (GIBCO)), and 50 μM β-mercaptoethanol (Sigma-Aldrich) and 
transferred to a 96 U-bottom well plate previously coated with aCD3 and aCD28 (2µg/ml and 
2.5µg/ml, respectively) over night at 4°C. The following cytokines were added: 10ng/ml TGF-
β (Peprotech), 20ng/ml recombinant human IL-2 (Peprotech). The following antibodies were 
added:  5μg/ml anti-IL-4 (11B11, BioLegend) and 10μg/ml anti-IFNγ (XMG1.2, BioLegend). 
After 3 days of culture, half of the media was carefully removed and replaced with fresh media 




2.5 Biochemical assays 
2.5.1 Polymerase chain reaction (PCR) 
Deletion of exon 21 of the Pik3c3 gene was confirmed by using the polymerase chain reaction 
(PCR). Treg cells were isolated from spleen and lymph nodes, enriched by enriched by 
immunomagnetic separation (EasySep™ Mouse CD4+ CD25+ Regulatory T Cell Isolation Kit II 
from StemCell) according to manufacturer’s protocol. Fluorescence-activated cell sorting 
(FACS) was performed to obtain a Treg cell purity of 98%. Cells were lysed in 75μl Cell Lysis 
Buffer for 30 mins at 95ᴼC, placed on ice for 10 mins, 75μl Neutralisation Buffer added and 
snap-frozen. 




The PCR reaction was performed in 50μL, comprising 2μl sample DNA and 48μl reaction 
mixture containing per reaction 5μl PCR buffer 10x (Invitrogen), 2μl MgCl2 (50mM), 1μldNTPs 
(10mM), 1μl of each primer (1450_33: GCTGGTAGTACTGATGTTGC; 1450_34: 
GCATGGTCCTACTTTCTTCC; 1451_38: AGTCGAAGGTTGACTGTACC; Sigma), 0.4μl Taq 
Polymerase (5U/μl, Invitrogen), 37.6μl H2O. Samples were run at the following programme: 
Step Details Cycles 
1 95°C for 5’ 1 
2 95°C for 30’’ 
60°C for 30’’ 
70°C for 1’ 
35 
3 72°C for 10’ 1 
4 4°C hold 1 
 
Expected fragments: 357bp (wt), 521bp (Pik3c3Δ21). PCR products were resolved on a 1% 
agarose gel at 100V for 60 mins. 
 
2.5.2 Western blot analysis  
For Western blot analysed, cells were lysed in 25µl/106 cells in lysis buffer (50mM HEPES, 
150mM NaCl, 10mM NaF, 10mM Indoacetamide, 1% IGEPAL and proteinase inhibitors 
(Complete Ultra tablets, Roche)) for 30mins. Following centrifugation at maximum speed for 
30 min at 4°C, the supernatants were mixed with 1xNuPage LDS sample buffer (Life 
Technologies) supplemented with 0.5% β-mercaptoethanol and boiled at 95°C for 5mins. 
Samples were either kept at -80°C or loaded straight away on a 4-12% NuPage Bis-Tris gel 
(Invitrogen) and run at 150V for 75mins. Proteins were transferred to a PVDF membrane for 
1h at 40V on ice. Proper transfer was assessed by Coomassie Red staining. The membrane 
was blocked for 1h at room temperature in Intercept ® Blocking buffer (Licor), shaking. For 
the detection of proteins of interest, membranes were incubated over night at 4°C, shaking, 
with the following antibodies: pAKT (T308, Cell Signaling, 1 in 1000 dilution); pS6 (S235/236, 
Cell Signaling, 1 in 500 dilution); VPS34 (Cell Signaling, 1 in 500 dilution); VPS15 (Cell Signaling, 
1 in 500 dilution); Atg14L (Cell Signaling, 1 in 500 dilution); β-actin (Sc47778, Santa Cruz 
Biotechnology, 1 in 2000 dilution). Membranes were washed trice with T-BST and incubated 




with either anti-mouse or anti-rat secondary antibodies coupled to IRDye800CW or IRDye 
680RD, respectively (1:5000), for 1.5h at room temperature, shaking.  A CLx Licor system was 
used for the detection of the proteins bands. ImageStudio (LiCor) was used for the analysis of 
the band density, Excel was subsequently used to perform normalization and data were 
plotted in GraphPad.   
 
 
2.6 Metabolic assays 
2.6.1 CellTiterGlo® Luminescent Cell Viability Assay 
20.000 cells/well in 100µl PBS were seeded in opaque-walled multiwell plates adequate for 
cell culture and treated with either the pharmacological inhibitor VPS34-IN1 (1µM) or the 
vehicle control DMSO for 4 or 24h. The plate and its contents was equilibrated at room 
temperature for 30 minutes, and 100µl CellTiter-Glo® Reagent was added to each well. The 
content was mixed for 2 minutes on an orbital shaker to induce cell lysis. Subsequently, the 
plate was incubated at room temperature for 10 minutes to stabilize luminescent signal. 
Luminescence was detected on a microplate reader using the software SkanIt (Thermo 
ScientificTM).  
 
2.6.2 Seahorse XF Cell Energy Phenotype Test Assay (with the help of Dr. Benoit Bilanges)  
Prior to the assay, Agilent Seahorse XF96 Cell Culture Microplate were coated with Cell-Tak 
solution for 20 minutes at room temperature. On the day of the assay, Cell-Tak 
coated XF96 Cell Culture Microplates Cell Culture Microplates were allowed to warm to room 
temperature for 1h. 0.5x105 cells per well in 50uL of assay medium (Seahorse XF Base Medium 
supplemented with 1mM pyruvate, 2mM glutamine, and 10mM glucose, pH 7.4) were 
transferred to the XF96 Cell and centrifuged at 200 × g (zero braking) for 1 minute. The plate 
was transferred to a 37 °C incubator not supplemented with CO2 for 30 minutes, subsequently 
130 µL warm assay medium were gently added to each well, and the plate was returned to 
the incubator for 15–25 minutes. The sensor cartridge was loaded with the appropriate 
volumes described in the manufacturer’s protocol. The Seahorse XF Cell Energy Phenotype 
Test Assay was performed using 0.5uM FCCP and 10µM oligomycin.  




At the end of the assay, protein levels were quantified to allow normalization. Supernatant 
was removed, cells washed once with PBS and lysed with 20µl 0.2M NaOH for 10 mins. 
Subsequently, a BCA assay was performed according to the manufacturer’s protocol using 5µl 
of the samples. After 30mins incubation at 37°C in a non-supplemented CO2 incubator, 
samples were read at 560nm. 
 
 
2.7 Bacterial strains and infection 
2.7.1  Listeria monocytogenes strains 
The recombinant strain of Listeria monocytogenes-OVA was a kindly obtained from Dr Hao 
Shen [260]. Lm-OVA is derived from the wild-type strain 10403s (WT-Lm) and was modified 
to secrete the recombinant chicken ovalbumin protein (aa 134-387), and to include an 
erythromycin resistance gene. An attenuated version of this strain with the gene encoding 
ActA being deleted (ΔActA- Lm-OVA) was purchased from DMXbio [261]. All of these strains 
were obtained from Verity Pearce and were subsequently expanded by Hicham Bouabe, 
Rafeah Alam and myself. The attenuated Lm-OVA and Lm expressing the yellow fluorescent 
protein (attenuated Lm-YFP) was used in experiments to detect CD8+ T cell responses. The 
Lm-YFP was used as a control to gate on antigen specific CD8+ T cells. The virulent strain was 
used to measure colony-forming units (CFU) to assess bacterial load.  
 
2.7.2 Listeria monocytogenes culture and stocks 
All Listeria strains were grown in BBLTM Brain Heart Infusion (BD) liquid medium 
supplemented with 5ug/mL erythromycin (Sigma-Aldrich) or 7μg/mL Chloramphenicol at 
37oC with shaking.  In vivo passage of all strains was performed as detailed in Current 
Protocols in Immunology [262]. Briefly, log phase bacteria (OD500=0.8-1.2) were washed and 
resupsended in PBS, then intravenously injected into a mouse. After 48 hours, a single cell 
suspension of the spleen was prepared, diluted and grown on BHI agar plates. A single colony 
was picked and grown to mid-log phase, washed in PBS, and then stocks were stored in 
aliquots at -80oC in 20% glycerol (Sigma-Aldrich). For all in vivo infections with attenuated Lm-
OVA, 5 x 106 CFU was intravenously injected into the lateral tail vein. For bacterial load 




experiments 5 x 104 CFU virulent Lm-OVA was used. For each experiment, a new aliquot was 
used. Frozen stocks were thawed at room temperature, washed and diluted in PBS to the 
appropriate concentration and injected within 2hrs. 
 
2.7.3  Assessing bacterial load in Listeria monocytogenes -infected tissues 
To determine colony-forming units (CFU) in spleens and liver, mice were injected 
intravenously with the virulent strain of Lm-OVA and culled 48 hours post infection. Livers 
were perfused by cutting the hepatic vein and injecting 5 ml of phosphate-buffered saline 
(PBS) into the hepatic artery. Livers were weighed, following which spleens and livers were 
passed through 40μM nylon strainers (BD Falcon) to generate single cell suspensions. Ten-
fold serial dilutions of homogenates in PBS were plated (100μL/plate) on BHI agar plates 
supplemented with 5μg/ml erythromycin (Sigma-Aldrich). Bacterial colonies were counted 
after incubation for approximately 48 hours and enumeration of CFUs were calculated 
according to the formula CFU/mL= colony count on plate x dilution factor x 10. 
 
2.7.4 Infection with attenuated Listeria monocytogenes-OVA  
Listeria monocytogenes strain expressing OVA (Lm-OVA) have been previously described 
[260]. Infections were performed i.v. with 106 CFU Lm-OVA per mouse. Mice were bled on 
day 0, 8, 14, 21 and 30. To assess the secondary response, mice were re-injected with 106 CFU 
Lm-OVA per mouse on day post 36 and spleen and lymph nodes (inguinal) were analysed five 
days post re-infection.  
 
 
2.8 Cancer cell lines and inoculation 
2.8.1 Cell culture 
The murine metastatic melanoma cell line B78ChOva-mCherry was obtained as a generous 
gift from Prof. Matthew F. Krummel (UCSF). This transgenic line expresses the specific antigen 
chicken ovalbumin (OVA) peptide tagged to a mCherry reporter that can be recognised by 
antigen-specific OT-I+ T-cells. The line was generated via the transfection of B78 parental cells 
with a MMTV-PyMT vector containing a mCherry reporter gene and a chicken ovalbumin gene 




intercalated with two porcine teschovirus-1 2A (P2A) sequences [263]. Cells were 
mycoplasma-tested and cultured in RPMI-1640 media containing L-glutamine (Gibco, Thermo 
Fisher Scientific) with 10% heat-inactivated fetal bovine serum (LabTech, UK) and 100 U/mL 
penicillin-streptomycin (Invitrogen) in a humidified atmosphere of 5% CO2 at 37°C. Cells were 
split using 10 mM EDTA in PBS when reaching >70% confluency.  
 
2.8.2 Inoculation with the melanoma cell line B78Ch-OVA mCherry 
 B78ChOva-mCherry cell line (1.5 – 5 x 105 cells in 100 µl PBS) were injected subcutaneously 
in the right flanks of mice. Tumours were palpable from day 1- to 12 and measured every 
second until day 18 where mice were culled by Schedule 1 and tumour, draining and resting 
lymph nodes and spleen were harvested for analysis. 
 
 
2.9 Liquid chromatography mass spectrometry proteomics (LC-MS/MS) 
2.9.1 Sorting of YFP+ Treg cells 
Single cell suspension from lymph nodes and spleen from mosaic FoxP3YFP-Cre/wt Pik3c3fl/fl and 
wild-type mice were prepared and stained in 500μl FACS buffer containing fixable live dead 
dye, anti-CD25, anti-CD4, and anti-CD8 antibodies for 45 minutes at 4°C. Cells were washed 
twice in FACS buffer and resuspended in PBS containing 0.5% FCS. Cells were sorted by FACS 
on viable CD8-, CD4+, CD25+ YFP+ cells. Sorted cells were washed twice in HBSS at maximum 
speed for 10 seconds, tubes were rotated by 180 degrees and cells were spun again at 
maximum speed for 10 seconds. Supernatant was removed, the cells snap frozen in liquid 
nitrogen and couriered to the laboratory of Doreen Cantrell at the School of Life Sciences, 
University of Dundee for subsequent sample processing and protein analysis by mass 
spectrometry.  
 
2.9.2 Sample processing (performed by Dr. Christina Rollings) 
An SP3 approach was used to process samples for proteomic analysis [264]. Cell pellets were 
resuspended in 400 μL lysis buffer (4% SDS, 10 mM TCEP, 50 mM TEAB), boiled for 5 mins 
then allowed to cool for 5 mins while being shaken at 500rpm on a thermomixer. Samples 




were sonicated and incubated with 1 μL benzonase for 15 mins at 37°C. Protein concentration 
was determined using an EZQ assay. Cysteine residues were carbaminomethylated by 
incubation with 20 mM iodoacetemide for 1hr at room temperature in the dark. Magnetic 
beads (200μg per sample of a 50:50 mix of hydrophobic and hydrophilic Sera-Mag Speedbead 
carboxylate-modified magnetic particles, GE Life Sciences) and 550μL of a 10:1 acetonitrile: 
10% formic acid solution was added to each sample. Samples were incubated for 8mins while 
mixing at 500rpm, centrifuged briefly and the supernatant removed following 2mins 
incubation on a magnetic rack. Beads were washed twice with 1mL 70% ethanol and once 
with 1mL acetonitrile. Beads were air-dried briefly, resuspended in 65 μL digestion buffer 
(0.1% SDS, 50mM TEAB, 1mM CaCl2) and LysC added at a ratio of 1μg LysC per 100μg protein. 
Samples were incubated overnight at 37°C with mixing at 500rpm. Following digestion with 
LysC, 1μg trypsin/100μg protein was added and samples were incubated overnight at 37°C 
with mixing at 500rpm. Beads were washed with 1.425 mL acetonitrile, then 500 μL 
acetonitrile. Peptides were eluted following incubation with 189μL 2% DMSO for 2mins and 
peptide concentration determined using a CBQCA assay. Samples were adjusted to 5% formic 
acid, then dried down in a SpeedVac.  
 
2.9.3 Fractionation (performed by Dr. Christina Rollings) 
Samples were resuspended with 210μL 5% formic acid. For each sample, 200μL was 
fractionated into 16 fractions using high pH reversed phase chromatography using an 
UltiMate 3000 HPLC with an XBridge Peptide BEH C18 column. The buffers used for separation 
were buffer A (10mM ammonium formate/2% acetonitrile, pH 9.0) and buffer B (10mM 
ammonium formate/80% acetonitrile, pH 9.0). A flow rate of 0.3mL/min was used throughout 
fractionation. An elution gradient increasing the percentage of acetonitrile was used for 
fractionation, beginning with 90% buffer A and 10% buffer B, then moving to 50% buffer A 
and buffer B at 11mins and to 0% buffer A and 100% buffer B at 12mins. Following 
fractionation, fractions were combined to form 8 fractions per sample, dried down in a 
SpeedVac and resuspended in 5% formic acid for submission to the University of Dundee 
FingerPrints Proteomics and Mass Spectrometry facility.  
 
 




2.9.4 Mass spectrometry 
Mass spectrometry analysis was performed by the Proteomics Facility at the University of 
Dundee. A maximum of 1μg per fraction was analysed. Before introduction to the mass 
spectrometer, samples were separated using an Ultimate 3000 HPLC (Thermo Scientific). 
Peptides were trapped and washed on an Acclaim PepMap 100 (C18, 100μM x 2 cm) column 
with a 0.1% formic acid buffer, then separated on an Easy-Spray Pep-Map RSLC C18 column 
(75 μM x 50 cm). The buffers used for separation were 0.1% formic acid (buffer A) and 0.08% 
formic acid in 80% acetonitrile (buffer B), and a flow rate of 0.3μL/min was used throughout 
fractionation. Samples were separated using an elution gradient, beginning with 2% buffer B, 
switching to 5% buffer B at 6mins, 35% buffer B at 130mins and reaching 98% buffer B at 
132mins, which was held until 152mins, at which point the buffers were reset to the starting 
concentration of 2% buffer B with a total run time of 170mins. Samples were then introduced 
to an LTQ OrbiTrap Velos Pro (Thermo Scientific) using an Easy-Spray Source (Thermo 
Scientific) at 50°C and source voltage of 1.9 kV. The mass spectrometer was run in a data-
dependent acquisition mode, using a top 15 method for selection of ions for fragmentation. 
MS spectra were collected over a range of 355 – 1800 m/z with a resolution of 60,000 using 
a full scan and in a positive ion mode. The top 15 most intense peptide ions were selected for 
fragmentation via CID (collision-induced dissociation) after the accumulation of 5000 ions, 
with normalised collision energy of 35%, activation Q of 0.25, and activation time of 10ms.  
 
2.9.5 Data analysis  
The raw data files generated during mass spectrometry were analysed using MaxQuant 
version 1.6.1.0 and searched against the reviewed mouse Uniprot database, the 
contaminants database supplied with MaxQuant and a reversed database used for FDR (false 
discovery rate) determination. Cysteine carbamidolyation was set as a fixed modification and 
methionine oxidation, protein N-terminal acetylation, deamidation of asparagine and 
glutamine and pyroglutamic acid formationfrom glutamine were set as variable 
modifications. Minimum peptide length was set to 6, digestion was set to trypsin/P and LysC 
with a maximum of two missed cleavages. Match between runs was enabled. Quantification 
used unique and razor peptides. PSM (peptide to spectrum match) FDR and protein FDR were 
set to 1%.  




Following protein identification and quantification, proteins identified in the reverse 
database, proteins listed as contaminants and proteins only identified by a modified peptide 
were filtered from the database. Copy numbers were then calculated using the proteome 
ruler plugin in the Perseus analysis software version 1.6.0.2 [265]. Copy numbers were log2 
transformed and an unpaired T-test with unequal variance performed. Proteins with a 1.5-
fold change in different conditions and a p value ≤ 0.05 were considered differentially 
abundant.  
The generated protein list was filtered for potential contaminants, reverse hits, and 
‘‘only identified by site’’. The label-free quantification (LFQ) values were transformed in log2 
scale, the three technical replicates per experimental condition grouped and averaged based 
on the median. To identify the proteins with the most prominent differences in expression 
profiles within the different T cell subsets statistical significance (p ≤ 0.05). 
Pathway analyses were performed using the Database for Annotation, Visualisation and 




2.10  Statistical Analysis 
Statistical analyses were carried out using GraphPad Prism (version 8.3.0). Where data were 
normally distributed, parametric tests were performed: unpaired students t-test with Welch’s 
correction was used when two groups were compared, or one-way ANOVA with Tukey post-
test when three or more groups were compared. A two-tailed Student’s t-test was used for 
the statistical analysis of differences between two groups with Sidak’s correction when 
comparing two groups at multiple time points. Comparison of multiple groups was done using 
one-way ANOVA followed by Tukey’s post-hoc test. Significance is shown as * p < 0.05, ** p 




VPS34 is critical for regulatory T cell functions 
  





The cell-intrinsic role of VPS34 in Treg cells was investigated by Elisabeth Slack, a previous 
PhD student in the laboratory of Klaus Okkenhaug. She used a mouse model in which exon 21 
of Pik3c3 is conditionally excised under the action of FoxP3-induced Cre-recombinase. 
Selective deletion of VPS34 in Treg cells led to a Scurfy-like phenotype, but since the number 
of Treg cells was near-normal in VPS34-deficient mice, this implied that VPS34 is critical for 
Treg cell functions rather than for survival. In line with that, the proportion of activated CD4+ 
and CD8+ T cells was greatly increased in the spleen and lymph nodes, suggesting that VPS34 
is required for effective suppressive functions of Treg cells. However, VPS34-deficient Treg 
cells supressed the proliferation of conventional T cells (Tcons) equally well in an in vitro 
suppression assay. 
Based on the knowledge that VPS34 is a kinase involved in autophagy and endocytosis 
in various cell types, Elisabeth tested the hypothesis that depletion of VPS34 impairs the 
consumption of IL-2 and/or the transendocytosis of CD80, two key effector mechanisms by 
which Treg cells suppress naïve T cell survival and activation. Although the cell surface level 
of CD25 was increased in VPS34-deficient Treg cells, resulting in increased IL-2 endocytosis, 
downstream IL-2 receptor signalling was intact, as assessed by STAT5 phosphorylation. 
Similarly, cell surface expression of CTLA-4 and CD80 on Treg cells and DCs, respectively, was 
increased in mice with VPS34-deficient Treg cells; concomitantly, the level of 
transendocytosed CD80 was increased in VPS34-deficient compared to wild-type Treg cells. 
She therefore concluded that VPS34 is not required for known Treg cell suppressive 
mechanisms relying on endocytosis (see Elisabeth’s thesis [266]). 
Together with Priya, she investigated whether VPS34-deficiency impairs autophagy. 
Autophagic flux, as assessed by monitoring LC3b lipidation, was unchanged in VPS34-deficient 
Treg cells and results obtained so far could not provide evidences that mitophagy, a selective 
form of autophagy required for the removal of excessive and/or damaged mitochondria, is 
affected by VPS34 depletion. Furthermore, when Atg7, a protein essential for the induction 
of autophagy, was specifically deleted in Treg cells, mice survived for a median time of 9 
months, suggesting that impaired autophagy cannot fully explain the observed phenotype in 
FoxP3YFP-Cre Pik3c3fl/fl mice. Taken together, Elisabeth and Priya established that VPS34 is 




essential for Treg cells homeostasis and/or function, as depletion leads to a striking 
lymphoproliferative disease but so far, its physiological role is still not completely understood.  
Therefore, I aimed to repeat some of the experiment to produce publication-ready figures (by 
including sufficient n numbers, for instance), and to continue the work of Elisabeth and Priya 
in order to understand which effector mechanism(s) is/are affected by the deletion of VPS34 
in Treg cells.  
 
For the sake of the comprehension of the here presented data and conclusions, I will, where 
needed, mention whether the results have been obtained by Elisabeth and/or Priya, however 
without showing data (i.e. I will notify as follow: data not shown). Where I have repeated 
experiments already performed by Elisabeth and/or Priya, with the aim to repeat and 
consolidate data, I will only show results obtained from my own experiments.  
 
  





3.2.1 Treg cell-specific deletion of VPS34 causes a Scurfy-like phenotype 
To study the function of VPS34 in vivo, two loxP sites flanking exon 21 of the VPS34 gene were 
introduced by homologous recombination (Fig. 3.1.1 a) [267]. Pik3c3flox/flox (Pik3c3fl/fl) mice 
were viable and fertile and did not present any overt phenotype, indicating that the insertion 
of the loxP sites does not alter Pik3c3 gene function (data not shown). To generate Treg cell-
specific deletion of exon 21 of Pik3c3, these mice were crossed to a transgenic mouce strain 
expressing the Cre-recombinase under the FoxP3 promoter (FoxP3YFP-Cre) (Fig. 3.1.1 b). FoxP3 
is a transcription factor unique and required for Treg cell identity [9]–[12].  Genomic excision 
was verified by the absence of the amplicon spanning exon 21-22 boundary in FACS-sorted 
Treg cells (purity > 98%, data not shown) from FoxP3YFP-Cre Pik3c3fl/fl mice but not in Treg cells 
from control FoxP3YFP-Cre Pik3c3+/+ mice (Fig. 3.1.1 c). Exon 21 of Pik3c3 encodes a critical 
stretch (Ala730 to Thr754) of the VPS34 kinase domain and its deletion renders the truncated 
VPS34 protein catalytically inactive, as assessed by a kinase assay performed by Elena Rebollo 
Gomez (Fig. 3.1.1 d). 
Elisabeth previously showed that loss of VPS34 kinase activity in Treg cells causes an 
early systemic lymphoproliferative disease from approximately 4 weeks of age (median 
survival time = 37 days) (data not shown). FoxP3YFP-Cre Pikc3c3fl/fl mice exhibited smaller body 
size, hunched posture, and crusting and scaling of the ears and abdomen (data not shown). 
Moreover, mutant mice developed splenomegaly and lymphadenopathy (data not shown), 
while the thymus was reduced in size, which is likely secondary to the observed inflammation 
relating to the autoimmune phenotype. We assessed cell numbers by flow cytometry and 
found that they were increased in the spleen and lymph nodes while reduced in the thymus 
(Fig. 3.1.2 a). Analyses by flow cytometry showed that these infiltrating cells were of 
macrophage-like origin (data not shown). Furthermore, histopathological analysis revealed a 
massive infiltration of lymphocytes into multiple organs such as the liver, the lung and the 
bone marrow (data not shown), suggesting an autoimmune lymphoproliferative disease. In 
support of this, FoxP3YFP-Cre Pikc3c3fl/fl mice had substantial expansion of CD4+ CD25- 
conventional T cells (Tcons) and CD8+ T cells in the spleen and the lymph nodes (Fig. 3.1.2 b 
and c), among which an increase proportion displayed an effector phenotype (CD44high 




CD62Llow) (Fig. 3.1.2 d). Additionally, a large amount of Tcons produced the immuno-
regulatory T cell cytokine interferon- γ (IFN-γ) (Fig. 3.1.2 e).  
 
 




Figure 3.1.1: Generation of Treg cell-specific VPS34-kinase dead mice. 
a) Targeting strategy to generate Treg cell-specific VPS34-kinase dead mice: exon 21 (located in the 
kinase domain) of the Pik3c3 gene encoding VPS34 was flanked with LoxP sites. The enframed region 
is 75 nucleotides long, and Cre-mediated excision does not change the open reading frame, thereby 
giving rise to a predicted truncated VSP34 protein that is 25 amino acids shorter than the wild-type 
version.  
b) For Treg cell-specific deletion, Pik3c3fl/fl mice were crossed with a transgenic mice strain expressing 
the Cre-recombinase under the FoxP3 promoter (FoxP3YFP-Cre mice), with all Treg cells expressing the 
Cre-recombinase also expressing the fluorescent tag YFP.  
c) A representative image of agarose electrophoresis showing PCR products generated from DNA 
isolated from FACS-sorted Treg cells using the primer trio #33/34/38 (marked in (a) for detection of 
heterozygous/homozygous or wild-type and loxP alleles. In wild-type cells, only the PCR product 
between the primers 33 and 34 will be generated (the distance between 33 and 38 being too long to 
generate a PCR product), leading to a PCR product of 350 kDa. Deletion of the floxed DNA stretch will 
remove the binding site for primer 34, but also decrease the length between the primers 33 and 38, 
leading the a PCR product of 450 kDa.  
d) Immunoprecipitation (IP), expression (WB) and in vitro Kinase assay of tagged version of the 
truncated (del21) and wild-type (WT) allele in transiently transfected HEK293 cells. IPs were performed 
using anti-HA (left part of the panel) or anti-Myc (right part of the panel) antibodies. Bar graphs 
showing the percentage of Kinase activity in both WT and del21 VPS34 proteins (HA tagged on the top 
graph panel and 6xMyc-tagged on the bottom graph). HEK293 were transiently transfected in 
duplicates (1, 2). NT corresponds to the non-transfected controls. In vitro lipid kinase assay was 
performed using PI as a substrate on either HA-tagged-VPS34 or 6xMyc-tagged VPS34 IPs. 
Representative data of 3 independent experiments is shown with 2 replicates per experiments 
(labelled as WT-1, WT-2, del21-1, del21-2). This experiment was performed by Elena Rebollo. 
 
 
The phenotype of mice with VPS34-deficent Treg cells is similar in severity to those observed 
in Scurfy mice. The Scurfy phenotype arises from a frame shift mutation in the fork head 
domain of FoxP3, resulting in the absence of thymus-derived Treg cells and leading to a fatal 
lymphoproliferative disease with multi-organ inflammation [23]. However, in contrast to 
Scurfy mice and other models that recapitulate the Scurfy phenotype, VPS34-deficient Treg 
cells developed and populated the peripheral lymphoid organs of FoxP3YFP-Cre Pik3c3fl/fl mice, 
albeit with reduced numbers in the spleen compensated by increased numbers in the lymph 
nodes (Fig. 3.1.3 a). Meanwhile, Treg cells were reduced in term of percentage in the lymph 
nodes and the spleen of FoxP3YFP-Cre Pik3c3fl/fl mice (Fig. 3.1.3 b and c), suggesting that VPS34-
deficient Treg cells fail to accumulate proportionally with effector T cells. In contrast, the 
thymus showed an increase percentage of Treg cells (Fig. 3.1.3 d); which is constituent with 
the reduced size of the thymus and near-normal number of Treg cells.  




As firstly observed by Elisabeth and confirmed by myself during the first year of my 
PhD, the expansion of activated T cells in presence of Treg cells, even if reduced in numbers, 
suggests that the loss of VPS34 interferes with Treg cell suppressive functions rather than 
simply by preventing their development. 





Figure 3.1.2: FoxP3YFP-Cre Pik3c3fl/fl mice have a substantial expansion of 
CD4+ and CD8+ T cells, among which an increase proportion displayed 
an effector phenotype. 
a) Absolute numbers of cells in spleen, lymph nodes (inguinal, brachial, 
and axiliary), and thymus. Absolute numbers of CD4
+
 CD25- (b) and CD8
+
 
T cells (c) in spleen and the lymph nodes (inguinal, brachial, and axiliary).  






 CD25- and CD8
+
 T cells in the 
spleen. e) Percentage of IFN-γ+ CD4+ CD25- T cells in the spleen.  
Mice were between 4 and 5.5 weeks old. n = 6 – 15 mice per group. 
Statistical significance was determined using a two-tailed Student’s t-
test. Results are pooled from three independent experiments. Similar 
data was produced by Elisabeth. 





Figure 3.1.3: VPS34-deficient Treg cells developed and populated the peripheral lymphoid organs of 
FoxP3
YFP-Cre Pik3c3fl/fl mice. 
a) Absolute numbers of Treg cells in spleen, lymph nodes (inguinal, brachial, and axiliary), and thymus 
of FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and wild-type control mice (WT). 
b – d) Percentage of Treg cells in the spleen (b), lymph nodes (inguinal, brachial, and axiliary) (c), and 
thymus (d) of FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and wild-type control mice (WT).  
Mice were between 4 and 5.5 weeks old. n = 6 – 15 mice per group. Statistical significance was 
determined using a two-tailed Student’s t-test. Results are pooled from three independent 
experiments. Similar data was produced by Elisabeth. 
 
  




3.2.2 Autophagy is important, but not critical, for the maintenance of Treg cells 
homeostasis 
Autophagy is a highly conserved degradation process that is critical for the maintenance of 
cellular homeostasis, required for the establishment of Treg cell-mediated immune tolerance, 
and supports  Treg cell lineage stability and survival [152]. Autophagy is increased after the 
initial activation of T cells, presumably as a mechanism to degrade the increasing cytoplasmic 
content that is generated as the T cells become more metabolically active [211]. 
To assess the involvement of VPS34 in autophagy, I monitored mitophagy, a selective 
form of autophagy that is required for the removal of defective and excessive mitochondria. 
Atg7-deficient Treg cells displayed increased staining for MitoTracker Orange dye, showing 
damaged mitochondria with altered membrane potential and oxidative phosphorylation 
(OXPHOS) (Fig. 3.2 a). Atg7 is a protein essential for the induction of autophagy [268]. 
Similarly, I observed an increase in mitochondrial potential and OXPHOS in VPS34-deficient 
Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice and mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice (Fig. 3.2 b 
and c, respectively). Since the incorporation of the MitoTracker Orange dye is not only 
dependent on mitochondrial potential, but also on mitochondrial mass, I assessed the level 
of mitochondrial DNA in Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice by quantitative PCR 
analysis. Results showed elevated mitochondrial DNA (Fig. 3.2 d), suggesting an increase in 
mitochondria number and impaired intracellular mitochondria clearance rather than 
increased mitochondrial potential.  
Priya considered whether defective autophagy may prevent VPS34-deficient Treg cells 
from functioning normally. To explore the implication of autophagy in the context of the 
phenotype observed in FoxP3YFP-Cre Pik3c3fl/fl mice, she analysed the phenotype of mice with 
Treg cell-specific deletion of Atg7. Remarkably, FoxP3YFP-Cre Atg7fl/fl mice were healthy at a 
younger age but developed systemic inflammation leading to death at around 36 weeks (data 
not shown). Interestingly, asymptomatic/moribund FoxP3YFP-Cre Atg7fl/fl mice displayed a 
reduced percentage of Treg cells in the spleen but not the lymph nodes already at two months 
of age (Fig. 3.2 e). Together, these results imply that defective autophagy may contribute to, 
but is not the primary cause of the profound autoimmune disease observed upon inactivation 
of VPS34 in Treg cells. 





Figure 3.2: Assessing autophagy in ATG7- and VPS34-deficient Treg cells. 
Mean fluorescence intensity (MFI) of the MitoTracker Orange in splenic Treg cells from FoxP3YFP-Cre 
Atg7fl/fl mice (KO) and the respective wild-type control mice (WT) (a); FoxP3YFP-Cre Pik3c3fl/fl mice (KO) 
and the respective wild-type control mice (WT) (b); VPS34-deficient (Cre+) and VPS34-sufficient (Cre-) 
Treg cells from mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice (KO) (c).  
d) Quantitative PCR analysis of the mitonchodria DNA (mtDNA) levels of FACS-sorted Treg cells from 
FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and wild-type control mice (WT). Normalised 2(ΔCT) are displayed for 
Treg cells from female and male mice. 
e) Percentage of Treg cells from the spleen and the lymph nodes of FoxP3YFP-Cre Atg7fl/fl mice (KO) and 
wild-type control mice (WT).  
FoxP3YFP-Cre Atg7fl/fl mice and the respective wild-type controls were between 8 and 20 weeks of age. 
FoxP3YFP-Cre Pik3c3fl/fl mice and the respective control mice were between 4 and 5.5 weeks of age. 
FoxP3YFP-Cre/WT Pik3c3fl/fl mice and the respective control mice were between 8 and 12 weeks of age. n 
= 3 – 10 mice per group. Statistical significance was determined using an unpaired two-tailed Student’s 
t-test (a, b, d, e) or paired two-tailed Student’s t-test (c). Results are representative of three 
independent experiments (a – c), representative of two independent experiments (d and e). 
 




3.2.3 VPS34 deficient Treg cells are not intrinsically pathological but have a competitive 
disadvantage compared to VPS34-sufficient Treg cells 
The severe inflammatory disease of FoxP3YFP-Cre Pik3c3fl/fl mice made it challenging to 
investigate the intrinsic role of VPS34 in Treg cells as we could not be certain whether the 
observed differences between VPS34-sufficient and -deficient Treg cells are due to an intrinsic 
role of VPS34 in Treg cells or whether the altered Treg cell phenotype is secondary to the 
inflammatory milieu. We therefore generated mosaic knockout mice by taking advantage of 
the localisation of the FoxP3 gene on the X chromosome (Fig. 3.3.1). Hence, random X 
chromosome inactivation should lead to the depletion of VPS34 in approximately 50% of Treg 
cells [269] in female mice heterozygous for the FoxP3YFP-Cre transgene (FoxP3YFP-Cre/WT). 
Accordingly, such mosaic female mice harbour two populations of Treg cells: a YFP- VPS34-
sufficient and a YFP+ VPS34-deficient Treg cell population. FoxP3YFP-Cre/WT Pik3c3WT/WT mice 
were used as control mice. Such mosaic female mice did not show any signs of inflammatory 
disease (data not shown), demonstrating that even when VPS34 is kinase-dead in about half 
of the Treg cells, the presence of wild-type, VPS34-sufficient Treg cells prevents 
autoimmunity. This system therefore allows to explore the cell-intrinsic role of VPS34 in Treg 
cells, independently of the Scurfy phenotype, i.e. external inflammation caused by Treg cell 
deficiency.  
In line with the lack of lymphoproliferative disease, FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic 
mice had normal numbers of CD4+ and CD8+ T cells in the spleen and the lymph nodes (Fig. 
3.3.2 a and b, respectively) which displayed a normal activation status (Fig 3.3.2 c). Similarly, 
Treg cell cellularity (Fig. 3.3.2 d) and proportions (Fig. 3.3.2 e) in the spleen, lymph nodes and 
thymus of FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice were comparable to control mice. However, 
a substantially lower proportions of YFP+ VPS34-deficient Treg cells were present in FoxP3YFP-
Cre/WT Pik3c3fl/fl mosaic mice compared to YFP+ VPS34-sufficient Treg cells from control mice 
(Fig. 3.3.3). Furthermore, even in wild-type control mice, the percentage of YFP+ Treg cells did 
not reach 50% (as one might have expected based on the random inactivation of the X 
chromosome), but rather 30%. 
Together, these data suggest that even though Treg cells with kinase-dead VPS34 are 
not intrinsically pathological, they suffer from a competitive disadvantage compared to 
VPS34-sufficient Treg cells. 





Figure 3.3.1: Generation of FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice. 
Mosaic knockout mice were generated by taking advantage of the localisation of the FoxP3 gene on 
the X chromosome. Random X chromosome inactivation leads to the depletion of VPS34 in 
approximately 50% of Treg cells in female mice heterozygous for the FoxP3YFP-Cre transgene (FoxP3YFP-
Cre/WT). Accordingly, such mosaic female mice harbour two populations of Treg cells: a YFP- VPS34-










Figure 3.3.2: FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice are phenotypically healthy. 
Absolute numbers of CD4
+
 (a) and CD8
+
 T cells (b) in spleen and the lymph nodes (inguinal, brachial, 
and axiliary) of FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice (KO) and wild-type control mice (WT).  






 T cells in the lymph nodes of FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic 
mice.  




d) Absolute numbers of Treg cells in spleen, lymph nodes (inguinal, brachial, and axiliary), and thymus 
of FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and wild-type control mice (WT). 
e) Percentage of Treg cells in the spleen, lymph nodes (inguinal, brachial, and axiliary), and thymus of 
FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and wild-type control mice (WT).  
Mice were between 8 and 12 weeks old. n = 6 – 13 mice per group. Statistical significance was 
determined using a two-tailed Student’s t-test. Results are pooled from three independent 
experiments. Similar data was produced by Elisabeth. 
 
 
Figure 3.3.3: YFP+ Treg cells are reduced in FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice. 
Percentage of YFP+ Treg cells in in spleen, the lymph nodes (inguinal, brachial, and axiliary), and the 
thymus of FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice (KO) and wild-type control mice (WT).  
Mice were between 8 and 12 weeks old. n = 3 – 7 mice per group. Statistical significance was 
determined using a two-tailed Student’s t-test. Results are representative from three independent 
experiments. 
  




3.2.4 Increased effector molecules levels on Treg cells is second to VPS34-deficiency 
The regulatory functions of Treg cells are closely associated with the expression of effector 
molecules. Therefore, we performed a detailed phenotypic analysis of Treg cells from 
FoxP3YFP-Cre Pik3c3fl/fl mice (lacking VPS34 kinase activity in all Treg cells) and VPS34-sufficient 
(Cre-) and VPS34-deficient (Cre+) Treg cells arising from female FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic 
mice. The expression levels of ICOS, a member of the CD28-superfamily that enhances 
stability and suppressive functions of Treg cells [270], and CD38, a marker for highly 
suppressive Treg cells [271] were assessed by flow cytometry.  VPS34-deficient Treg cells from 
FoxP3YFP-Cre Pik3c3fl/fl mice expressed elevated level of ICOS (Fig. 3.4.1 a) while CD38 
expression was decreased by half (Fig. 3.4.1 b) compared to control mice. Interestingly, there 
was no difference in the expression of both markers on VPS34-sufficient (Cre-) compared to 
VPS34-deficient (Cre+) Treg cells from FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice (Fig. 3.4.1 c and d, 
respectively). These results indicate that the differential expression of ICOS and CD38 
observed on Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice is due to a cell-extrinsic effect, probably 
such as the inflammatory milieu, and is not primarily due to the lack of VPS34. 
Treg cells are characterised by the constitutive expression of the interleukin-2 (IL-2) 
receptor and CTLA-4. CTLA-4 on Treg cells captures CD80 and CD86 from antigen-presenting 
cells through a process termed transendocytosis, thus depriving conventional T cells (Tcons) 
of these costimulatory ligands  [42], [49]. Similarly, the IL-2 receptor on Treg cells internalises 
and degrades IL-2, thus depriving Tcons of this essential cytokine [53] . CTLA-4 expression was 
increased on Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice (Fig. 3.4.2 a). Concomitantly, the co-
stimulatory molecule CD80 was increased on splenocytes from FoxP3YFP-Cre Pik3c3fl/fl mice (Fig. 
3.4.2 b) while CD86 levels were unchanged (Fig. 3.4.2 c). Next, we tested whether the 
increased expression of CTLA-4 on Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice is a secondary 
effect due to the inflammatory environment rather than a direct effect of VPS34-deficiency. 
The expression CTLA-4 on VPS34-deficient (Cre+) Treg cells was unchanged compared to 
VPS34-sufficient Treg cells (Cre-) (Fig. 3.4.2 d), and we detected normal levels of CD80 and 
CD86 on splenocytes from FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice (Fig. 3.4.2 e and f, 
respectively).  
 




The expression of the IL-2Rα-chain (also referred to as CD25) was markedly increased on Treg 
cells from FoxP3YFP-Cre Pik3c3fl/fl mice (Fig. 3.4.2 g), while it was unchanged on VPS34-deficient 
(Cre+) Treg cells compared to VPS34-sufficient Treg cells (Cre-) on splenocytes from FoxP3YFP-
Cre/WT Pik3c3fl/fl mosaic mice (Fig. 3.4.2 h). 
 
 
Figure 3.4.1: Increased expression of ICOS and CD38 is a secondary effect of the inflammatory 
environment rather than a direct effect of VPS34-deficiency.  
Mean fluorescence intensity (MFI) of ICOS and CD38 in splenic Treg cells from FoxP3YFP-Cre Pik3c3fl/fl 
mice (KO) and the respective wild-type control mice (WT) (a and b) and VPS34-deficient (Cre+) and 
VPS34-sufficient (Cre-) Treg cells from mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice (c and d).  
FoxP3YFP-Cre Pik3c3fl/fl mice and the respective control mice were between 4 and 5.5 weeks of age. 
FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice and the respective control mice were between 8 and 12 weeks of 
age. n = 3 – 4 mice per group. Statistical significance was determined using an unpaired two-tailed 
Student’s t-test (a, b, d, e) or paired two-tailed Student’s t-test (c). Results are representative of three 
independent experiments. Similar data was produced by Elisabeth. 




Figure 3.4.2: Increased expression of CTLA-4 on Treg cells and CD80/CD86 on splenic APC is a 
secondary effect of the inflammatory environment rather than a direct effect of VPS34-deficiency.  
(a – c) Mean fluorescence intensity (MFI) of CTLA-4 on splenic Treg cells and MFI of CD80 and CD86 
on antigen-presenting cells (APCs) from FoxP3YFP-Cre Pik3c3fl/fl mice (KO) and the respective wild-type 
control mice (WT). (d – f) Mean fluorescence intensity (MFI) of CTLA-4 on VPS34-deficient (Cre+) and 
VPS34-sufficient (Cre-) splenic Treg cells and MFI of CD80 and CD86 on antigen-presenting cells (APCs) 
from FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice (KO) and the respective wild-type control mice (WT).  
(g) Mean fluorescence intensity (MFI) of CD25 on splenic Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice 
(KO) and the respective wild-type control mice (WT). (h) Mean fluorescence intensity (MFI) of CD25 
on VPS34-deficient (Cre+) and VPS34-sufficient (Cre-) splenic Treg cells from FoxP3YFP-Cre/WT Pik3c3fl/fl 
mosaic mice. 
FoxP3YFP-Cre Pik3c3fl/fl mice and the respective control mice were between 4 and 5.5 weeks of age. 
FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice and the respective control mice were between 8 and 12 weeks of 
age. n = 3 – 7 mice per group. Statistical significance was determined using an unpaired two-tailed 




Student’s t-test (a, b, c, e, f, g) or paired two-tailed Student’s t-test (d and h). Results are representative 




3.2.5 Expression of CD69 and LAG-3 are reduced while GITR is increased on VPS34-deficient 
Treg cells from mosaic mice 
Next, I performed a more detailed phenotypical analysis of activation markers that have been 
shown to regulate the suppressive capacity of Treg cells. To ascertain that observed 
differences in the expression profile of these markers is only based on cell-intrinsic effects, I 
performed this analysis using Treg cells from FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice. I noted 
that KLRG1, CD69 and LAG3 were significantly downregulated in Cre+ VPS34-deficient Treg 
cells compared to Cre- VPS34-sufficient Treg cells (Fig. 3.5 a, b, and c, respectively). CD69 is 
an early activation marker that modulates the balance between Th1/Th17 and Treg cells and 
has been proposed as a metabolic gatekeeper [272]. Meanwhile, LAG3 is expressed after 
activation and has been shown to be required for maximal regulatory activity of Treg cells 
[273]. Interestingly, GITR expression was upregulated on VPS34-deficient Treg cells (Fig. 3.5 
d). GITR is involved in Treg cells differentiation and expansion and it has been suggested that 
triggering of GITR decreases the suppressive activity of Treg cells [274]. 






3.2.6 VPS34 is required for the maturation of Treg cells into CD44-expressing cells 
I also assess the expression of the activation cell surface marker CD44. In support of the 
hypothesis that the lack of VPS34-kinase activity impairs Treg cell function rather than 
survival, we observed that fewer VPS34-deficient Treg cells expressed high levels of CD44 in 
FoxP3YFP-Cre Pik3c3fl/fl mice (Fig. 3.6.1 a). However, CD44-expression was reduced on VPS34-
deficient (Cre+) compared to VPS34-sufficient (Cre-) Treg cells arising from FoxP3YFP-Cre/WT 
Pik3c3fl/fl mosaic mice (Fig. 3.6.1 c). These data suggest that VPS34 is required for Treg cells 
to differentiate into a CD44high phenotype or that CD44high Treg cells depend on VPS34 for 
their survival and/or proliferation, especially under inflammatory conditions.  
In line with this hypothesis, VPS34-deficient Treg cells from the lymph nodes of 
FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice were less proliferative than VPS34-sufficient Treg cells 
from the same mice (Fig. 3.6.2 a). However, in the spleen, VPS34-deficient Treg cells had a 
proliferation potential similar to their wild-type Treg cells (Fig. 3.6.2 b). 
Figure 3.5: KLRG1, CD69, LAG3 expression is increased on GITR 
is decreased on VPS34-deficient Treg cells from FoxP3YFP-Cre/WT 
Pik3c3
fl/fl mosaic mice. 
Percentage of KLRG1+ (a), CD69+ (b) and MFI of LAG3 (c) and GITR 
(d) on VPS34-deficient (Cre+) and VPS34-sufficient (Cre-) splenic 
Treg cells from mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice.  
Mice were between 8 and 12 weeks of age. n = 4 – 7 mice per 
group. Statistical significance was determined using a paired 
two-tailed Student’s t-test. Results are representative of two 
independent experiments. 




Figure 3.6.1: VPS34-deficient Treg cells have a reduced expression of the activation marker CD44. 
a) Representative flow cytometry plot for CD44 and CD62L expression (left) and bar graph 
representing levels of CD44-expression (right) on splenic Treg cells of FoxP3YFP-Cre Pik3c3fl/fl mice (KO) 
and the respective wild-type control mice (WT).  
b) Representative flow cytometry plot for CD44 and CD62L expression (left) and bar graph 
representing levels of CD44-expression (right) on splenic VPS34-deficient (Cre+) and VPS34-sufficient 
(Cre-) Treg cells from FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice. FoxP3YFP-Cre Pik3c3fl/fl mice and the respective 
control mice were between 4 and 5.5 weeks of age. FoxP3YFP-Cre/WT Pik3c3fl/fl mosaic mice and the 
respective control mice were between 8 and 12 weeks of age. n = 6 mice per group. Statistical 
significance was determined using an unpaired two-tailed Student’s t-test (a and b) or paired two-
tailed Student’s t-test (c). Results are pooled from four independent experiments. 
 
 




Figure 3.6.2: VPS34-deficient Treg cells from the lymph nodes proliferate less. 
Percentage of Ki67+ VPS34-deficient (Cre+) and VPS34-sufficient (Cre-) Treg cells in the lymph nodes 
(pooled from inguinal, brachial, and axiliary) (a) and spleen (b) from from FoxP3YFP-Cre/WT Pik3c3fl/fl 
mosaic mice. Mice were between 8 and 12 weeks of age. n = 6 mice per group. Statistical significance 
was determined using a paired two-tailed Student’s t-test. Results are representative of two 
independent experiments. 
  




3.2.7 VPS34-deletion does not interfere with IL-2 consumption nor CD80-transendocytosis 
The ongoing lympho-proliferative disease in FoxP3YFP-Cre Pik3c3fl/fl mice, along with the low 
expression levels of the activation markers CD44, CD69, and LAG3 on the cell surface of 
VPS34-deficient Treg cells from mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice suggested that the loss 
of VPS34-kinase activity impairs the maturation of Treg cells in effector cells, thereby 
compromising the suppression of conventional T cells.  
However, Elisabeth demonstrated that VPS34-deficient Treg cells from FoxP3YFP-Cre 
Pik3c3fl/fl mice were similarly competent at suppressing the proliferation of Tcons in vitro 
(data not shown), and even in a superior manner compared to wild-type Treg cells at the ratio 
1:1, 1:2, and 1:4. Meanwhile, IL-2 concentration was reduced in a stepwise manner with 
increasing Treg:Tcon ratio but did not differ between co-cultures with Treg cells from 
FoxP3YFP-Cre Pik3c3fl/fl and wild-type mice (data not shown). These results demonstrate that 
Treg cells are able to develop without VPS34 and maintain functions associated with wild-
type Treg cells in vitro, yet fail to prevent lethal autoimmune disease in vivo. We therefore 
hypothesised that another suppressive mechanism than the suppression of Tcon proliferation 
is critical for immune homeostasis.  
Treg cells employ diverse mechanisms of suppression to ensure peripheral tolerance, 
including the production of immunomodulatory cytokines, the expression of inhibitory 
receptors, the consumption of cytokines and direct cytotoxic killing through granzymes and 
perforin. Elisabeth therefore assessed whether the suppressive functions of Treg cells were 
abrogated by the loss of VPS34-kinase activity. Her results indicated that loss of VPS34-kinase 
activity does not affect the consumption and downstream signalling of IL-2 (data not shown). 
Next, the capacity of VPS34-deficient Treg cells to indirectly suppress the activation of 
naïve CD4+ T cells by capturing the co-stimulatory molecules CD80/CD86 from the cell surface 
of DCs through the CTLA-4 receptor expressed on Treg cells was evaluated. The ability of Treg 
cells to rip off and endocytose CD80/CD86 from the cell surface of DCs was shown in an in 
vitro assay using ex vivo isolated Treg cells and CD80-GFP expressing Chinese hamster ovary 
(CHO) cells and is referred to as transendocytosis [42], [275]. When CTLA-4 expressed on the 
cell surface of Treg cells binds to these molecules, the CTLA-4 – CD80 /CTLA-4 – CD86 
complexes are rapidly internalized by clathrin-mediated endocytosis and degraded through 
the lysosomal pathway [276]. Based on the altered expression of CTLA-4 and CD80 on Treg 




cells and DCs, respectively, from FoxP3YFP-Cre Pik3c3fl/fl mice, we hypothesized that VPS34-
deletion impairs the transendocytosis of CD80 in CTLA-4 – expressing Treg cells.  
To test that, Treg cells were co-cultured with Chinese Hamster Ovary (CHO) cells 
expressing a C-terminally tagged CD80-GFP (CD80-GFP) protein (Fig. 3.7 a). Using flow 
cytometry, we observed a transfer of CD80-GFP into Treg cells (data not shown). Strikingly, 
Treg cells from FoxP3YFP-Cre Pik3c3fl/fl mice acquired more CD80 than Treg cells from FoxP3YFP-
Cre Pik3c3WT control mice (data not shown). Following transendocytosis, the internalized cargo 
is degraded through the endo-lysosomal pathway, a system relying on PI3P for the 
recruitment of several endosomal sorting machineries, such as retromer and ESCRT (16). 
Therefore, I considered whether the delivery of the endosomal cargo to the lysosomes for 
degradation is impaired, despite intact initial internalisation. To test this hypothesis, I 
developed a ‘pulse-chase’ assay. To ensure similar uptakes of CD80 and to delimit the effect 
of VPS34-deficiency to the degradation step, I used wild-type Treg cells for the initial co-
culture with CHO cells (pulse) (Fig. 3.7 a). Treg cells were then separated from CHO cells by 
fluorescence-activated cell sorting (FACS) (gated on GFP+ CD25+ CD4+ cells) and treated with 
VPS34 IN1, a selective inhibitor of VPS34 [277]. The percentage of GFP-positive Treg cells was 
assessed by flow cytometry at 0h, 24h, and 48h and taken as a measure for the presence of 
CD80 (Fig. 3.7 b). In the presence of pharmacological inhibitor VPS34-IN1, the degradation of 
the internalised CD80 was delayed (Fig. 3.7 c). Together, these results suggest that VPS34-
inhibition results in alterations in endolysosomal dynamics, possibly resulting in knock-on 
effects on Treg cells and reduce their overall capacity for suppression. 





Figure 3.7: VPS34 inhibition impairs the degradation, but not the trans-endocytosis, of CD80-GFP in 
vitro.  
a) Schematic representation of the trans-endocytosis assay: CD4+ cells from the lymph nodes of 
FoxP3YFP-Cre Pik3c3fl/fl mice by magnetic cell sorting (MACS) and co-cultured for 24 hours with in a 10:1 
ratio with Chinese Hamster Ovary (CHO) cells expressing CD80-GFP on their surface. Treg cells should 
internalize and accumulate CD80-GFP. Modified from Elisabeth Slack. 
b) Schematic of the pulse-chase assay: trans-endocytosis as shown in a) and after 24h co-culture, Treg 
cells were separated from the rest of the cells by fluorescence-activated cell sorting (FACS) and 
cultured presence of VPS34 IN1, a selective Vps34 inhibitor for up to 48 hours.  
c) The percentage of the GFP signal was assessed by flow cytometry directly after separation from the 
CHO cells (0h), and then 24 and 48 hours after separation. n = 4 biological replicates. Results are 
pooled from two independent experiments. Statistical significance was determined using an unpaired 
two-tailed Student’s t-test for each time point.   





3.3.1 Inactivation of VPS34 has interfered with a fundamental suppressive mechanism 
essential for Treg cell functions 
When Elisabeth started to investigate the role of VPS34 in Treg cells, only two studies had 
investigated the contribution of VPS34 in T cell homeostasis [227], [257], but none has 
concentrated on the role of VPS34 in Treg cells. During her PhD thesis, Elisabeth established 
that Treg cells critically rely on VPS34.  
McLeod et al. assessed the role of VPS34 in CD4+ and CD8+ T cells using the Lck-Cre 
recombinase system [227]. Doing so, they observed a defect in IL-7Rα trafficking and 
therefore impaired naïve T cell survival. Willinger and Flavell described a similar phenotype 
using a CD4-Cre recombinase system, but showed that impaired IL-7Rα trafficking in VPS34-
deficient T cells was due to the lymphopenic environment rather than a direct effect of VPS34-
deletion [257]. They observed that loss of VPS34 results in impaired mitochondrial 
homeostasis and thus reduced T cell survival. Neither studies reported any gross phenotype 
associated with T cell-specific deletion of VPS34. It was therefore a surprise to Elisabeth that 
Treg cell-specific deletion of VPS34 resulted in such a fatal inflammatory and 
lymphoproliferative disease, strikingly resembling the Scurfy phenotype. However, unlike the 
Scurfy mouse, the onset of the disease was delayed: while Scurfy mice become sick at around 
14 days after birth and succumb to their phenotype around 24 days after birth [278], FoxP3YFP-
Cre Pik3c3fl/fl mice started to develop abnormalities at around 21 days of age, and reached on 
average 35 days before they had to be sacrificed. Secondly, Treg cells were present in mice 
with VPS34-deficient Treg cells while Scurfy mice completely lack functional Treg cells.  
The absence or presence of Treg cells could reflect the point at which cells become 
affected by the lack of FoxP3 or VPS34. Since FoxP3 is necessary [278], [279] and sufficient 
[21] to generate Treg cells, a frame shift mutation in this gene impairs the formation of Treg 
cells in the Scurfy mouse. In FoxP3YFP-Cre Pik3c3fl/fl mice, VPS34 is only deleted once FoxP3 is 
expressed. FoxP3-expression occurs three days after birth and Treg cells should therefore 
develop normally in the thymus of FoxP3YFP-Cre Pik3c3fl/fl mice. Furthermore, VPS34 has a long 
half-life [227], so that Treg cells could easily contain functional VPS34 for some time after 
FoxP3 induction and Cre-recombinase expression. This resulting lag phase between Treg cells 




development, the induction of FoxP3, and the actual functional defect due to the lack of 
VPS34-kinase activity could explain the delayed onset of the fatal phenotype.  
The development of the fatal immune-proliferative disease in the presence of Treg 
cells established that inactivation of VPS34 interferes with a fundamental suppressive 
mechanism essential for Treg cells rather than their survival. A few genetic manipulations of 
Treg cells or their key molecules recapitulate the Scurfy phenotype. Obviously, the deletion 
of FoxP3 and the selective ablation of Treg cells are virtually identical to the firstly described 
Scurfy mouse [21], [280]. Other deletions have generated similar phenotypes. Among those, 
Treg cell-specific deletion of the transcription factor Foxo1 causes a similar disease to the 
Scurfy mouse, and Treg cell numbers are greatly reduced [281]. Foxo1 regulates around 300 
target genes that are distinct from the FoxP3-regulated gene repertoire [281] and suppresses 
detrimental IFN-γ transcription in Treg cells. However, deletion of Foxo1 does not affect any 
mechanisms relating to Treg cell functions and the observed phenotype is solely based on a 
lack of Treg cells [21], [280] or wider-ranging effects on their transcriptional programme 
[281]. In contrast, FoxP3YFP-Cre Pik3c3fl/fl mice do not lack Treg cells, and as a kinase whose role 
has been, so far, ascribed to autophagy and endocytosis, we speculated that VPS34 is unlikely 
to control Treg cell transcriptional programmes.  
CTLA-4 is a critical negative regulator of T cell activation and its deletion is sufficient 
to cause fatal disease [46]. Hence, mice with Treg cell-specific deletion of CTLA-4 develop 
lymphadenopathy and splenomegaly from seven weeks of age onwards, and ultimately die 
from severe myocarditis [48]. In CTLA-4 deficient mice, Treg cells are unable to downregulate 
CD80 and CD86 from dendritic cells, resulting in the uninterrupted co-stimulation of naïve T 
cells [48]. This was of particular interest in the context of FoxP3YFP-Cre Pik3c3fl/fl mice since CD80 
and CD86 expression is increased on the surface of dendritic cells despite increased 
expression of CTLA-4 on VPS34-deficient Treg cells. This raised the hypothesis that VPS34-
deficient Treg cells have a defect in CD80 transendocytosis, that is the ripping off and the 
internalization of the CD80 molecules by CTLA-4. However, Elisabeth observed that the 
transendocytosis of CD80 by VPS34-deficient Treg cells was elevated compared to VPS34-
sufficient Treg cells. The enhanced uptake likely reflects higher levels of CTLA-4 on the surface 
of VPS34-deficient Treg cells. This increase is most likely due to the activated immune 
phenotype of these mice, since VPS34-deficient Treg cells from FoxP3YFP-Cre/WT Pik3c3fl/fl 
mosaic mice display normal levels of CTLA-4. 




3.3.2 Impaired function of VPS34-deficient Treg cells may relate to impaired 
endolysosomal trafficking 
Autophagy is a highly conserved degradation process that is critical to maintain cellular 
homeostasis, is critical to establish Treg cell-mediated immune tolerance, and supports  
lineage stability and survival fitness [152]. Autophagy is increased after the initial activation 
of T cells, presumably as a mechanism to degrade the increasing cytoplasmic content that is 
generated as the T cells become more metabolically active [282]. 
Kabat et al. showed that autophagy is essential for Treg cell homeostasis and control 
of effector T cell responses in the gut by depleting Atg16l1 in Treg cells (Atg16l1ΔFoxp3 mice) 
[224]. Atg16l1 is an essential part of the autophagy complex with Atg5 and Atg12 that 
facilitates the elongation of the initial isolation membrane, resulting in the engulfment of the 
cargo and formation of the autophagosome. Atg16l1ΔFoxp3 mice appeared normal in early life, 
but developed a severe inflammatory disease characterized by progressive weight loss, 
splenomegaly, lymphadenopathy and leukocyte infiltration in multiple organs at around 5 
months [224]. 
We therefore considered whether defective autophagy may be the reason of the fatal 
lymphoproliferative disease observed in FoxP3YFP-Cre Pik3c3fl/fl mice. In order to specifically 
disable autophagy in Treg cells, we deleted Atg7, a protein essential for the induction of 
autophagy [268]. These mice were initially healthy and survived for up to a year (t1/2 = 269 
days). Hence, defective autophagy may contribute to, but is not the primary cause of the 
profound autoimmunity observed upon inactivation of VPS34 in Treg cells. Furthermore, 
these results strongly imply that inactivation of VPS34 has interfered with a fundamental 
suppressive mechanism essential for Treg cell function which we suspect is related to the role 
of VPS34 in endocytosis rather than autophagy.  
PI3P is localised to early endosomes where it is required for the recruitment of PX- or 
FYVE- domain – containing proteins, as found in several endosomal sorting machineries, such 
as retromer and ESCRT [283]. Inhibition of VPS34, and subsequent loss of PI3P, prevents the 
recruitment of Armus, a Rab7 GAP, and results in the hyperactivation of Rab7, enlarged 
endosomes, and altered endosomal dynamics [239]. Therefore, I considered whether the 
delivery of the endosomal cargo to lysosomes for degradation is impaired, despite intact 
initial internalisation. Indeed, in the presence of VPS34-IN1, a pharmacological inhibitor of 




VPS34, the degradation of the internalised CD80 was delayed. A block in the degradation of 
endocytosed material could have knock-on effects on Treg cells and reduce their overall 
capacity for suppression, either because the total number of ligands endocytosed per Treg 
cell may be reduced or because Treg cells become congested and stop functioning altogether.  
 
3.3.3 VPS34 is either required for Treg cell differentiation into a CD44high phenotype or 
CD44high Treg cells depend on VPS34 for their survival 
TCR signalling is essential for the maintenance and function of Treg cells [284]. The lack of 
Treg cells with a more mature phenotype may therefore reflect an inability of VPS34-deficient 
Treg cells to respond to TCR-dependent cues that promote their maturation and hence the 
development of a fully suppressive phenotype in vivo.  
Phenotypic analyses of Treg cells in FoxP3YFP-Cre x Pik3c3fl/fl mice revealed that a smaller 
proportion expressed high levels of CD44, a marker of activated or memory T cells. However, 
VPS34-deficient Treg cells were able to suppress CD4+ CD25- Tcon in vitro. These results 
demonstrate that Treg cells maintain suppressive functions in vitro, yet fail to acquire a 
mature phenotype and to prevent lethal autoimmune disease. 
Analysis of mosaic mice showed that the VPS34-deficient Treg cells were at a 
competitive disadvantage compared to VPS34-sufficient Treg cells. Furthermore, the 
proportion of Treg cells expressing CD44 was lower among VPS34-deficient Treg cells from 
mosaic mice, suggesting that VPS34 is intrinsically required for Treg cells to differentiate into 
a more mature phenotype or alternatively, that mature Treg cells depend on VPS34 for their 
survival. Future work will aim to provide an answer to this open question. 
 
  




3.4 Chapter summary 
I consolidated the data produced by Elisabeth and further worked on understanding the role 
of VPS34 in Treg cells. I have established that while VPS34-deficiency does not affect CD80 
transendocytosis, it is required for the degradation of the endocytosed cargo. At which point 
the blockage occurs remains to be determined and is the content of future work that I am 
currently undertaking.  
While autophagy might be defective in VPS34-deficient Treg cells, I have shown that 
mitophagy is indeed impaired in VPS34-deficient Treg cells. The implications of this 
observation will be further investigated and put into context in Chapter 4.  
Based on the observations that VPS34-defiicent Treg cells have a competitive 
disadvantage and express less of the activation marker CD44, I have started to investigate 
whether VPS34 is required for the maturation of Treg cells using a tumour model. Together, 






Discovery of novel mechanisms of regulatory 
T cell suppression 
  





Results presented in the previous chapter suggest that while VPS34 is redundant for Treg cell 
development and survival, it is critical for Treg cell suppression and maintenance of immune 
homeostasis. Which Treg cell suppression mechanism(s) is/are affected needs to be 
determined. Although the lysosomal degradation of the endocytosed cargo appears to be 
impaired, VPS34-deficient Treg cells are still able to deplete costimulatory ligands and 
cytokines and yet lack one or more hitherto unrecognised mechanisms of suppression.  
The abundance of newly-synthesised proteins is regulated by post-transcriptional 
mechanisms. It is therefore important to determine the relative amount of any given protein 
in a cell in addition to determining individual mRNA expression levels. This is especially 
pertinent for VPS34, which is primarily thought to affect trafficking of subcellular vesicles and 
their associated proteins. A block at any stage in these processes should alter the steady-state 
levels of proteins involved in steps before and after the block had occurred. Therefore, with 
the aim to discover such novel suppressive functions of Treg cells, I determined how VPS34-
deficiency affects the Treg cell proteome. 
Because FoxP3YFP-Cre Pik3c3fl/fl mice develop such a profound inflammatory disease, we 
could not be certain whether any observed Treg cell phenotype is due to VPS34 specifically 
or whether alterations are secondary to the inflammatory milieu. Therefore, the studies 
performed and described in this chapter are conducted using female FoxP3YFP-Cre/WT Pik3c3fl/fl 
mosaic mice in which VPS34 was lacking in only about half of the Treg cells.  
 
  





4.2.1 Ablation of VPS34 kinase activity destabilizes VPS34 complex II 
To gain insight into the molecular mechanisms underlying the defects in VPS34-deficient Treg 
cells, I used quantitative label-free high-resolution mass spectrometry (MS) to compare the 
proteome of VPS34-deficient and VPS34-sufficient Treg cells (in collaboration with Prof. 
Doreen Cantrell, Dr. Laura Spinelli and Dr. Christina Rollings from the University of Dundee, 
School of Life Sciences). To exclude potentially secondary effects caused by systemic 
inflammation, I performed the analysis on YFP+ VPS34-deficient Treg cells from phenotypically 
normal mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl female mice and used YFP+ VPS34-sufficient Treg cells 
from FoxP3YFP-Cre/WT Pik3c3WT/WT mice as a control. Proteins from three different biological 
replicates were analysed. Identified peptides were matched to a single protein or multiple 
proteins, termed protein groups, using MaxQuant software [285]. This approach led to the 
identification of more than 6400 protein groups per biological replicate (see: 
https://drive.google.com/open?id=1Cvc7qbHMBNE6pF-ZypL3GzAJhxxDhihZ). Copy numbers 
for proteins from three biological replicates showed strong Pearson correlation coefficients 
(r2=0.9899 – 0.9948), with very few outliers indicating robustness and reproducibility of this 
MS-based peptide quantitation method (Fig. 4.1.1 a). 
The percentage of histone content from the total protein content was slightly but 
significantly reduced for VPS34-deficient compared to VPS34-sufficient Treg cells (Fig. 4.1.1 
b). Assuming that the histone content is consistent in a same population, a relative reduction 
in the histone content indicates that the amount of the remaining non-histone proteins is 
elevated, suggesting an increase in the cell size. Indeed, the protein content was significantly 
increased in VPS34-deficient Treg cells compared to wild-type Treg cells (Fig. 4.1.1 c); 
however, this was not reflected by flow cytometry analysis of forward (FSC-A) and side scatter 
(SSC-A) (Fig. 4.1.1 d). 
In total, 6498 proteins with a minimum of two unique peptides were identified in both 
VPS34-deficient and –sufficient Treg cells (Fig. 4.1.2 a and b, respectively). There was >99% 
overlap in the proteins identified among the three biological replicates of each condition (Fig. 
4.1.2 c).  
 





Figure 4.1.1: Proteomic profiling of VPS34-deficient Treg cells. 
a) Scatter plots of estimated protein copy numbers using the proteomic ruler approach show high 
reproducibility of protein intensities and ~98% of identified proteins are detected in all three biological 
replicates for VPS34-sufficent and VPS34-deficient Treg cells. R2 = coefficient of determination.  
b) Total histone content as the percentage of total protein content of VPS34-sufficent (WT) and VPS34-
deficient (KO) Treg cells.  
c) Total protein content of VPS34-sufficent (WT) and VPS34-deficient (KO) Treg cells.  
d) Flow cytometry plot of forward and side scatter VPS34-sufficent (WT, grey) and VPS34-deficient 
(KO, orange) Treg cells.  
n = 3 biologically independent samples for each of the Treg cell populations.  Statistical significance 
was determined using an unpaired two-tailed Student’s t-test. Histogram bars represent means ± S.D. 
 





Figure 4.1.2: Commonality of proteins identified in the proteomic analysis. 
The Venn diagram shows the commonality of proteins identified in the proteomic analysis among the 
three biological replicates for VPS34-sufficent and VPS34-deficient Treg cells (a and b), and 
commonality between total VPS34-sufficient and VPS34-deficient Treg cells (c). n = 3 biologically 
independent samples for each of the Treg cell populations.   
 
I carried out statistical analyses to classify proteins specifically up- or down-regulated in 
VPS34-deficient Treg cells compared to VPS34-sufficient Treg cells. A two-sided paired t-test 
was performed on the three biological replicates and the proteins presenting a p-value under 
or equal to 0.05 and a minimum 2-fold change between VPS34-deficient and VPS34-sufficient 
Treg cells were considered significative. According to these criteria, I identified a total of 140 
differentially expressed proteins, 122 more abundant and 18 less abundant in VPS34-deficient 
Treg cells compared to VPS34-sufficient Treg cells (Fig. 4.1.3 a).  
Among proteins down-regulated in VPS34-deficient Treg cells, VPS34 protein level was 
reduced by half (Fig. 4.1.3 b), suggesting that the internal deletion of 25 amino acids in the 
kinase domain not only inhibits kinase activity but also affects the stability of the VPS34 
protein. The copy numbers of VPS15, Beclin-1 and UVRAG, three binding partner of VPS34 
complex II (endocytosis complex), were also decreased by half in VPS34-deficient Treg cells 




compared to VPS34-sufficient Treg cells (Fig. 4.1.3 b). Atg14L was not detectable in this data 
set for both VPS34-deficient and VPS34-sufficient Treg cells. Taken together, these results 
suggest that VPS34 is necessary for the stability of the endocytosis complex, and loss of 
VPS34-kinase activity results in the reduction by half of VPS34, along with its binding partners 










Figure 4.1.3: Differentially expressed proteins in 
VPS34-deficient Treg cells. 
a) The volcano plot shows the ratio of the protein 
copy numbers in VPS34-deficient Treg cells 
compared to VPS34-sufficient Treg cells. Proteins 
that exhibited statistically significant increase in 
abundance (P < 0.05 by one-sample Student’s t test) 
by greater than 1.5-fold are shown in red, while 
proteins that exhibit statistically significant 
reduction in abundance are shown in blue (the cut-  
A twofold decrease in protein abundance is indicated by the vertical dashed line.  
b) Volcano plots of the VPS34-dependent proteome in Treg cells: ratio of the protein abundance 
(copy number) in VPS34-deficient compared to VPS34-sufficent Treg cells was plotted against P value 
(as determined by one-sample Student’s t test). Proteins with ratios that were statistically 
significantly regulated (P < 0.05) by >1.5-fold are shown in blue, with binding partners of the VPS34 
complex II highlighted. Bar graphs show estimated copy numbers calculated using the proteomic data 
for Atg14L, VPS15, Beclin-1, UVRAG, and VPS34. Individual data points from the three biological 
replicates performed for the proteomic analysis are shown, with the bar showing the 
means ± S.D. p values were calculated by two-tailed, one-sample Student’s t test.  
off is indicated by the horizontal dashed line).  




4.2.2 Various protein classes are affected by VPS34-deletion in Treg cells 
To understand the dominant consequences of VPS34-deletion on the Treg cell proteome, I 
first focused on proteins that were most increased and decreased in VPS34-deficient Treg 
cells (i.e. outliers). The rationale behind this approach was that a striking difference in the 
abundance of a specific protein might reveal of strong dependency of this protein and related 
pathways to VPS34 kinase activity. 
In total, ten proteins were considered as ‘outliers’, among which three were highly 
upregulated (Fig. 4.2 a) while seven downregulated (Fig. 4.2 b). Tables 4.2.1 and 4.2.2 
summarize the function of each protein. Apart of Beclin-1, none of the down- or upregulated 
proteins mapped to a common pathway or biological process, nor was I able to attribute any 
of the given proteins to a process involved in known Treg cell suppression mechanisms or T 
cell function, nor were any of them PI3P binders.  
 
Figure 4.2: Volcano plots of strongly differentially expressed proteins in VPS34-deficient Treg cells. 
Volcano plots of the VPS34-dependent proteome in Treg cells: ratio of the protein abundance (copy 
number) in VPS34-deficient compared to VPS34-sufficent Treg cells was plotted against P value (as 
determined by one-sample Student’s t test). Strongly downregulated proteins with ratios that were 
statistically significantly downregulated (p < 0.05) by >1.5-fold are highlighted in blue (a) while strongly 
upregulated proteins are shown in red (b). n = 3 biologically independent samples for each of the Treg 



















Table 4.2.2: List of upregulated ‘outliers’ in VPS34-deficient Treg cells. 
 
 
Downregulated ‘outlier’ proteins were H1F0 (Histone H1.0), Mdr-1 (Multidrug resistance 
protein 1A), TMEM-38 (Trimeric intracellular cation channel type B), GPR68 (Ovarian cancer 
G-protein coupled receptor 1), GBP-1 (Interferon-induced guanylate-binding protein 1), S100-
A1 (Protein S100), and Beclin-1 (Table 4.2.1).  
Downregulation of S100-A1, which is involved in the regulation of a number of cellular 
processes such as cell cycle progression and differentiation, could support the observation 
made in Chapter 3 (Fig. 3.5.1) that VPS34-deficient Treg cells have a block in cell maturation, 
thus do not differentiate into effector cells with suppressive functions. Furthermore, 
downregulation of histone H1F0, found in cells that are in terminal stages of differentiation 




or that have low rates of cell division [286], rather suggests that VPS34-deficient Treg cells are 
in a state of high proliferation, and not yet in a state of final differentiation. 
Upregulated ‘outlier’ proteins were protein FAM134B, Gabarapl2 (Gamma-
aminobutyric acid receptor-associated protein-like 2), and AMARC (Alpha-methylacyl-CoA 
racemase).  
It has been suggested that protein FAM134B overexpression results in ER fragmentation and 
lysosomal degradation. Gabarapl2 is involved in autophagosome maturation and mitophagy, 
and regulates mitochondrial quantity and quality by eliminating mitochondria to a basal level. 
Upregulation of Gabarapl2 would therefore be predicted to lead to less mitochondria and 
more autophagy, contrary to the results described in Chapter 3 (Fig. 3.2.1). 
 
4.2.3 Known pathways and biological functions of Treg cells are not affected by VPS34-
deletion 
VPS34 has been attributed to two main functions, depending on the proteins it complexes 
with. In metazoans, VPS34 has been found to play a critical role in endocytosis, autophagy, 
and mTOR activation [287]. I therefore quantified the effect of VPS34-deletion on the content 
of proteins involved in processed known to be dependent on VPS34, pathways relating to 
autophagy, endocytosis, and trafficking as well as proteins required for Treg cell 
development, survival and fitness. 
Regarding Treg cell or broader T cell identity, protein content of FoxP3, CD25 (IL2-Rα), 
CD4, and CD45 was unchanged changed (Fig. 4.3.1 a). In contrast to the results from the 
phenotyping performed in Chapter 3 (Fig. 3.6.1 c, Fig. 3.5.1 b and Fig. 3.6.2), protein levels of 
CD44, CD69, and Ki67 (Mki67) were similar between VPS34-deficient and –sufficient Treg cells 
(Fig. 4.3.1 b). Only CTLA-4 and ICOS levels matched previous observations, i.e. were 
unchanged in VPS34-deficient Treg cells compared to VPS34-sufficient Treg cells (Fig. 3.4.1 b 
and Fig. 3.4.2 d).  
 





Figure 4.3.1: Estimated copy numbers of proteins involved in Treg cell identity and cell activation. 
a) Bar graphs show estimated copy numbers calculated using the proteomic data for FoxP3, IL2Rα, 
CD4, and CD45. b) Bar graphs show estimated copy numbers calculated using the proteomic data for 
CD44, IL7-R, CTLA-4, ICOS, CD69, and Ki67 (Mki67). Individual data points from the three biological 
replicates performed for the proteomic analysis are shown, with the bar showing the 
means ± S.D. p values were calculated by two-tailed, one-sample Student’s t test. 
 
Next, I assessed protein levels of different Foxo and Stat transcription factors, components of 
the TCR, tyrosine kinases and phosphatases (involved in T cell receptor (TCR) and IL-2 receptor 
signalling), as well as IL-2 receptor and associates tyrosine kinases and found no differences 
between VPS34-deficient and – sufficient Treg cells (Fig. 4.3.2 a – d).  
Since VPS34 has been linked to mTORC1, I analysed whether VPS34-deficiency would 
affect mTOR signalling and downstream signalling. I found no differences in protein levels 
(Fig. 4.3.3 a – c). Similarly, proteins involved in glycolysis as well as nutrient transporters and 
nutrient receptors were unchanged (Fig. 4.3.4 a – c, respectively). 
Next, I assessed autophagy genes, autophagy-related and – interacting proteins (Fig. 
4.3.5 a – c and Fig. 4.3.6). The only differentially expressed protein was Atg2A, which was 
significantly upregulated (ratio WT/KO = 1.989889802, p = 0.0014) in VPS34-deficient Treg 
cells. Atg2A binds to WIPI (WD-repeat protein interacting with phosphoinositides). WIPI plays 
an important role in recognising and decoding the PI3P signal at the nascent autophagosome, 
hence Atg2A contributes in regulating the size of nascent auto-phagosomes [288]. 




Figure 4.3.2: Estimated copy numbers of Foxo and Stat transcription factors, proteins of the TRC 
complex, tyrosine kinases and phosphatases, and IL-2R subunits. 
a) Bar graphs show estimated copy numbers calculated using the proteomic data for Foxo and Stat 
transcription factors.  
b) Bar graphs show estimated copy numbers calculated using the proteomic data for proteins of the T 
cell receptor (TCR) complex. Volcano plots of the VPS34-dependent proteome in Treg cells: ratio of 
the protein abundance (copy number) in VPS34-deficient compared to VPS34-sufficent Treg cells was 
plotted against P value (as determined by one-sample Student’s t test). Proteins of the TRC complex 
are highlighted.   
(c - d) Bar graphs show estimated copy numbers calculated using the proteomic data for tyrosine 
kinases and phosphatases (c) and IL-2R subunits (d). Individual data points from the three biological 
replicates performed for the proteomic analysis are shown, with the bar showing the 








Figure 4.3.3: Estimated copy numbers of proteins involved in mTOR signalling and AMPK, tyrosine 
kinases and phosphatases, and IL-2R subunits. 
a) Bar graphs show estimated copy numbers calculated using the proteomic data for of proteins 
involved in mTOR signalling.  
b) Bar graphs show estimated copy numbers calculated using the proteomic data for AMPK (Prkaa 1 
and Prkab1).  




c) Volcano plots of the VPS34-dependent proteome in Treg cells: ratio of the protein abundance (copy 
number) in VPS34-deficient compared to VPS34-sufficent Treg cells was plotted against P value (as 
determined by one-sample Student’s t test). Proteins of mTORC1 complex are highlighted.  Individual 
data points from the three biological replicates performed for the proteomic analysis are shown, with 
the bar showing the means ± S.D. p values were calculated by two-tailed, one-sample Student’s t test. 
 
 
Figure 4.3.4: Estimated copy numbers of proteins involved in glycolysis, nutrient transporters and 
nutrient receptors.  
a - c) Bar graphs show estimated copy numbers calculated using the proteomic data for of proteins 
involved in glycolysis (a), nutrient transporters (b), and nutrient transporters (c). Individual data points 
from the three biological replicates performed for the proteomic analysis are shown, with the bar 
showing the means ± S.D. p values were calculated by two-tailed, one-sample Student’s t test. 
 
 





Figure 4.3.5: Estimated copy numbers of proteins involved in autophagy and autophagy-related 
proteins. 
a) Bar graphs show estimated copy numbers calculated using the proteomic data for proteins involved 
in autophagy.  
b) Volcano plots of the VPS34-dependent proteome in Treg cells: ratio of the protein abundance (copy 
number) in VPS34-deficient compared to VPS34-sufficent Treg cells was plotted against P value (as 
determined by one-sample Student’s t test). Proteins involved in autophagy are highlighted.  
c) Bar graphs show estimated copy numbers calculated using the proteomic data for autophagy-
related proteins (Atg’s). Individual data points from the three biological replicates performed for the 
proteomic analysis are shown, with the bar showing the means ± S.D. p values were calculated by two-









Figure 4.3.6: Estimated copy numbers of Atg-related and interacting proteins involved. 
Bar graphs show estimated copy numbers calculated using the proteomic data for Atg-related and 
integrating Individual data points from the three biological replicates performed for the proteomic 
analysis are shown, with the bar showing the means ± S.D. p values were calculated by two-tailed, 
one-sample Student’s t test. 
 
Within the Rab proteins, members of the Ras-related small GTPases family, Rab1a, Rab2a, 
Rab2b, and Rab18 were significantly upregulated (Fig. 4.3.7 a). Table 4.3 summarizes the 
function of each differentially expressed Rab protein in this data set. In regards to proteins 
associated with vesicle and membrane trafficking (Syntaxins, Vamps and LAMPs), none of 
these were differentially expressed in VPS34-sufficient Treg cells (Fig. 4.3.7 b – d). Similarly, 
vacuolar protein sorting (Vps)-associated proteins and lysosomal components were 
expressed as levels similar to VPS34-sufficient Treg cells (Fig. 4.3.8 a – d), apart of VPS34 as 































































































Figure 4.3.7: Estimated copy numbers of Rab proteins, syntaxins, VAMPs and LAMPs.  
a - d) Bar graphs show estimated copy numbers calculated using the proteomic data for Rab proteins 
(a), syntaxins (b), vesicle-associated membrane proteins (VAMPs) (d), and lysosome-associated 
membrane glycoprotein (LAMPs) (d). Individual data points from the three biological replicates 
performed for the proteomic analysis are shown, with the bar showing the means ± S.D. p values were 










Figure 4.3.8: Estimated copy numbers of vacuolar protein sorting-associated proteins and lysosomal 
components.  
Bar graphs show estimated copy numbers calculated using the proteomic data for vacuolar protein 
sorting-associated proteins (a - c) and lysosomal components (d). Individual data points from the three 
biological replicates performed for the proteomic analysis are shown, with the bar showing the 









Table 4.3: Function of Rab-proteins differentially expressed in VPS34-deficient Treg cells. 
Protein Description 
Rab1a This protein controls vesicle traffic from the endoplasmic reticulum to the 
Golgi apparatus. 
Diseases associated with RAB1A include Hypotrichosis 3 and Rectum 
Adenocarcinoma. Among its related pathways are Vesicle-mediated 
transport and Transport to the Golgi and subsequent modification. 
An important paralog of this gene is RAB1B. 
Rab2a This protein is a resident of pre-Golgi intermediates, and is required for 
protein transport from the endoplasmic reticulum (ER) to the Golgi complex. 
Diseases associated with Rab2a include Sezary's Disease and Warburg Micro 
Syndrome 4. Among its related pathways are AMP-activated Protein Kinase 
(AMPK) signalling and cell cycle (mitosis). An important paralog of this gene 
is RAB2B. 
Rab2b Among its related pathways are Sertoli-Sertoli Cell Junction Dynamics and 
RAB geranylgeranylation.  
An important paralog of this gene is RAB2A. 
Rab18 This protein may have a role in eye and brain development.  
Diseases associated with RAB18 include Warburg Micro Syndrome 
3 and Warburg Micro Syndrome 1. Among its related pathways are Vesicle-
mediated transport and Innate Immune System.  
An important paralog of this gene is RAB2A. 
 
Next, I used DAVID functional annotation clustering [289] to assess whether differentially 
expressed proteins map to common pathways. This could shed light on the process(es) 
altered in mice VPS34-deficient Treg cells leading to the overt lymphoproliferative phenotype, 
as well as identify possible blockage in these pathways that would alter the steady-state levels 
of proteins involved in steps before and after the block occurred. To this end, I ran DAVID 
clustering analysis using the combined list of differentially expressed proteins (i.e. combining 
both up- and downregulated proteins) and observed that these proteins mapped to five 
different pathways (Fig. 4.3.9 – Fig. 4.3.11). Two pathways, namely ‘TLR9 cascade’ and ‘Signal 
transduction: RHO GTPases Activate NADPH Oxidases’ involved only downregulated proteins 
(Fig. 4.3.9 a and b, respectively). Only three proteins, i.e. early endosome antigen 1 (EEA1), 
VPS15 and VPS34 mapped to ‘TLR9 cascade’ (Fig. 4.3.9 a). In the ‘Signal transduction: RHO 
GTPases Activate NADPH Oxidases’ pathway, three proteins were downregulated, i.e. 
cytochrome b-245, beta polypeptide (Cybb), as well as VPS15 and VPS34 (Fig. 4.3.9 b). 




Two other pathways mapped only proteins that were upregulated in VPS34-deficient Treg 
cells: ‘Golgi Stack Pericentriolar Reorganization’ and ‘O-linked glycolysation’ (Fig. 4.3.10 a and 
b, respectively). Proteins those expression was upregulated and that mapped to ‘Golgi Stack 
Pericentriolar Reorganization’ pathway were Rab1A, Rab2A and Golgi reassembly stacking 
protein 2 (GORASP2) (Fig. 4.3.10 a). GORASP2, also known as GRASP55, may play a role in the 
stacking of Golgi cisternae and Golgi ribbon formation, as well as Golgi fragmentation during 
apoptosis or mitosis. Furthermore, it also plays a role in the intracellular transport of 
transforming growth factor alpha and may function as a molecular chaperone. 
GORASP2/GRASP55 and Rab2A are part of a larger complex located on medial-Golgi that is 
essential for normal protein transport and Golgi structure [290]. GORASP1, also referred to 
as GRASP65, is important for the organization of cis-Golgi cisternae [290]. The GTP form of 
Rab1 interacts with GRASP65 the vesicle tethering factor p115 and the cis-Golgi matrix 
protein GM130, and together regulate the transport from the endoplasmatic reticulum (ER) 
to the Golgi apparatus. 
Five proteins were significantly upregulated in the ‘O-glycolysation’ pathway: Galnt7, 
Galnt12, Galnt1, C1galt1c1, and C1galt1 (Fig. 4.3.10 b). 
The N-acetylgalactosaminyltransferase 7 (Galnt7) is a type II transmembrane protein and a 
member of the GalNAc-transferase family. It controls the initiation step of mucin-type O-
linked protein glycosylation and the transfer of N-acetylgalactosamine to serine and 
threonine amino acid residues [291]. An important paralog is Galnt1. 
The polypeptide N-acetylgalactosaminyltransferase 1 (Galnt1) is a member of the UDP-N-
acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family 
of enzymes  and catalyses the initial reaction in O-linked oligosaccharide biosynthesis, i.e. the 
transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the 
protein receptor [292]. 
Galnt12 encodes a member of a family of UDP-GalNAc:polypeptide N-
acetylgalactosaminyltransferases, which catalyse the transfer of N-acetylgalactosamine 
(GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the 
initial step of O-linked protein glycosylation [293]. It induces the initial reaction in O-linked 
oligosaccharide biosynthesis, i.e. the transfer of an N-acetyl-D-galactosamine residue to a 
serine or threonine residue on the protein receptor [293]. 




C1galt1c1 is a type II transmembrane protein that is similar to the core 1 β1,3-
galactosyltransferase 1, which catalyses the synthesis of the core-1 structure, also known as 
Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks the 
galactosyltransferase activity itself, but instead acts as a molecular chaperone required for 
the folding, stability and full activity of the core 1 β1,3-galactosyltransferase 1 [294]. It is 
probably a molecular chaperone required for the generation of 1 O-glycan Gal-β1-3GalNAc-
α1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins, 
and probably assists the folding/stability of core 1 β-3-galactosyltransferase (C1galt1) [295]. 
C1galt1 (Core 1 Synthase, Glycoprotein-N-Acetylgalactosamine 3-Beta-Galactosyltransferase 
1) generates the common core 1 O-glycan structure, Gal-β-1-3GalNAc-R, by the transfer of 
Gal from UDP-Gal to GalNAc-α-1-R, which is a precursor for many extended O-glycans in 










Figure 4.3.9: Pathway analysis of proteins downregulated in VPS34-deficient Treg cells. 
DAVID functional clustering analysis using the combined list of differentially expressed proteins 
identified in the proteomic profiling analysis was performed to assess to which pathway(s) the 
differentially expressed proteins in VPS34-deficient Treg cells mapped to. The pathways involving only 
downregulated proteins are shown here. Scheme based on https://reactome.org/content/detail/R-










Figure 4.3.10: Pathway analysis of proteins upregulated in VPS34-deficient Treg cells. 
DAVID functional clustering analysis using the combined list of differentially expressed proteins 
identified in the proteomic profiling analysis was performed to assess to which pathway(s) the 
differentially expressed proteins in VPS34-deficient Treg cells mapped to. The pathways involving only 
upregulated proteins are shown here. Scheme based on https://reactome.org/content/detail/R-HSA-
162658 and https://reactome.org/content/detail/R-HSA-5173105. 




‘Macroautophagy’ was the only pathway that includes both up- and downregulated proteins 
(Fig. 4.3.11). Downregulated proteins comprised the VPS34 complex 2 (UVRAG, Beclin-1, 
VPS34, and VPS15). Meanwhile, only one protein, gamma-aminobutyric acid (GABA) A 
receptor-associated protein-like 2 (Gabarapl2), was upregulated in this pathway. Gabarapl2 




Figure 4.3.11: Pathway analysis of proteins up- and downregulated in VPS34-deficient Treg cells. 
DAVID functional clustering analysis using the combined list of differentially expressed proteins 
identified in the proteomic profiling analysis was performed to assess to which pathway(s) the 
differentially expressed proteins in VPS34-deficient Treg cells mapped to. ‘Macroautophagy’ was the 
only pathway involving both up- and downregulated proteins and is shown here. Scheme based on 
https://reactome.org/content/detail/R-MMU-1632852. 




In conclusion, analysis of expression levels of proteins involved in pathways known to be 
dependent on VPS34, relating to autophagy, endocytosis, and trafficking as well as proteins 
required for Treg cell development, survival and fitness did not provide obvious insights into 
pathways or processes being affected by loss of VPS34 kinase activity in Treg cells. From the 
few differentially expressed proteins mentioned above, it is hard to deduce the effects of the 
loss of VPS34-kinase activity and the ensuing effects on Treg cells at a protein level. 
Furthermore, I could not map more than a few proteins (apart of the known complex binding 
partners of VPS34) to a common pathway, and only ‘macroautophagy’ involved both up- and 
downregulated proteins. From this analysis, the primary reason for the observed phenotype 
of FoxP3YFP-Cre Pik3c3fl/fl mice remains elusive. 
 
4.2.4 Loss of VPS34 kinase activity increases metabolic potential in Treg cells 
Using DAVID functional annotation clustering to identify biologically relevant groups of 
proteins with altered expression, I observed that downregulated proteins are involved in 
biological processes relating to ‘Regulation of cytokinesis’, ‘Receptor catabolic process’, 
‘Macroautophagy’, ‘Cellular response to glucose starvation’, ‘Late endosome to vacuole 
transport’, ‘Autophagy’, ‘Intestinal absorption’, ‘Endocytosis’, ‘Cytokinesis’, ‘Lysosome 
reorganization’, ‘Positive regulation of autophagy’, ‘Autophagosome assembly’, and 
‘Negative regulation of neuron projection development’ (Fig. 4.4.1 a). None of these 
biological processes entailed more than four differentially expressed proteins, and VPS34 and 
VPS15 were always among the proteins listed. Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway analysis of downregulated proteins revealed two pathways – ‘Regulation of 
autophagy’ and ‘Phagosome’, each with only three differentially regulated proteins, which 
were namely VPS34, VPS15 and UVRAG (Fig. 4.4.1 b).  
I noted that the loss of VPS34 kinase activity led to the up-regulation of proteins 
involved in biological processes (BP) relating to oxidation-reduction processes (Fig. 4.4.2 a). 
Up-regulated proteins related to cellular components (CC) involved mitochondrial functions, 
specifically mitochondrial inner membrane, mitochondrion, respiratory chain, mitochondrial 
respiratory chain complex I, mitochondrial intermembrane space, and membrane (Fig. 4.4.2 
a). Proteins upregulated in VPS34-deficient Treg cells relating to molecular function (MF) 
included cytochrome c-oxidase activity (Fig. 4.4.2 a). 






Figure 4.4.1: GO Term and KEGG pathway analyses of downregulated proteins. 
a) Gene Ontology (GO) Term analysis of biological processes involving proteins downregulated in 
VPS34-deficient Treg cells identified in the proteomic profiling analysis. 
b) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of biological processes 
involving proteins downregulated in VPS34-deficient Treg cells identified in the proteomic profiling 
analysis. 
 
These data suggested that VPS34-deficiency leads to the upregulation of proteins involved in 
mitochondrial function and energy metabolism. Specifically, I identified increased levels of 
proteins involved in metabolic pathways (Fig. 4.4.2 b), and oxidative phosphorylation 
(OXPHOS) (Fig. 4.4.2 b and c) with subunits of the electron transport chain complexes I, III and 
IV, namely Uqcrb, Cox6b1, Cox7a2l, Cox5a, Ndufs5, and Ndufv3 (Fig. 4.4.2 b), being the most 
affected.  





To assess if alterations in mitochondrial protein levels translated into augmented 
mitochondrial respiration/activity, I assessed ATP levels. ATP is an indicator of metabolically 
active cells, and the number of viable cells can be assessed based on the amount of ATP 
available. Indeed, pharmacological inhibition of VPS34-kinase activity resulted in an increased 
ATP production (Fig. 4.4.3 a). These findings led to the hypothesis that the loss of VPS34 
kinase activity induces a state of metabolic dysregulation in Treg cells. I therefore assessed 
whether differences in protein levels identified by proteomic profiling in VPS34-deficient Treg 
cells were accompanied by biologically relevant differences in energy levels. To quantify 
Figure 4.4.2: Pathway analyses of upregulated 
proteins. 
a) Analysis of biological processes (PB), cellular 
components (CC), molecular function (MF) 
involving proteins upregulated in VPS34-deficient 
Treg cells identified in the proteomic profiling 
analysis. 
b) Heat map presenting proteins upregulated in 
VPS34-deficient Treg cells identified in the 
proteomic profiling analysis.  
 




mitochondrial respiration in VPS34-deficient Treg cells, I measured the mitochondrial oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) using the Seahorse 
extracellular flux Energy Phenotype assay and found that VPS34-deficient Treg cells displayed 
increased OCR and ECAR (Fig. 4.4.3 b), leading to an increase metabolic potential (Fig. 4.4.3 
c). An elevated OCR is indicative of increased mitochondrial respiration, while ECAR serves as 
an indicator of whether glucose is also catabolized through mitochondrial respiration. These 
results are in line with increased mitochondrial mass (Fig. 3.2.1 c) and numbers (Fig. 3.2.1 d). 
Collectively, these data indicate an increase in the metabolic activity of VPS34-deficient Treg 
cells. 
Figure 4.4.3: Metabolic rate is increased in VPS34-deficient Treg cells.  
a) ATP levels of Treg cells treated with the pharmacological inhibitor VPS34-IN1 or the vehicle control 
DMSO. Individual data points from the three biological replicates, with the bar showing the 
means ± S.D. p values were calculated by two-tailed, one-sample Student’s t test. Results are 
representative of three independent experiments.  
b and c) Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of VPS34-deficient 
Treg cells at before and after addition of 0.5uM FCCP and 10µM oligomycin following the Seahorse XF 




Cell Energy Phenotype Test Assay protocol. c) Bar showing the means ± S.D. of the metabolic potential. 
p values were calculated by two-tailed, one-sample Student’s t test. Results are representative of two 
independent experiments. 
  





Recent advances in proteomics allow for the unprecedented quantification of the total 
proteome such that one can determine the copy number of more than 8000 proteins from 
one million or fewer primary T cells [297]. The known role of VPS34 in trafficking of subcellular 
vesicles (and their associated proteins), rather than regulating transcriptional activities, 
supported the rationale to determine the proteome rather than individual mRNA expression 
levels. I have therefore analysed the protein content of VPS34-deficient Treg cells and 
compared it to VSP34-sufficient Treg cells. I generated a list of differentially expressed 
proteins as well as assessed whether the level of proteins involved in pathways and cellular 
processes relating to autophagy, endocytosis, and trafficking or required for Treg cell 
development, survival and fitness are affected by the loss of VPS34 kinase activity.  
 
4.3.1 Analysis of differentially expressed proteins in VPS34-deficient Treg cells 
Analysis of the data set led to a list of 140 differentially expressed proteins – among which 
122 were more abundant and 18 less abundant in VPS34-deficient Treg cells. Loss of VPS34-
kinase activity led to a reduction by half of VPS34 as well as of binding partners of VPS34 
complex II (namely VPS15, UVRAG, and Beclin-1). This suggested that kinase-dead VPS34 
protein is not stable, and reduced amounts of VPS34 induces a reduction of the other VPS34 
complex binding partners. This might represent a disadvantage as we cannot ascertain the 
observed phenotype solely to VPS34-kinase activity. We aimed to circumvent the complete 
loss of VPS34 protein by inducing a truncation rather than a deletion of the VPS34 protein 
through the excision of exon 21 of Pik3c3, rather than exon 4 as used by Willinger and Flavell 
[228]. In our mouse model, the loxP sites are flanking a region of 75 nucleotides, leading to 
an in-frame mutation that is predicted to produce a truncated VPS34 protein. Indeed, we have 
confirmed that such a truncated protein can be expressed in cells and is kinase dead (Fig. 3.1 
d).   
Among the differentially expressed proteins, I first focused on proteins the most 
affected by loss of VPS34-kinase activity – i.e. ‘outliers’. Among those, Beclin-1 was highly 
downregulated, in line with the notion that Beclin-1 stability requires the presence of VPS34 
[298]. Strikingly, none of these ‘outliers’ mapped to a common pathway nor were PI3P-




binders. Next, I focused on pathways and known biological functions of Treg cells as well as 
proteins required for Treg cell development, survival and fitness. Using this approach, I could 
only partially confirm results obtained from flow cytometric analyses (described in Chapter 
3). In contrast to results from phenotyping analyses performed in Chapter 3, protein levels of 
CD44, CD69 and Ki67 (Mki67) were similar between VPS34-deficient and –sufficient Treg cells. 
Only CTLA-4 and ICOS levels matched previous observations, i.e. were unchanged.  
One class of proteins was overrepresented in the list of differentially expressed 
proteins in Treg cells lacking VPS34-kinase activity. Members of the Ras-related small GTPases 
family, Rab1a, Rab2b, and Rab18 were significantly upregulated. Rab proteins are small 
molecular weight guanosine triphosphatases (GTPases) that contain four highly conserved 
domains involved in GTP binding and hydrolysis and cycle between inactive GDP-bound and 
active GTP-bound form [299]. These proteins are membrane-bound proteins, involved in 
vesicular fusion and regulate membrane trafficking in organelles and transport vesicle [300]. 
This is in line with the hypothesis presented in Chapter 3, suggesting that loss of VPS34-kinase 
activity is affecting endolysosomal trafficking. As proposed in Chapter 3.4, I will follow up on 
this observation.  
Two RASP proteins, namely GRASP55 and GRASP65 [301]–[303] were significantly 
upregulated in VPS34-deficient Treg cells. The balance between membrane trafficking to and 
from the Golgi apparatus is critical for the maintenance of normal secretion and Golgi 
functions.  In this context, Golgi matrix proteins, together with Rab GTPases, are perfectly 
positioned to control both Golgi structure and membrane traffic. Sort et al. observed that 
GRASP55- and GRASP65-golgin complexes interact with multiple Rab GTPases and 
upregulation of these proteins in VPS34-deficient Treg cells might promote the stacking of 
Golgi cisternae [302]. The implications of this observations will have to be studied further.  
Four of the downregulated proteins related to cytokinesis. Recent findings have 
suggested that PI3P is required for the recruitment and the assembly of the ESCRT-III complex 
during cytokinesis [248]. PI3P recruits several effector proteins to the endosome, such as 
FYVE-CENT [249]. In turn, FYVE-CENT recruits other effector proteins, such as Beclin-1, VPS15, 
and UVRAG, that I found to be downregulated in VPS34-deficient Treg cells. These results 
suggest that VPS34-deficient Treg cells do not progress through the cell cycle – specifically 
mitosis. This hypothesis is supported by the decrease in the protein S100.A1 and the histone 
H1F0 (results presented in Chapter 4.2.2), and further reinforced by the lack of mature Treg 




cells (presented in Chapter 3.2.5) and decreased proliferation potential (presented in Chapter 
3.2.6). S100-A1 is involved, amongst other processes, in cell cycle progression and 
differentiation. Histone H1F0 accumulates in cells that are in a terminal stage of 
differentiation or have a low rate of cell divisions [286]. Together, data obtained from flow 
cytometric analyses (Chapter 3) and proteomic profiling data (Chapter 4) suggest that loss of 
VPS34-kinase activity in Treg cells impairs cell cycle progression, which has an impact on 
proliferation potential and cellular maturation.  
 
4.3.2 Metabolic potential is increased in VPS34-deficient Treg cells  
Using DAVID functional annotation clustering, I observed that loss of VPS34-kinase activity in 
Treg cells leads to the upregulation of proteins involved in biological processes relating to 
mitochondrial functions and energy metabolism, suggesting that VPS34-deficient Treg cells 
display an increased metabolic state. I confirmed this hypothesis by measuring the 
mitochondrial respiration rate by Seahorse. These observations seemed contra-intuitive to 
the lack of activated Treg cells in mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice, as determined by the 
expression of the activation markers CD44 and CD69. Possibly, loss of VPS34-kinase activity 
induces a state of higher metabolic activity, which in turn leads to faster exhaustion of VPS34-
deficient Treg cells, and a reduced level of maturation. It is increasingly accepted that 
metabolism can shape immune cell development, trafficking, and functions [127]. In this 
context, mTORC1 has a critical role in bridging environmental cues to cell homeostasis and 
suppressive functions of Treg cells [131], [132], [137]–[139]. Hence, Treg cell-specific deletion 
of mTORC1 results in the spontaneous activation of effector T cells leading to the 
development of inflammation in barrier tissues [141]. By contrast, Toll-like receptor (TLR) 
signals enhance Treg cell proliferation through mTORC1 signalling pathway, glucose 
transporter 1 (Glut1) upregulation, and glycolysis. However, these signals decrease the 
suppressive ability of Treg cells [142]. It is likely that TLR signal results in high levels of pro-
inflammatory cytokines that decrease Treg cells functions even when mTORC1 expression is 
maintained in Treg cells [136]. However, I could not find evidence from the proteomic 
profiling data that mTORC1, associated proteins and downstream signalling were affected by 
the loss of VPS34-kinase activity in Treg cells. I rather found an increase in proteins associated 




with metabolic pathways, and downstream analyses confirmed that VPS34-deficient Treg 
cells are metabolically more active.  
It has been proposed that Treg cells need to reduce transiently their metabolic rate to 
enter the cell cycle and proliferate [131]. This would imply that because of their increased 
metabolic rate, VPS34-deficient Treg cells cannot progress through the cell cycle and hence 
proliferate. Should indeed VPS34 also regulate the maturation of Treg cells, the combined 
effect of VPS34-kinase loss would lead to a smaller Treg cell population which is less mature, 
and suppressive.  
 
 
4.4 Chapter summary 
In this chapter, I investigated the effect of the loss of VPS34-kinase activity on the proteome 
of Treg cells. More proteins were upregulated than downregulated in VPS34-deficient Treg 
cells. VPS34 as well as its complex II binding partners Beclin-1, UVRAG, and VPS15 were 
downregulated by half. Most upregulated proteins were involved in metabolic pathways, and 
indeed, VPS34-deficient Treg cells were metabolically more active, as assessed by SeaHorse 
assay and increased ATP-levels. Future work will aim at further investigating how VPS34-
kinase activity links to kinase-associated signalling networks in Treg cells and how these in 
turn control metabolic fitness and potentially the generation of metabolites or other soluble 





































To study the role of VPS34 in activated CD8+ T cells, I used a mouse model in which the Cre-
recombinase is expressed under the Granzyme B promoter, and exon 21 of Pik3c3 is only 
excised in activated CD8+ T cells while the full length VPS34 protein is present in naïve CD8+ T 
cells. To activate naïve CD8+ T cells, I used three different approaches: 
First, I bulk-activated total splenocytes in vitro with αCD3/CD28 for 48h followed by expansion 
in the presence of human recombinant IL-2 (hrIL-2). This approach allows to routinely 
generate large amounts of activated CD8+ T cells, that can be used for flow cytometric and 
biochemical analyses.  
The second and the third approach were used to activate CD8+ T cells in vivo. In the 
first instance, I infected mice with the Gram-positive intracellular bacterium Listeria 
monocytogenes known to elicit a robust CD8+ T cell response.  Genetic modification of Listeria 
monocytogenes (Lm) to secrete foreign chicken antigen ovalbumin (OVA) allows to track the 
responding CD8+ T cells using recombinant MHC tetramer molecules. 
Lm induces a CD8+ T cell response which peaks between eight to nine days after infection. 
The effector CD8+ T cell pool can be divided into MPECs, which develop into memory T cells, 
and SLECs, which kill infected cells through the release of cytotoxic granules, and eventually 
die by apoptosis during the contraction phase. Memory T cells are maintained and remain 
ready to respond faster and stronger to re-infection.  
Thirdly, I inoculated mice with the murine melanoma cell line B78ChOVA-mCherry. I 
used this model as tumours are fast growing (tumours reach the humane endpoint of 300m3 
at around 18 days post inoculation), express OVA, allowing me to use recombinant MHC 
tetramer molecules to detect antigen-specific T cells, and can be tracked using the mCherry 
reporter. This model allowed me to assess the proportions, phenotype, and effector functions 
of antigen-specific CD8+ T cells infiltrating the tumour mass. Similar to the Listeria infection 
model, I aimed to assess whether the inactivation of the kinase activity of VPS34 may affect 
the development or effector functions of effector and/ or memory T cells.  
  





5.2.1 Specific deletion of VPS34-kinase activity in activated CD8+ T cells 
To investigate the role of VPS34 in activated CD8+ T cells, I used a system to ablated VPS34 in 
effector CD8+ T cells by crossing mice containing loxP sites flanking exon 21 of Pik3c3 
(Pik3c3fl/fl) to mice carrying the transgenes encoding the Cre recombinase and a ROSA26-loxP-
STOP cassette followed by the transgene for enhanced YFP (eYFP) driven by the granzyme B 
promoter (GzmBYFP-Cre mice) to generate GzmBYFP-Cre Pik3c3fl/fl mice (the targeting strategy is 
summarized in Fig. 5.1). I refer to these mice as GzmBYFP-Cre Pik3c3fl/fl or KO mice, heterozygous 
mice as GzmBYFP-Cre Pik3c3fl/wt or HET mice and wild-type littermate controls as GzmBYFP-Cre 
Pik3c3wt or WT mice. This targeting strategy allows to breed reporter mice in which naïve CD8+ 
T cells develop normally because exon 21 of Pik3c3 is deleted only after the activation of CD8+ 
T cells. In this system, deletion of the exon 21 of Pik3c3 occurs specifically upon the expression 
of GzmB, which is expressed in activated CD8+ T cells, and these cells become YFP+. I will refer 
at this genetic deletion as Pik3c3Δ21. 
 
Figure 5.1: Generation of VPS34-kinase dead activated CD8+ T cell. 
Targeting strategy to generate activated CD8+ T cell with cell-specific VPS34-kinase dead mice: exon 21 
(located in the kinase domain) of the Pik3c3 gene encoding VPS34 was flanked with LoxP sites. The 
enframed region is 75 nucleotides long, and Cre-mediated excision does not change the open reading 
frame, thereby giving rise to a truncated VSP34 protein that is 25 amino acids shorter than the wild-
type version. For activated CD8+ T cell-specific deletion, Pik3c3fl/fl mice were crossed with a transgenic 
mice strain carrying the transgenes encoding the Cre recombinase and a ROSA26-loxP-STOP cassette 
followed by the transgene for enhanced YFP (eYFP) driven by the granzyme B promoter (GzmBYFP-Cre 
mice) to generate GzmBYFP-Cre Pik3c3fl/fl mice.  
 




5.2.2 Immuno-phenotyping of unchallenged GzmBCre-YFP Pik3c3fl/fl mice 
In a first instance, I assessed the percentage of lymphocytes including CD4+ and CD8+ T cells, 
regulatory T cells (Treg cells), and B cells as well as the activation status of CD8+ T cells in the 
spleen, lymph nodes (axillary, brachial, cervical, and inguinal), and thymus of unchallenged 
mice by flow cytometry (Fig. 5.2.1 a – d, Fig. 5.2.2 a – d, and Fig. 5.2.3 a – c, respectively). I 
did not observe any differences between knock-out GzmBYFP-Cre Pik3c3fl/fl mice, heterozygous 
GzmBYFP-Cre Pik3c3fl/wt mice, and wild-type GzmBYFP-Cre Pik3c3wt littermate controls for any of 
the analysed cell populations. Of note, eYFP+ cells constituted around 5% of the NK cell 
population as well as the above mentioned cell populations (Fig. 5.2.4). In addition to CD8+ T 
cells, NK cells also express Granzyme B, explaining the presence of YFP+ NK cells.  
In summary, these data show that in unchallenged mice, CD8+ T cells have a minimal 
expression of the Cre-recombinase and that VPS34 kinase activity is therefore virtually 
untouched in CD8+ T cells from naïve mice.  
 
 





Figure 5.2.1: Immuno-phenotyping of splenocytes of unchallenged GzmBCre-YFP Pik3c3fl/fl mice. 
a – d) The percentage of CD4+ T cells (a), B cells (b), Treg cells (c), CD8+ T cells as well as the percentage 
of activated and naïve CD8+ T cells (d) in the spleen of GzmBCre-YFP Pik3c3fl/fl and GzmBCre-YFP Pik3c3fl/+ 
and littermate controls (GzmB-Cre- mice) was analysed by flow cytometry. n = 3 – 6 mice. Results are 
representative of two independent experiments. Statistical significance was determined using a one-
way ANOVA followed by a Tukey’s post-hoc test.   
 




Figure 5.2.2: Immuno-phenotyping of lymphocytes in the lymph nodes of unchallenged GzmBCre-YFP 
x Pik3c3fl/fl mice. 
a – d) The percentage of CD4+ T cells (a), B cells (b), Treg cells (c), CD8+ T cells as well as the percentage 
of activated and naïve CD8+ T cells (d) in the lymph nodes (pooled from axiliary, brachial, cervical and 
inguinal) of GzmBCre-YFP Pik3c3fl/fl and GzmBCre-YFP Pik3c3fl/+ and littermate controls (GzmB-Cre- mice) was 
analysed by flow cytometry. n = 3 – 6 mice. Results are representative of two independent 
experiments. Statistical significance was determined using a one-way ANOVA followed by a Tukey’s 
post-hoc test.   
  









a – c) The percentage of CD4+ T cells (a), Treg cells (c), and CD8+ T cells (c) in the thymus of GzmBCre-YFP 
Pik3c3fl/fl and GzmBCre-YFP Pik3c3fl/+ and littermate controls (GzmB-Cre- mice) was analysed by flow 
cytometry. n = 3 – 6 mice. Results are representative of two independent experiments. Statistical 
significance was determined using a one-way ANOVA followed by a Tukey’s post-hoc test.   
  





Figure 5.2.4: Diverse immune cell types express eYFP in unchallenged GzmBeYFP-Cre x Pik3c3fl/fl mice. 
Representative FACS plot for the expression of eYFP in CD4+ and CD8+ T cells, Treg cells, B cells and 
NK cells of an unchallenged GzmBeYFP-Cre Pik3c3fl/fl mouse. 
  




5.2.3 In vitro analyses of Pik3c3Δ21 CD8+ T cells 
To assess the role of VPS34 in activated CD8+ T cells, I induced Cre-mediated deletion of exon 
21 of the Pik3c3 gene in vitro by bulk-activating total splenocytes with α-CD3/CD28 for 24h 
followed by expansion in the presence of human recombinant IL-2 (hrIL-2) for five days. On 
day 7 after stimulation, the extent of Pik3c3Δ21 deletion was reflected by the abundance of 
VPS34 protein in bulk-activated CD8+ T cells: VPS34 protein was reduced by half in the CD44hi 
CD8+ T cell population from GzmBYFP-Cre Pik3c3fl/fl mice (Fig. 5.3.1 a). Similarly, protein levels of 
VPS15 were also decreased by half in activated CD8+ T cells from GzmBYFP-Cre Pik3c3fl/fl mice 
compared to heterozygous GzmBYFP-Cre Pik3c3fl/wt mice and wild-type control mice (Fig. 5.3.1 
b).  Strikingly, levels of Atg14L was increase by factor 2 in CD8+ T cells from GzmBYFP-Cre 
Pik3c3fl/fl mice compared to heterozygous and wild-type CD8+ T cells (Fig. 5.3.1 c).  
Seven days after activation, the proportion of CD44+ from CD8+ T cells was similar across the 
three genotypes (GzmBYFP-Cre Pik3c3fl/fl (KO), heterozygous GzmBYFP-Cre Pik3c3fl/wt (HET), and 
wild-type littermate control GzmBYFP-Cre Pik3c3wt mice (WT)) (Fig. 5.3.2 a). Against my 
expectation, the percentage of YFP+ cells among activated CD8+ T cells was only around 15%, 
while I would have assumed that nearly all activated CD8+ T cells would express GzmB and 
therefore the Cre-recombinase, eventually leading to the excision of exon 21 of Pik3c3 and 
the expression of the reporter transgene eYFP. Of note, when comparing the proportion of 
YFP+ cells among CD44+ CD8+ T cells, I did not observe any differences between heterozygous 
(HET) and Pik3c3Δ21 CD8+ T cells (KO) (Fig. 5.3.2 b). Similarly, the percentage of activated cells 
expressing CD103 or PD-1 among CD44+ CD8+ T cells (Fig. 5.3.2 c) or YFP+ CD44+ CD8+ T cells 
(Fig. 5.3.2 d) did not differ between KO, HET and WT CD8+ T cells.  
Next, I assessed the expression of the transcription factors T-bet and Eomes. T-bet is 
required for the differentiation of CD8+ T cells into functioning cytokine secreting SLECs [304] 
while Eomes is key for the function of CD8+ T cells. There was a trend towards increase T-bet 
level, and reduced Eomes/T-bet double positive cells in activated CD8+ T cells lacking VPS34, 
but this was not significant (Fig. 5.3.3 a). Interestingly, the level of IFN-γ was greatly increased 
in VPS34-deficient CD44+ CD8+ T cells (Fig. 5.3.3 b). These data suggest that while the absence 
of VPS34 kinase activity does not affect the differentiation of CD8+ T cells into activated CTLs, 
it might affect the effector functions, as suggested by changes in IFN-γ levels.  





Figure 5.3.1: Loss of VPS34-kinase activity affects the stability of its binding partners. 
Western blot analysis of the protein content of VPS34 (a), VPS15 (a and b) and Atg14L (c) from CD8+ T 
cells bulk-activated with αCD3 and αCD28 for 48h and further expanded in human recombinant IL-2 
for five days. Results are representative of two independent experiments. 
 
  





Figure 5.3.2: In vitro activated VPS34-deficient CD8+ T cells display normal levels of CD44, CD103 
and PD-1. 
(a – b) Percentage of CD44+ cells (a) and CD44+ YFP+ cells (b) from CD8+ T cells bulk-activated with 
αCD3 and αCD28 for 48h and further expanded in human recombinant IL-2 for five days.  
(c – d) Percentage of CD103+ CD44+ cells and PD-1+ CD44+ cells (c) and CD103+ YFP+ CD44+ cells and PD-
1+ YFP+ CD44+ cells (d) from CD8+ T cells bulk-activated with αCD3 and αCD28 for 48h and further 




expanded in human recombinant IL-2 for five days. Statistical significance was determined using a one-
way ANOVA followed by a Tukey’s post-hoc test.  n = 6 – 9 biological replicates per group.  Results are 
pooled from three independent experiments. 
 
Figure 5.3.3: In vitro activated VPS34-deficient CD8+ T cells display normal levels of T-bet and 
Eomes, but have an increase in IFN-γ production.  
(a) Percentage of Tbet+, Eomes+, or Tbet+ Eomes+ CD44+ cells from CD8+ T cells bulk-activated with 
αCD3 and αCD28 for 48h and further expanded in human recombinant IL-2 for five days.  
(b) Percentage of IFN-γ+ CD44+ cells from CD8+ T cells bulk-activated with αCD3 and αCD28 for 48h and 
further expanded in human recombinant IL-2 for five days. Statistical significance was determined 
using a one-way ANOVA followed by a Tukey’s post-hoc test. n = 3 biological replicates per group.  
Results are representative from three independent experiments. 
  




5.2.4 In vitro activated Pik3c3Δ21 CD8+ T cells do not show increased cell death but a 
decrease in cell division 
During the naïve-to-effector-to-memory – differentiation stages, CD8+ T cells proliferate and 
differentiate into distinct CD8+ T cell subsets. As VPS34 is an evolutionary conserved protein 
and essential for autophagy and endocytosis, two processes key for proliferative and 
differentiating cells, I investigated whether the inactivation of the kinase activity of VPS34 
may affect the proliferation and/or the survival of activated CD8+ T cells.  
First, I considered whether the loss of VPS34 might increase the proportion of cells 
that undergo apoptosis. Activated CD8+ T cells were generated by bulk-activating splenocytes 
with αCD3/CD28 for 48h and subsequent expansion in rhIL-2 for five days. On days seven after 
in vitro activation, the proportions of early apoptotic cells determined as Annexin V-single 
positive cells was significantly decreased in Pik3c3Δ21 and heterozygous Pik3c3Δ21 CD44+ CD8+ 
T cells compared to wild-type CD8+ T cells (Fig. 5.4.1 a, left graph). The proportion of late 
apoptotic cells, determined as positive for Annexin V and the live dead dye, was slightly, but 
not significantly increased for both heterozygous and Pik3c3Δ21 CD44+ CD8+ T cells compared 
to wild-type CD8+ T cells (Fig. 5.4.1 a, right graph). When assessing YFP+ CD44+ CD8+ T cells 
from heterozygous and Pik3c3Δ21mice, I could not detect any differences in the proportions 
of early apoptotic or late apoptotic cells (Fig. 5.4.1 b).  
Secondly, I considered whether the loss of VPS34 might affect the proportion of cells 
undergoing cell division. Seven days after in vitro activation with αCD3/CD28 and subsequent 
expansion in rhIL-2, I measured the incorporation of the nucleotide analogue bromo-2ʹ-
deoxyuridine (BrdU) in activated CD8+ T cells to investigate their ability to proceed through 
the cell cycle, and Ki67-levels to determine cell proliferation capacity. 
I did not observe any differences between activated CD44+ CD8+ T cells and YFP+ CD44+ CD8+ 
T cells from wild-type, heterozygous and Pik3c3Δ21 CD8+ T cells in terms of proliferation, as 
assessed by the proliferation marker Ki67 (Fig. 5.4.2 a and b, respectively). Ki67 antigen is 
expressed in all phases of the cell cycle except G0 and provides an estimate of the fraction of 
dividing cells [305].  
In regards to cell cycle analysis, proportions of Pik3c3Δ21 CD8+ T cells were found to be 
reduced in the G2/M phase, while increased proportions of Pik3c3Δ21 CD8+ T cells were 




incorporating BrdU, reflecting the S phase (Fig. 5.4.2 c). Since this experiment was done only 
once, I need to perform further repeats to confirm these observations. 
 
 
Figure 5.4.1: Granzyme B and LAMP1 are reduced in GzmBPik3c3Δ21 mice during the primary but not 
the secondary response.  
Graphical representation of Annexin V+ Viability Dye- (left) and Annexin V+ Viability Dye+ (right) of  
CD44+ cells (a) and YFP+ CD44+ cells (b) from CD8+ T cells bulk-activated with αCD3 and αCD28 for 48h 
and further expanded in human recombinant IL-2 for five days. Results are representative of two 
independent experiments. n = 9 per group. Statistical significance was determined using a one-way 
ANOVA followed by a Tukey’s post-hoc test (a) or a two-tailed Student’s t-test (b). Results are pooled 









Figure 5.4.2: VPS34-deficiency impairs the cell cycle of in vitro activated CD8+ T cells.  
(a) Representative flow cytometry plots and graphical representation of the percentage of the 
proliferation marker Ki67 and the nucleotide analog bromo-2ʹ-deoxyuridine (BrdU) in CD44+ cells from 
CD8+ T cells bulk-activated with αCD3 and αCD28 for 48h and further expanded in human recombinant 
IL-2 for five days.  
(b – c) Representative flow cytometry plots and graphical representation of the percentage of the 
nucleotide analog bromo-2ʹ-deoxyuridine (BrdU) and 7-AAD in CD44+ cells from CD8+ T cells bulk-
activated with αCD3 and αCD28 for 48h and further expanded in human recombinant IL-2 for five 
days. n = 2 – 3. Results are from one experiment. 
  




5.2.5 Antigen-specific CD8+ T cells are reduced in VPS34-deficient cells during the primary 
and the secondary response to L. monocytogenes infection 
To assess the role of VPS34 in activated CD8+ T cells in vivo, I infected mice with a transgenic 
strain of L. monocytogenes that expresses chicken OVA and detected OVA-specific CD8+ T cells 
using MHC class I H-2b tetramers loaded with OVA257–264 (SIINFEKL) peptide. The kinetics 
of the CD8+ T cell response to Listeria is shown in Fig. 5.5.1. Naïve CD8+ T cell are activated in 
response to Listeria infection, proliferate rapidly and reach the peak of expansion and effector 
functions at around 8-9 days during the primary response. Subsequently, most of the CD8+ T 
cells die by apoptosis, and a pool of memory cells remains. Upon re-infection, memory CD8+ 
T cells are activated and generate a larger secondary response that peaks 5 days after re-
infection. 
 
Figure 5.5.1: Kinetics of the CD8+ T cell response following intravenous infection with Listeria. 
Following infection with Listeria, the bacterial load in the spleen and liver increases until the peak at 
around two to three days post infection (blue line). At the same this time, antigen-specific CD8+ T cells 
become activated and proliferate, reaching a peak response at eight days post infection (orange line). 
A pool of antigen-specific CD8+ memory T cells remains and will generate a faster and larger immune 
response that peaks around five days in the case of reinfection, leading to a faster and better control 
of the bacterial load during the secondary infection. Modified from Verity Pearce. 
 




The proportions of CD8+ T cells in the blood that stained positive with the tetramer (Tet+ CD8+) 
were reduced in GzmBYFP-Cre Pik3c3fl/fl mice (Fig. 5.4.2 a). This reduction in the proportion of 
Tet+ CD8+ T cells was apparent both at the peak of the response (7 days after the first 
challenge) as well as five days after subsequent re-challenge (Fig. 5.4.2 b – d). 
Figure 5.5.2: Defective primary and secondary immune response in GzmBYFP-Cre Pik3c3fl/fl mice.  
GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) were 
infected with Lm-OVA on days 0 with 5x106 CFU Lm-OVA. Representative flow cytometry plots and 
graph show the percentage of tetramer+ (antigen-specific) CD8+ T cells in blood samples on day 7 (a) 
and on day 14, 21, 30 and five days after re-infection (b); n = 5 – 7 per group. Results are representative 
of two independent experiments. n = 9 per group. Statistical significance was determined using a one-
way ANOVA followed by a Tukey’s post-hoc test. Results are representative from two independent 
experiments. 
  




To address whether the reduced proportion of antigen-specific CD8+ T cells in the blood 
reflected their altered distribution, I enumerated Tet+ CD8+ T cells in the spleen and lymph 
nodes. In GzmBYFP-Cre Pik3c3fl/fl mice, the proportions of Tet+ CD8+ T cells were significantly 
reduced at the peak of the primary response (7 days post infection) in the spleen but not in 
the lymph nodes (Fig. 5.5.3 a and b, respectively). During the secondary response (5 days after 
re-challenge), Tet+ CD8+ T cell numbers were significantly reduced in the spleen and in the 
lymph nodes (Fig. 5.5.4 a and b, respectively). These data indicate that in GzmBYFP-Cre Pik3c3fl/fl 
mice, VPS34 deletion leads to a reduced magnitude of antigen-specific CD8+ T cells upon acute 
challenge with Lm-OVA.  
 
Figure 5.5.3: Defective primary immune response in the 
spleen of GzmBPik3c3Δ21 mice.  
Representative flow cytometry plots and bar graph showing 
the percentage of tetramer+ CD8+ T cells recovered for the 
spleen (a) and the lymph node (b) 7 days after primary 
infection of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre Pik3c3fl/wt 
(HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) with 5x106 CFU Lm-
OVA; n = 5 – 7 per group. Results are representative of two 
independent experiments. n = 9 per group. Statistical 
significance was determined using a one-way ANOVA 
followed by a Tukey’s post-hoc test.  Results are pooled from 
two independent experiments. 







Figure 5.5.4: Defective secondary immune response in the spleen 
and the lymph nodes of GzmBPik3c3Δ21 mice.  
Representative flow cytometry plots and bar graph showing the 
percentage of tetramer+ CD8+ T cells recovered for the spleen (a) 
and the lymph node (b) five days after secondary infection of 
GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre Pik3c3fl/wt (HET), and GzmBYFP-
Cre Pik3c3fl/fl mice (KO) with 5x106 CFU Lm-OVA; n = 6 – 7 per group. 
Results are representative of two independent experiments. n = 9 
per group. Statistical significance was determined using a one-way 
ANOVA followed by a Tukey’s post-hoc test.  Results are pooled 
from two independent experiments. 




5.2.6 VPS34 activity within CD8+ T cell populations impairs bacterial clearance by innate 
immunity 
The reduced primary and recall T cell response in GzmBYFP-Cre Pik3c3fl/fl mice could be the 
consequence of impaired signalling within CD8+ T cells or due to factors extrinsic to the 
responding T cells, such as differences in bacterial load, antigen presentation, or cytokine 
production by macrophages and dendritic cells and/or paracrine help from other responding 
or bystander T cell populations. To assess whether GzmB-driven deletion of VPS34 is affecting 
the innate immune response, I infected wild-type and GzmBYFP-Cre Pik3c3fl/fl mice with a 
virulent strain (still expressing the ActA protein) of Lm-OVA (5x104 CFUs) and measured CFUs 
in the liver and the spleen 48h after infection.  
I found the counts to be significantly increased in the spleen but not in the liver of 
GzmBYFP-Cre Pik3c3fl/fl mice (Fig. 5.6 a and b, respectively). Because Listeria clearance happens 
before Listeria-specific CD8+ T cells can be detected, these findings suggest that bacterial 
clearance by the innate immune system is slightly impaired by VPS34 deletion. Since NK cells 
also express Granzyme B, VPS34 is also being deleted in these cells, thereby possibly affecting 
the ability of these cells to clear infected cells.  
 
Figure 5.6: Reduced bacteria clearance in GzmBYFP-Cre Pik3c3fl/fl mice.  
GzmBYFP-Cre Pik3c3wt (WT) and GzmBYFP-Cre Pik3c3fl/fl mice (KO) were infected with a virulent Listeria 
strain (5x104 CFUs). Colony forming units (CFUs) recovered from the liver (a) and the spleen (b) were 
enumerated 48h after infection. n = 8 – 11 per group. Statistical significance was determined using a 
one-way ANOVA. Results are pooled from two independent experiments. 
  




5.2.7 Short-lived effector cells from the spleen are affected by VPS34-deletion in GzmBYFP-
Cre Pik3c3fl/fl mice  
During the primary immune response, responding CD8+ T cells can be classified as short-lived 
effector cells (SLECs) or as memory precursor effector cells (MPECs) based on the differential 
expression of KLRG1 and CD127 (41). SLECs (KLRG1high, CD127low) are responsible for the 
immediate clearance of bacteria and most die following resolution of the infection. Some of 
the MPECs (KLRG1low, CD127high), in contrast, form long-lived memory T cells. At the peak of 
the primary infection, the numbers of SLECs and MPECS in the blood and the lymph nodes 
were similar in WT, heterozygous GzmBYFP-Cre Pik3c3fl/wt and GzmBYFP-Cre Pik3c3fl/fl mice 7 days 
following infection (Fig. 5.7.1 a and b, respectively). In the spleen, the percentage of SLECs 
was slightly but insignificantly decreased while the percentage of MPECs was unchanged in 
GzmBYFP-Cre Pik3c3fl/fl mice (Fig. 5.7.1 c - e, respectively). During the secondary response, the 
proportions of SPECs and MPECs were unchanged in the spleen and lymph nodes for wild-
type, heterozygous GzmBYFP-Cre Pik3c3fl/wt and GzmBYFP-Cre Pik3c3fl/fl mice (Fig. 5.7.2 a – e, 
respectively).  
T cell activation leads to the expression of activation markers such as CD44 and the 
downregulation of CD62L, which facilitates the trafficking of T cells to the lymph nodes. 
Consistent with normal proportions of SLECs, Pik3c3Δ21 Tet+ CD8+ T cells in the lymph nodes 
expressed similar levels of CD44 compared to wild type CD8+ T cells 7 days post infection and 
5 days after re-challenge (Fig. 5.7.2 f and g, respectively).   
Together, these results suggest that inhibition of VPS34 in activated CD8+ T cells preferentially 
impairs the generation of antigen-specific cells without having a strong impact on the 
generation of memory T cells. 




Figure 5.7.1: Intact formation of memory T cells in GzmBPik3c3Δ21 mice during the primary response.  
(a) Representative flow cytometry plots and graphical representation showing KLRG1 expression on 
tetramer+ CD8+ T cells isolated from the blood of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre Pik3c3fl/wt (HET), 
and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 7 days after the primary infection with Lm-OVA.  
(b) Graphical representation of CD127low KLRG1high SLECs in the lymph node 7 days after infection.  
(c) Representative flow cytometry plots and graphical representation showing CD127 and KLRG1 
expression on tetramer+ CD8+ T cells isolated from the spleem of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre 
Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 7 days after the primary infection with Lm-OVA. 
n = 5 – 13 per group. Results are representative of two independent experiments. Statistical 




significance was determined using a one-way ANOVA followed by a Tukey’s post-hoc test. Results are 





Figure 5.7.2: Intact formation of memory T cells in GzmBPik3c3Δ21 mice during the secondary response.  
(a) Representative flow cytometry plots and graphical representation showing CD127 and KLRG1 
expression on tetramer+ CD8+ T cells isolated from the spleen of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre 
Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 5 days after re-infection with Lm-OVA.  
(b – c) Graphical representation of CD127low KLRG1high SLECs (b) and CD127high KLRG1low MPECs in the 
spleen 5 days after re-infection (c). 




(d – e) Graphical representation of CD127high KLRG1low MPECs (d) and CD127low KLRG1high SLECs in the 
lymph nodes 5 days after re-infection (e).  
(f – g) Graphical representation of CD44high tetramer+ CD8+ T cells in the spleen eight days after the 
primary infection (f) and 5 days after re-infection (g).  
n = 5 – 13 per group. Results are representative of two independent experiments. n = 9 per group. 
Statistical significance was determined using a one-way ANOVA followed by a Tukey’s post-hoc test. 
 
 
5.2.8 Pik3c3Δ21 CD8+ T cells responding to Listeria infection express reduced amounts of 
cytokines, LAMP-1, and GzmB 
An important function of CD8+ T cells is the ability to produce the antiviral cytokines 
interferon-γ (IFN-γ) and tumour-necrosis factor-α (TNF-α). Ex vivo stimulation of splenocytes 
at the peak of the primary immune response, i.e. 7 days after infection, and 5 days after re-
infection, using OVA-peptides indicated a reduced ability of Pik3c3Δ21 CD8+ T cells to produce 
these cytokines (Fig. 5.8.1 a – c, and Fig. 5.8.2 a – c, respectively). Interestingly, the 
production of Granzyme B was significantly reduced at the peak of the primary immune 
response (7 days after the first challenge), but unchanged in Pik3c3Δ21 CD8+ T cells after 
subsequent challenge (5 days after re-infection) (Fig. 5.8.3 a and b, respectively).  
Based on the role of VPS34 in endocytosis and vesicle trafficking, I investigated the cell 
surface expression of LAMP-1, a marker of vesicle release. After ex vivo stimulation of 
splenocytes, the level of LAMP-1 (CD107a) was reduced by half in Pik3c3Δ21 CD8+ T cells at the 
peak of the primary infection, whereas only slightly reduced after re-challenge (Fig. 5.8.3 c 
and d, respectively). Of note, results about CD107a expression after re-challenge would 
require an increase in the group size in order to make a definite conclusion.  
Together, these results suggest that VPS34-kinase activity is critical for effector 
functions of activated CD8+ T cells during both the primary and the secondary immune 
response. Levels of cytokine production and cell surface CD107a expression were reduced, 
suggesting that the lack of VPS34 kinase activity impairs the production of effector cytokines 
and the formation/release of vesicles possibly containing these effector cytokines.  
 





Figure 5.8.1: Cytokine production is reduced in GzmBYFP-Cre Pik3c3fl/fl mice during the primary immune 
response.  
(a – c) Representative flow cytometry plots and graphical representation showing TFN-α (a), IFN-γ (b) 
and double positive TFN-α IFN-γ (c) CD44+ CD8+ T cells isolated from the spleen of GzmBYFP-Cre Pik3c3wt 
(WT), GzmBYFP-Cre Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 8 days after infection with Lm-
OVA. n = 5 – 13 per group. Results are representative of two independent experiments. n = 9 per 
group. Statistical significance was determined using a one-way ANOVA followed by a Tukey’s post-hoc 









Figure 5.8.2: Cytokine production is reduced in GzmBYFP-Cre Pik3c3fl/fl mice during the secondary 
response.  
(a – c) Representative flow cytometry plots and graphical representation showing TFN-α (a), IFN-γ (b) 
and double positive TFN-α IFN-γ (c) CD44+ CD8+ T cells isolated from the spleen of GzmBYFP-Cre Pik3c3wt 
(WT), GzmBYFP-Cre Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 5 days after re-infection with Lm-
OVA. n = 7 – 10 per group. Results are representative of two independent experiments. n = 9 per 
group. Statistical significance was determined using a one-way ANOVA followed by a Tukey’s post-hoc 
test. Results are pooled from two independent experiments. 
 






Figure 5.8.3: Granzyme B and LAMP1 are reduced in GzmBYFP-Cre Pik3c3fl/fl mice during the primary 
but not the secondary response.  
(a – b) Graphical representation of Granzyme B production in CD44+ CD8+ T cells isolated from the 
spleen of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 7 
days after the primary infection (a) and 5 days after re-infection (b) with Lm-OVA. 
(c – d) Representative flow cytometry plots and graphical representation of LAMP1 (CD107a) 
expression on CD44+ CD8+ T cells isolated from the spleen of GzmBYFP-Cre Pik3c3wt (WT), GzmBYFP-Cre 
Pik3c3fl/wt (HET), and GzmBYFP-Cre Pik3c3fl/fl mice (KO) 7 days after the primary infection (c) and 5 days 
after re-infection (d) with Lm-OVA. Representative flow cytometry plots and n = 5 – 13 per group. 
Results are representative of two independent experiments. n = 9 per group. Statistical significance 








5.2.9 Mice with Pik3c3Δ21 CD8+ T cells have increased tumour growth 
The immune system responds to intracellular bacterial pathogens (such as Listeria 
monocytogenes) and cancer in a similar way. Antigen-specific CD8+ T cells recognize antigens 
presented in the context of MHC class I and eliminate malignant cells (expressing neo-
antigens) or infected cells (expressing pathogen antigens) by direct cytotoxicity. 
The reduced proportions of tetramer-positive CD8+ T cells in infection studies with 
Listeria, along with the reduced proportions of cells undergoing mitosis prone me to further 
explore the effect of VPS34-deficiency using another model, i.e. I inoculated mice 
subcutaneously with the murine melanoma cell line B78ChOVA-mCherry. B78ChOVA-
mCherry is derived from the amelanotic clone B16.F10, but has been genetically engineered 
to express the mCherry reporter and OVA.  
I injected GzmBYFP-Cre Pik3c3fl/fl, heterozygous GzmBYFP-Cre Pik3c3fl/wt and wild-type 
control mice sub. cut. in the right flank with 1.5 x 105 B78ChOVA-mCherry tumour cells and 
measured the tumour growth until day 28 post-inoculation or when human endpoint was 
reached. Only half of the mice developed tumours and I am currently working on the 
optimization of the cell culturing and inoculation protocol. From the mice that developed 
tumours, I observed rapid tumour growth from day 14 onwards and by day 28, two GzmBYFP-
Cre Pik3c3fl/fl mice had developed tumours four times bigger than the only wild-type mouse 
that had developed a tumour. From the three heterozygous GzmBYFP-Cre Pik3c3fl/wt mice that 
had developed tumours, two displayed a tumour growth curve similar to the wild-type mouse, 
while the third followed the growth curve of tumours from knock-out GzmBYFP-Cre Pik3c3fl/fl 
mice (Fig. 5.9.1 a).  
Because only half of the mice developed tumours, I injected a second cohort of 
GzmBYFP-Cre Pik3c3fl/fl, GzmBYFP-Cre Pik3c3fl/w and wild-type mice, this time with 5 x 105 
B78ChOVA-mCherry tumour cells. Nine from eleven mice developed tumours. The weights of 
the tumours harvested at the end of the second experiment on day 13 were variable among 
the different genotypes, but there was a trend towards bigger tumours in GzmBYFP-Cre 




Pik3c3fl/fl mice compared to wild-type control mice (Fig. 5.9.1 b). Of note, the tumour volume 
deduced from the measurements of the tumours with a calliper (calculated as mm3 = 
½(a*b*(a+b)/2, where a was the length and b the width) correlated with the actual mass of 
the tumours (tumours where weighted after harvesting) (Fig. 5.9.1 c), validating our method 
to determine tumour size.  
 
I performed a simple functional analysis of the infiltrating CD8+ T cell, assaying for the 
expression of antigen-specific CD8+ T cells (Fig. 5.9.2 a), YFP+ cells amongst CD8+ cells (Fig. 
5.9.2 b), TNF-α production (Fig. 5.9.2 c), and PD-1 expression (Fig. 5.9.2 d). None of the 
analysed markers were significantly different in Pik3c3Δ21 compared to wild-type CD8+ T cells, 
solely a trend towards decrease expression of PD-1 was detectable for Pik3c3Δ21 CD8+ T cells. 
I also analysed the expression of other markers and cytokines, such as CD184 (CXCR-4), IFN-
γ, CD103, CD127, KLRG1, and the transcription factors T-bet and Eomes, but did not obtain 
any results for those markers due to technical issues.  
I used Annexin V to assess apoptosis. Pik3c3Δ21 CD8+ T cells displayed a trend towards 
increase Annexin V staining (Fig. 5.9.2 e), however the percentage of cells staining for both 
Figure 5.9.1: Increased tumour growth in GzmBYFP-Cre Pik3c3fl/fl 
mice. 
(a) Tumour growth curve of GzmBYFP-Cre Pik3c3fl/fl (KO), GzmBYFP-
Cre Pik3c3fl/wt (HET), and wild-type control mice (WT) injected 
sub. cut. with 1.5 x 105 B78ChOVA-mCherry tumour cells.  
(b – c) Mice were injected with 5 x 105 B78ChOVA-mCherry 
tumour cells. (b) Tumour volumes on day 13 measured as mm3 
= ½(a*b*(a+b)/2, where a was the length and b the width. 
(c) Tumour weight harvested on day 13. Results are from a 
single experiment with n = 2 – 4 mice per group. 




Annexin V and the viability dye was similar between Pik3c3Δ21 and wild-type CD8+ T cells (Fig. 
5.9.2 f). These results are obtained from one single experiment and while the experiment has 
to be repeated to examine a greater number of mice, these initial results lend support to the 
conclusions drawn from Listeria infection studies, i.e. that loss of VPS34-kinase activity in CD8+ 
T cells affects the effector phase of CD8+ T cells, leading to less antigen-specific CD8+ T cells 
with reduced effector functions (in Listeria infection studies) or reduced tumour control (in 
B78ChOVA-mCherry tumour studies).  
 
Figure 5.9.2: Flow cytometric analysis of B78ChOVA-mCherry – infiltrating lymphocytes.  
Mice were injected with 5 x 105 B78ChOVA-mCherry tumour cells and tumours harvested on day 13.  
Flow cytometric analyses of antigen-specific CD8+ T cells (a), YFP+ CD8+ T cells (b), TNF-α production 
after restimulation with PdbU/Ionomycin for 5.5h (c), PD-1+ CD8+ T cells (d), and of the apoptosis 
marker Annexin V and the viability dye (L/D) (e-f). Results are from a single experiment with n = 2 – 4 
mice per group.  





So far, the role of VPS34 has been investigated in CD4+ T cells by Willinger and Flavell, Mcleod 
et al., and Parekh et al. [227], [228], [254] and in Treg cells by Elisabeth, Priya, and me. 
However, its role in activated CD8+ T cells has so far not been, to my knowledge, a matter of 
investigation. Here, I describe for the first time the effects of VPS34-kinase activity loss on 
CD8+ T cell functions and memory formation. 
The importance of intact autophagy for CD8+ T cells has been previously demonstrated 
using a mouse model lacking the gene encoding for either the autophagy-related molecules 
Atg7 or Atg5 specifically in CD8+ T cells [219], [223]. While Atg7 or Atg5-deletion had little 
effects on the proliferation and effector functions, these cells displayed a survival defect and 
a compromised memory formation [219]. In light of the involvement of VPS34 in endocytosis 
and autophagy, it is of great interest to investigate whether VPS34-deletion in antigen-specific 
CD8+ T cells results in a similar phenotype. For this mean, I used the same Granzyme B-Cre 
system as used by Xu et al. [219], in which naïve CD8+ T cells develop normally and VPS34 is 
deleted only after CD8+ T cell activation.  
In line with my expectations, naïve CD8+ T cells developed normally and the phenotype 
of unchallenged GzmBCre-eYFP Pik3c3fl/fl mice was similar to wild-type mice; the proportion of 
key immune cell populations and the activation status of CD8+ T cells in Cre-positive mice 
were comparable to Cre-negative mice.  
 
5.3.1 Unchallenged GzmBYFP-Cre Pik3c3fl/fl mice are phenotypically similar to wild-type mice 
Unchallenged GzmBYFP-Cre Pik3c3fl/fl mice developed normally and had normal ratio of CD4+ T 
cells, CD8+ T cells, B cells, and NK cells.  The Cre-recombinase being expressed under the 
Granzyme B promoter, VPS34-kinase activity is abrogated only in cells expressing Granzyme 
B, hence activated CD8+ T cells and NK cells. Flow cytometric analyses of naïve GzmBYFP-Cre 
Pik3c3fl/fl mice showed that indeed, 95% of CD8+ T cells were YFP-. Surprisingly, only 5% of NK 
cells were positive for YFP, while I assumed that GzmB is constitutively expressed in those 
cells. It is known that certain fixation/permeabilisation methods used for the staining of 
intracellular markers affects YFP fluorescence, possibly explaining the low proportion of YFP+ 




NK cells. Immune phenotyping of naïve GzmBYFP-Cre Pik3c3fl/fl mice will have to be repeated 
while leaving out fixation/permeabilisation of the cells.  
Other than CD8+ T cells, CD4+ T cells and B cells had a minimal expression of YFP. This 
suggests that the Cre-recombinase is active in those cells, either because these cells 
transiently express the Cre-recombinase during early development (referred to as ‘ectopic’ 
expression [306]) or because indeed a small subset of CD4+ T cells [307] and B cells [308] 
express Granzyme B. However, since the percentage of YFP+ cells was relatively low (5%), 
hence the percentage of Cre+ cells, I concluded that VPS34-kinase activity is preserved in the 
majority of lymphocytes in unchallenged mice.  
 
5.3.2 In vitro activated Pik3c3Δ21 CD8+ T are similar to wild-type CD8+ T cells 
I supplemented results from in vivo studies with in vitro assays using bulk-activated CD8+ T 
cells to gather mechanistic information regarding cell cycle assay, proliferation potential and 
cell death. In vitro stimulation with αCD3 and αCD28 for 48h followed by expansion in 
recombinant human IL-2 up to five more days is a frequently used method to activate T cells 
in vitro allowing to harvest large numbers of the desired cell population.  
In vitro bulk-activated CD8+ T cells from GzmBYFP-Cre Pik3c3fl/fl mice were phenotypically 
similar to CD8+ T cells from wild-type mice in regards to the activation marker CD44, CD103 
and PD-1 as well as the expression of the transcription factors T-bet, Eomes and Granzyme B. 
The only difference was an increase in the production of the cytokine IFN-γ. This might stay 
in contrast to the unchanged expression of T-bet, as it has been previously observed that T-
bet regulates IFN-γ to some extent [80]. However, I have to acknowledge that the in vitro 
conditions might not have been robust enough to ensure efficient deletion of VPS34 in most 
of the CD8+ T cells. This issue will have to be addressed in future experimental settings. 
 
5.3.3  Loss of VPS34-kinase activity leads to reduced antigen-specific CD8+ T cells with 
impaired effector functions 
Listeria infection is a mouse model widely used to study both the innate and the adaptive 
immune system. Since Listeria replicates within cells and move from cell to cell without being 




exposed to antibodies, the cell-mediated immunity is key for the clearance of the bacteria 
[309]. Fifteen minutes following intravenous injection of Listeria into a mouse, 60% can be 
found within the liver while 40% are found in the spleen [310]–[312]. The bacterial load 
increases in those organs until it reaches a peak at 2 to 3 days post infection. In the spleen, 
the detection and the uptake of the bacteria is taking place in the marginal zone by CD8+ 
dendritic cells (DCs) [313], [314]. One to two days after infection with Listeria, T cell activation 
is initiated by the presentation of processed bacterial peptides. Although the innate immunity 
is ultimately required for the clearance of the infection, the adaptive immune response is 
necessary to avoid chronic infection (or to achieve sterile immunity) [315]. While CD4+ T cells 
control the infection through the release of IFN-γ, CD8+ T cells are the main contributors to 
long-term protective immunity to Listeria monocytogenes; hence Listeria is a suitable model 
to study CD8+ T cell responses.  
In this study, I aimed to assess the role of VPS34 at distinct stages of the CD8+ T cell 
response: at the peak of expansion (day 8 after infection, when effector CD8+ T cells stop to 
proliferate); during the contraction phase (day 14 and 21 after infection); and the memory 
phase (day 30 after infection).  
Upon infection with Lm-OVA, CD8+ T cells from GzmBCre-YFP Pik3c3fl/fl mice showed a reduced 
capacity to respond to the infection. At the peak of the immune response, the percentage of 
antigen-specific CD8+ T cells was reduced. Meanwhile, the proportions of short-lived effector 
cells (SLECs) and memory precursor effector cells (MPECs) were comparable between VPS34-
deficient and -sufficient CD8+ T cells.  
Memory CD8+ T cells provide protection against re-infection with the same pathogen and 
contribute to the long-term control of chronic infection, such as during infection with herpes 
viruses or hepatitis viruses [114]. Memory cells allow the organism to respond to re-infection 
by mounting an immune response which is faster and higher than the primary immune 
response. Memory formation involves cellular and metabolic reprogramming and is 
dependent of catabolic processes that mediate the reduction in cell size and cell numbers. In 
accordance with that, autophagy is crucial for memory formation [219]. To investigate 
whether CTLs are also dependent on VPS34 kinase activity for memory formation, I re-
infected GzmBCre-YFP Pik3c3fl/fl mice with Lm-OVA thirty days after the primary infection.  
 




In line with the reduced level of antigen-specific CD8+ T cells during the primary infection, the 
percentage of antigen-specific CTLs during the secondary response was similarly decreased in 
the spleen. The unchanged proportions of MPECs and SLECs during the primary response 
suggested that the pool of memory cells is unaffected by VPS34-deletion and that reduced 
levels of OVA-specific CD8+ T cells during the secondary immune response was due to 
impaired survival or proliferation of effector cells rather than a defective memory formation.  
However, these observations were against the expectation that, since VPS34 is involved in 
autophagy, VPS34-deficiency would lead to an impaired CD8+ T cell memory formation, as 
depicted for Atg7-/- or Atg5-/- CD8+ T cells.  
Although the percentage of SLECs was unchanged during the primary and the 
secondary immune responses, the production of effector molecules was significantly 
decreased in VPS34-deficient CTLs. The proportions of activated Pik3c3Δ21 CD8+ T cells 
producing IFN-γ and TNF-α was reduced in response to OVA257-264 peptide re-stimulation in 
vitro, both seven days after the primary infection and five days after re-challenge. This 
suggested that loss of VPS34-kinase activity influences the effector functions of CD8+ T cells. 
The proportion of Granzyme B-producing Pik3c3Δ21 CD8+ T cells was also reduced, further 
supporting the idea that VPS34-deficient CD8+ T cells have an impaired effector molecule 
production. Furthermore, the level of LAMP-1 (CD107a) was also reduced in those cells, 
suggesting either a defect in vesicle trafficking or a primary reduced production of cytokines, 
leading to a reduced numbers of vesicles to be released.  
An effect on vesicle trafficking would be in line with what is already know about the 
function of VPS34 [316]. Reduced levels of Lamp-1 affects the movement of lytic granules, i.e. 
leads to the retention of transport vesicles with lytic granules outside the lysosomal 
compartments in trans-Golgi network–derived transport vesicles, and results in reduced 
levels of perforin, but not granzyme B, in lytic granules [317]. Similarly, inhibition of the Lamp-
1 binding partner adaptor protein 1 (AP-1) sorting complex also leads to the retention of 
perforin in the transport vesicles. Disrupted motility and levels of perforin in lytic granules 
would lead to the inability to deliver Granzyme B to the target cells and therefore impairs 
cytotoxicity. 
Furthermore, VPS34 is possibly involved in the trafficking and recycling of cell-surface 
receptors required for the sensing of proliferation and/or activation clues. For example, the 
activation of CD8+ T cells depends, besides signal 1 and signal 2, on stimulation with 




inflammatory cytokines including IL-12 and type I IFNs. IL-12 signalling is critical for the 
accumulation of antigen-specific CD8+ T cells in the context of Lm-infection [318], [319]. 
Failure to sense IL-12 due to defective trafficking of IL-12 receptor to the cell surface would 
therefore lead to impaired CTL activation. This hypothesis could be tested by staining the IL-
12Rβ2 subunit for flow cytometry and assess phosphorylation of STAT4 to test intact IL-12 
signalling.  
Finally, mitophagy is essential for T cell development and homeostasis [320] and data 
obtained from FoxP3YFP-Cre Pik3c3fl/fl mice suggest that loss of VPS34-kinase activity increases 
mitochondrial load and functions in Treg cells. During activation and differentiation of naïve 
cells to effector cells, CTLs undergo drastic metabolic changes relying on anabolic processes. 
Loss of VPS34-kinase activity might increase the number of mitochondria, which might 
generate high levels of energy and ROS, or alternatively, lead to the accumulation of defective 
mitochondria as there are not being cleared by mitophagy. In the phase of CD8+ T cells and 
concomitant metabolic reprogramming, T cells might rely even more on appropriate energy 
levels and the removal of toxins and mal-functioning organelles, and failure to do so could 
ensue in impaired survival and/or reduced effector functions. 
 
5.3.4 Reduced proportions of antigen-specific CD8+ T cells in mice infected with Listeria is 
probably due to a defect in cell division following antigenic stimulation 
To stimulate CD8+ T cells in vivo, I infected mice with Listeria and evaluated the proportions 
of CD8+ T cells and their phenotype in the blood, spleen and lymph nodes of GzmBYFP-Cre 
Pik3c3fl/fl mice. GzmBYFP-Cre Pik3c3fl/fl mice have reduced proportions of antigen-specific CD8+ 
T cells in the blood and the spleen seven days after infection. The level of antigen-specific 
CD8+ T cells was also reduced in the blood and the spleen five days after re-challenge of 
GzmBYFP-Cre Pik3c3fl/fl mice compared to wild-type mice, nevertheless, GzmBYFP-Cre Pik3c3fl/fl 
mice did show evidence of memory formation, as the secondary response achieved a greater 
peak magnitude than during the primary response. 
Memory cell precursors can be identified in the effector CD8+ T cell response to 
Listeria using the surface markers CD127 and KLRG1. CD127 is the alpha chain of the IL-7 
receptor, and signalling through the IL7R is required for T cell survival [321]. KLRG1 is currently 
the best-described SLEC marker although it is recognised that it does not play a significant 




role in their formation [76]. Within the pool of antigen-specific CD8+ T cells in GzmBYFP-Cre 
Pik3c3fl/fl mice responding to Listeria, the proportions of CD127high KLRG1low MPECs and 
CD127low KLRG1high SLECs was unchanged. These results suggested that loss of VPS34 kinase 
activity impairs the generation or the survival rather than the activation or the memory 
formation of antigen-specific CD8+ T cells. 
Results form in vitro studies suggested that VPS34 is not required for the survival of 
activated CD8+ T cells. Meanwhile, cell cycle analysis suggested that the reduced number of 
Tet+ CD8+ Pik3c3Δ21 T cells found in mice infected with Listeria likely reflects the inability to 
undergo mitosis, i.e. an inability to undergo cell division following antigenic stimulation in 
vivo, thereby leading to a reduced number of cells going back to the G1 phase. These 
hypothesis is in line with the suggested role of VPS34 in cytokinesis and the results obtained 
for VPS34-deficient Treg cells (presented in Chapter 3 and Chapter 4), suggesting that loss of 
VPS34-kinase activity impairs cell cycle progression due to increased metabolic rate hence 
impaired cell proliferation. It would now be of interest to confirm a cell cycle defect in CD8+ T 
cells activated in vivo (using either the Listeria infection model or the tumour model) as well 
as perform metabolic analyses to investigate whether activated CD8+ T cells are metabolically 
more active, similar to VPS34-deficient Treg cells.  
In summary, these results suggest that while VPS34 is not required for the survival of 
activated CD8+ T cells in vitro, it might interfere with the capacity of activated CD8+ T cells to 









5.4 Chapter summary 
I used a mouse model in which the Cre-recombinase is expressed under the Granzyme B 
promoter, and exon 21 of Pik3c3 is only excised in activated CD8+ T cells while the full length 
VPS34 protein is present in naïve CD8+ T cells. I first investigated the phenotype of immune 
cell populations in unchallenged GzmBYFP-Cre Pik3c3fl/fl mice and did not observed any 
differences in proportions and phenotype compared to littermate controls. Next, I chose 
three different approaches to activated CD8+ T cells. In vitro activated Pik3c3Δ21 CD8+ T cells 
were similar to activated wild-type CD8+ T cells, apart of increased production of the cytokine 
IFN-γ in Pik3c3Δ21 CD8+ T cells. 
In vivo activated CD8+ T cells using a Lm-OVA infection model displayed a reduced level 
of antigen-specific CD8+ T cells, with impaired cytokine productions (IFN-γ and TNF-α) as well 
as reduced degranulation capacity, as assessed by Lamp-1 levels. Interestingly, both SLECs 
and MPECs proportions were unaffected by the loss of VPS34-kinase activity. Data gained 
from in vitro assays suggested that VPS34-deficiency affects cell cycle progression, in line with 
the described role of VPS34 in cytokinesis.  
I used a second model to activate CD8+ T cells in vivo. GzmBYFP-Cre Pik3c3fl/fl mice 
injected with B78ChOVA-mCherry cancer cells did not control the tumour growth as well as 
wild-type control mice. I will analyse in depth the phenotype of antigen-specific CD8+ T cells 
as well as by-stander cells within the tumour as well as in the draining lymph node and extend 
this analysis to further lymphoid organs if needed.  
 Taken together, these results suggest that VPS34 is important for the formation of 
antigen-specific CD8+ T cells, probably involved in cytokinesis, as well the trafficking and 













6.1 General discussion 
6.1.1 The role of VPS34 in Treg cell maturation 
The evolutionary conserved class III PI3-kinase VPS34 is critically involved in autophagy and 
endocytosis in yeast and similar roles have been described for some mammalian cells [186], 
[322]. Meanwhile, the role of VPS34 in immune cells is yet not perfectly understood. T cell-
specific deletion of VPS34 in mice leads to defective T cell homeostasis [217], [227], [228], 
which was attributed to either impaired autophagy and organelle removal [217], [228], or 
compromised survival due to altered IL-7Rα trafficking dynamics [227]. Furthermore, aged 
CD4Cre Pik3c3fl/fl mice developed intestinal inflammation and anaemia, which was due to 
reduced Treg cell numbers and impaired in vitro and in vivo suppressive functions [217]. 
The intrinsic role of VPS34 in Treg cells was investigated by Elisabeth Slack who found that 
Treg cell-specific deletion of VPS34 caused a Scurfy-phenotype despite the presence of Treg 
cells, suggesting that loss of VPS34 affects Treg cell suppressive functions rather than survival. 
However, none of the known Treg cell suppressive mechanisms were impaired by the loss of 
VPS34. 
We hypothesised that the inflammatory environment present in FoxP3YFP-Cre Pik3c3fl/fl 
mice might drive compensatory mechanisms masking the effect of VPS34-deficiency in Treg 
cells. Indeed, the generation of mice with a ‘mosaic’ deletion of VPS34 in Treg cells (using the 
location of the FoxP3 promoter on the X chromosome to generate heterozygous FoxP3YFP-
Cre/WT female mice which were crossed to Pik3c3fl/fl mice) showed that VPS34-deficient Treg 
cells are not intrinsically pathological. However, VPS34-deficient Treg cells from mosaic 
FoxP3YFP-Cre/WT Pik3c3fl/fl mice had a competitive disadvantage compared to VPS34-sufficient 
Treg cells. Furthermore, the proportion of Treg cells expressing CD44 was lower among 
VPS34-deficient Treg cells from mosaic mice, similar to what we had observed when VPS34 
was knocked out in all Treg cells, suggesting that VPS34 is intrinsically required for Treg cells 
to differentiate into a more mature phenotype or alternatively, that mature Treg cells depend 
on VPS34 for their survival (Chapter 3). Furthermore, lack of systemic inflammation in mosaic 
FoxP3YFP-Cre/WT Pik3c3fl/fl mice provided us with a suitable tool to assess the cell intrinsic effects 
of VPS34-deficiency in Treg cells.  
Consistent with previous reports, I observed that the frequency of YFP+ Treg cells in 
mosaic FoxP3YFP-Cre/WT Pik3c3fl/fl mice was less than 50% of total Treg cells, as would be 




expected given random X chromosome inactivation. This hypomorphic effect of FoxP3Cre 
alleles on Treg cells in a competitive context (i.e. in chimeric/mosaic mice) has been previously 
described [323], [324]. In our experiments, we controlled for these Cre-mediated effects by 
using both control and experimental mice expressing the same FoxP3YFP-Cre/WT genotype.  
Treg cells can be divided into resting Treg (rTreg) cells and activated Treg (aTreg) cells 
based on the expression of T cell activation markers (such as CD44, KLRG1, and CD69) and 
homing molecules, e.g. CD62L  [325]. rTreg cells are predominantly found in secondary 
lymphoid organs, whereas aTreg cells are enriched in peripheral tissues [326]. Signals from 
the T cell receptor (TCR) play a critical role in Treg cell differentiation and survival [327]. 
Indeed, TCR signalling is required for the differentiation of rTreg cells into aTreg cells, and 
conditional ablation of TCR components following Treg cell lineage commitment results in loss 
of aTreg cells and the inability of the residual population of rTreg cells to limit inflammation 
[284], [328]. 
Treg cells are maintained over time, suggesting a mechanism to limit TCR-driven 
activation programs among rTreg cells. Since loss of VPS34-kinase activity reduced the 
proportions of aTreg cells, this implies that VPS34 might be involved in TCR-driven activation 
programs in Treg cells. The relationship between VPS34 and the activation of Treg cells is an 
attractive subject of investigation, not at least offering additional targets for the therapeutic 
suppression of Treg cells in cancer, with the potential to avoid deleterious effects on effector 
cells. This hypothesis will be subject to investigations (discussed in Chapter 6 – ‘Ongoing 
work’). 
 
6.1.2 VPS34-deletion induces a state of heightened metabolic activity in Treg cells 
In an attempt to determine which Treg cell suppression mechanisms are affected by the loss 
of VPS34, I performed proteomic profiling and while the results could not provide a definite 
clue about the mechanism(s) leading to the observed phenotype in mice with VPS34-deficient 
Treg cells, they suggested that loss of VPS34-kinase activity induces a state of heightened 
metabolic activity (Chapter 4).  
A number of recent reports have shown that the numbers of Treg cells and their 
phenotypical plasticity are regulated by metabolic processes [329]. Treg cells are known to 
have a ‘‘metabolic edge’’ for survival through their bias toward mitochondrial respiration, and 




mitochondrial metabolism supports both their immunosuppressive functions as well as 
survival in lactate-rich environments [330].   
Reports investigating the relationship between Treg cell fitness, suppressive functions, 
and metabolic activity, show that mice developed a fatal inflammatory disorder similar to the 
one observed in FoxP3Cre-YFP Pik3c3fl/fl mice when impairing mitochondrial function and 
cellular metabolism, rather than increasing metabolic activity [331]–[334]. For example, Treg 
cell-specific deletion of Uqcrsf1 (encoding RISP) or Uqcrq (encoding QPC) in mice led to a 
lymphoproliferative pathology, with enlarged lymph nodes and spleen, increased lymphocytic 
cell infiltration in multiple organs and increased proportions of activated CD4+ and CD8+ T 
cells in lymph nodes and spleen [335]. These mice died by weeks 4 of age, similar to Scurfy 
mice and FoxP3Cre-YFP Pik3c3fl/fl mice. Like FoxP3Cre-YFP Pik3c3fl/fl mice, RISP-KO and QPC-KO 
mice had normal Treg cell numbers. However, their metabolic flux was drastically shifted 
away from mitochondria and cytoplasmic glycolysis.  
A recent study reports that FoxP3 reprograms T cell metabolism by suppressing Myc 
and glycolysis and enhancing oxidative phosphorylation (OXPHOS), suggesting a close 
collaboration between FoxP3 and mitochondrial respiratory complexes to ensure functioning 
Treg cells. In FoxP3Cre-YFP Pik3c3fl/fl mice and FoxP3Cre-YFP/WT Pik3c3fl/fl mosaic mice, expression 
of FoxP3 was unchanged (data not shown), suggesting that VPS34 influences metabolic 
reprogramming towards OXPHOS at another level. 
Rapamycin was routinely used to elucidate how mTOR inhibition modulates Treg cell 
functions. Rapamycin induces de novo expression of FoxP3 in naïve T cells in vitro  [336], and 
promotes the expansion of CD4+ CD25+ T cells which then display enhanced suppressive 
functions. However, rapamycin treatment ablates some, but not all, of mTORC1 function – 
e.g., rapamycin treatment can suppress S6 phosphorylation, while 4E-BP1 phosphorylation 
remains largely intact [337], [338]. 
mTORC1 activity is essential for the metabolic programming of Treg cells and their 
functional fitness [132]. mTORC1 activity is associated with an increase in Treg cell 
suppressive ability, and mice with Treg cell-specific deletion of Raptor, the fundamental 
component of mTORC1 [339], developed a Scurfy-like inflammatory disease [132]. Treg cell 
numbers, activation and suppressive capacity appeared normal in these mice, but this was 
due to a compensatory response to the ongoing inflammation. Using bone marrow 




chimaeras, it was shown that mTORC1 is essential for Treg cell suppressive functions and 
proliferation. 
The same study revealed that genes involved in cholesterol biosynthesis were strikingly 
downregulated in mTORC1-deficient Treg cells and, accordingly, mTORC1-deficient Treg cells 
failed to synthesise lipids from glucose following TCR stimulation. Moreover, inhibiting lipid 
synthesis by blocking the rate-limiting enzyme HMGCR (3-hydroxy-3-methyl-glutaryl-CoA 
reductase) abrogated Treg cell suppressive abilities, proliferation and the ability to upregulate 
effector molecules. This state was overcome by the addition of mevalonate, the direct 
downstream metabolite of HMGCR. Therefore, mTORC1 critically regulates Treg cell fitness 
by promoting lipogenesis, demonstrating the importance of mTORC1 to mediate metabolic 
programming and suppressive functions of Treg cells.  
In order to meet metabolic demands during the ongoing immune response, T cells 
must regulate nutrient uptake, including amino acids. Activation of T cells via antigens or IL-2 
promotes the uptake of large neutral amino-acids via the induction of system L transporters 
[340]. System L transporters are heterodimers, comprising CD98 and Slc7a5, Slc7a6, Slc7a7 or 
Slc7a8 [341]–[344]. Slc7a5 is the most highly induced transporter following TCR stimulation, 
and T cell-specific deletion of Slc7a5 results in abnormal immune responses [340]. Slc7a5-
deficient T cells showed impaired phosphorylation of S6 following activation, demonstrating 
that mTORC1 is not activated in the absence of this key amino-acid transporter. Furthermore, 
inhibition of system L transporters and deprivation of amino-acids reduced mTORC1 in 
effector T cells, which was overcome by the provision of leucine. Therefore, mTORC1 is 
critically regulated by amino acid uptake in T cells.  
The mechanism by which amino acids control mTORC1 in T cells is still under 
investigation. It is proposed to occur at the lysosome, involving amino acid-dependent 
activation of the Ragulator complex [340].  The Ragulator complex comprises five proteins 
(p18, p14, and MP1, HBXIP and C7orf59), which tether the heterodimeric Rag GTPases to the 
lysosome, facilitating the recruitment of mTORC1 to the lysosome and its activation by Rheb 
[345]. 
Nutrient-induced activation of S6 and 4E-BP, downstream of mTORC1, requires VPS34 
[346], [347]. Conventionally, mTOR function is regulated via class I PI 3-kinases, but 
overexpression of VPS34 in cell lines increases the activation of the mTORC1 target S6K1, 
thereby increasing the levels of phosphorylated S6 (pS6) [347]. On the other hand, inhibition 




of VPS34 blocks S6K1 induction [347]. VPS34-kinase activity and PI3P levels are reduced under 
conditions of amino acid or glucose starvation [346], [347], and knock-down of VPS34 
prevents amino acid-induced activation of S6K1 [348]. Therefore, a role for VPS34 upstream 
of mTORC1 in amino acid-mediated activation has been proposed [346], [347], and it is 
possible that VPS34 integrates amino acid availability with mTORC1 activation to promote 
Treg cell fitness. The striking resemblance of FoxP3YFP-Cre Pik3c3fl/fl mice to those with Treg cell-
specific deletion of mTORC1 [132] strongly supports this hypothesis. Both strains of mice 
develop a Scurfy-like inflammatory disease despite the present of Treg cells, Treg cells of both 
genotype suppress effectively in vitro, and both mTORC1- and VPS34-deficient Treg cells are 
at a competitive disadvantage in bone marrow chimera or mosaic mice, respectively. 
However, a link between mTORC1 and VPS34 did not become apparent from investigations 
using proteomic profiling. It would be of great interest to focus on the phosphorylation status 
of mTORC1 target proteins, such as phospho-S6 and phospho-4E-BP1, in VPS34-deficient Treg 
cells as a measure of mTORC1 activity.  
Based on published studies and the knowledge I have gained from my studies, I 
hypothesise that under stimulating conditions (TCR-activating, stress, etc), autophagy is 
upregulated in VPS34-sufficient Treg cells, leading to the sequestration of mitochondria, and 
a reduction of glycolysis. Stimulation of VPS34- and PI3P-dependent pathways negatively 
regulates mTOCR1, repressing c-Myc expression and favouring the expression of protein 
supporting quality control mitochondria, energetic balance, and proteome remodelling 
required for Treg cell maintenance and homeostasis (Fig. 6.1 a). Under activating conditions, 
VPS34-deletion in Treg cells (Fig. 6.1 b), on the other side, leads to a defect in TCR signalling, 
with altered cell proliferation and survival. The reduced turn-over of specific proteins, due to 
a (mild) defect in autophagy, is also detrimental for the proliferation and the survival of Treg 
cells. VPS34-deletion might also lead to the dysregulation of programs of cell senescence and 
activation programs of cell exhaustion. Lack of VPS34 leads to an increased activation of 
mTORC1 signalling, which drives c-Myc expression, leading to an aberrant increase in 
glycolysis. Together with the accumulation of mitochondria, this drives ATP production, 
leading to a dysregulated T cell metabolism, and an abnormal energetic balance.  






Figure 6.1: Proposed model of the role of VPS34 in Treg cells. 
a) VPS34 is required for maintaining Treg cell homeostasis by coupling multiple pathways to ensure 
mitochondrial quality control, energetic balance, and proteome remodelling.  
b) In stimulating conditions, lack of VPS34 in Treg cells leads to the dysregulation of Treg cell 
metabolism, defect in TCR signalling, and dysregulated programs of cell senescence and activation 
programs of cell exhaustion.  
 




6.1.3 The role of VPS34 in activated CD8+ T cells 
During the course of an infection, CD8+ T cells initially expand and differentiate to effector T 
cells. Upon successful clearance of the pathogen, the majority of short-lived effector T cells 
die and the remaining cells differentiate into a population of memory T cells (Tmem) that 
provides long lasting immunity. Cytokines, surface molecules, and signalling components 
involved in T cell memory formation have been extensively studied. However, the molecular 
pathways supporting cell fate decisions are poorly understood.  
Several studies have described a role for autophagy in CD8+ T cell memory formation, 
while the effector phase seems unaffected by impaired autophagy. Hence, mice lacking the 
autophagy gene Atg7 or Atg5 in T cells failed to establish CD8+ T cell memory to influenza and 
MCMV infection [219], [223]. While Atg7−/− T cells responded normally during the early stages 
of a pathogenic challenge, the compartment of memory CD8+ T cells was severely reduced in 
response to influenza and murine cytomegalovirus (MCMV). Antigen-specific Atg7−/− CD8+ T 
cells displayed increased cell death at the time of memory formation, compromised 
mitochondrial health, and increased expression of the glucose receptor GLUT1, a marker for 
glycolysis.  
The pool of memory T cells is controlled by PI3K/Akt and AMPK signalling as well as 
mTOR inhibition [349]–[351], all of which also control autophagy [352]. The maintenance of 
memory CD8+ T cells relies on autophagy to eliminate damaged mitochondria and ROS and to 
facilitate the switch from glycolysis to mitochondrial respiration important for the survival of 
memory CD8+ T cells [223]. In the context of metabolic switching, studies have shown the 
involvement of TRAF6 (TNFR-associated factor 6) in the regulation of CD8+ Tmem 
development by modulating fatty acid metabolism and thereby increasing mitochondrial 
respiration [353], [354]. TRAF6 is an E3 ubiquitin ligase and stabilizes essential proteins in the 
autophagy pathway such as ULK1 [355] and Beclin-1 [356].  
Since VPS34 complex I (comprising VPS34, VPS15, Beclin-1, and Atg14) and the 
production of PI3P at the isolation membrane is required for autophagy induction, it was 
striking to observe that deletion of VPS34 in activated CD8+ T cells did not result in a 
phenotype similar to the one observed by Xu et al. in mice with deletion of Atg7 or Atg5 in 
activated CD8+ T cells (using the same GzmB-Cre system) [219]. Rather, GzmBYFP-Cre Pik3c3fl/fl 
mice infected with an attenuated Lm-OVA strain displayed reduced proportions of antigen-




specific CD8+ T cells with reduced effector functions at the peak of expansion (both during the 
primary and the secondary challenge), while memory formation seemed intact. Loss of 
VPS34-kinase activity led to reduced levels of TNF-α and IFN-γ, as well as reduced proportions 
of the degranulation marker LAMP-1. Overall, however, the percentage of shortly-activated 
effector cells and memory precursor cells were unchanged (Chapter 5). Results from in vitro 
data suggested that while the proliferation of activated CD8+ T cells was not affected, the 
transition into the mitotic phase was impaired by VPS34-deficiency.  
Figure 6.2 summarizes the findings and depicts a proposed model for the effect of 
VPS34-deficiency in activated CD8+ T cells.  
 
Figure 6.2: Proposed model of the role of VPS34 in activated CD8+ T cells. 
a) Cell division, trans-Golgi trafficking and degranulation of effector molecules (TNF-α and IFN-γ) in 
VPS34-sufficient, activated CD8+ T cells. 
b)  Proposed effect VPS34-deletion on cell division, trans-Golgi trafficking, and degranulation of 
effector molecules (TNF-α and IFN-γ) in activated CD8+ T cells.  




6.2 Ongoing work 
6.2.1 Investigating whether VPS34 is required for Treg cell maturation 
In order to explore the role of VPS34 during the recruitment, the expansion and the activation 
of Treg cells in vivo, I will use two different experimental strategies to analyse the numbers 
and phenotype of Treg cells responding to an antigenic stimulus in vivo. Currently, I am 
implanting female FoxP3Cre/WT Pik3c3fl/fl mosaic mice subcutaneously with the murine 
melanoma cell line B78ChOVA-mCherry. B78ChOVA-mCherry is derived from the amelanotic 
clone B16.F10, but has been genetically engineered to express the mCherry reporter and OVA 
(obtained as a generous gift from Prof. Matthew F. Krummel (UCSF)). Treg cells infiltrate the 
tumour and become activated by cognate antigens expressed by the cancer cells. 
Alternatively, the presence of TGF-β within the tumour might increase the conversion of naive 
CD4+ T cells into induced Treg cells (iTreg cells). Since the tumour cells express OVA, I can use 
recombinant MHC tetramer molecules to detect antigen-specific T cells. Eighteen days after 
inoculation, I will isolate tumours, draining and resting lymph nodes, and spleens, and 
compared the number and phenotype of VPS34-sufficient and VPS34-deficient Treg cells 
within these tissues.  
In the future, I will also analyse antigen-specific Treg cells that have undergone clonal 
expansion in response to infection with Listeria using antigen-specific MHC-II tetramers. Using 
this model system, I will be able to address whether the TCR can drive clonal expansion of 
Treg cells in the absence of VPS34.  
I want to use both models to assess whether the expression of CD44 and additional 
differentiation markers on antigen-challenged Treg cells depend on VPS34. Furthermore, a 
competitive disadvantage will be become evident by determining changes in the ratio 
between VPS34-deficient (YFP+) and VPS34-sufficient (YFP-) Treg cells.  
Future work will involve the fluorescence-activating cell sorting of naïve and tumour-
infiltrating VPS34-deficient and -sufficient Treg cells and profile their mRNA by next 
generation sequencing. The analysis of mRNA expression levels will not only reveal potential 
changes in gene-expression due to VPS34-deficiency, but will also allow to track gene 
expression patterns associated with changes in Treg cell maturation and differentiation as 
described recently [357]. 
 




It remains possible that the inactivation of VPS34 has an impact on the thymic development 
of Treg cells that would subsequently affect mature Treg cells in the periphery. In order to 
specifically test the function of VPS34 on fully developed Treg cells, we plan to cross Pik3c3fl/fl 
mice with a FoxP3ERT2-Cre and a Rosa26tdRFP reporter mouse line. This new cross will enable us 
to determine if acute elimination of VPS34 in Treg cells following the administration of 
tamoxifen in adult mice also leads to lethal lymphoproliferation and autoimmunity. It may 
also provide a window of opportunity to challenge mice with homozygous deletion of Pik3c3 
in vivo, should they survive for a few weeks following tamoxifen administration. The RFP 
reporter will allow us to distinguish iTreg cells from tTreg cells if tamoxifen is administered 
before tumour implantation, since iTreg cells derived from Tcon will not be marked by RFP 
expression whereas all Treg cells present at the time of tamoxifen administration will be 
positive for RFP. 
These different approaches will demonstrate whether VPS34 plays a role in antigen-
dependent activation of Treg cells in vivo, help identifying transcriptional profiles associated 
with Treg cell-activation and differentiation and how those are affected by the loss of VPS34. 
 
6.2.2 VPS34-deficiency affects signalling pathways regulating Treg cell metabolism 
To further explore the involvement of VPS34 in maintaining metabolic and functional fitness 
of Treg cells, I focused on genes involved in cellular metabolism and energy homeostasis. The 
evolutionary conserved regulator of cellular metabolism Liver-Kinase B1 (LKB1, encoded by 
the Stk11 gene) was down-regulated by half (p = 0.05724) (data not shown). There is evidence 
from studies using Drosophila that inactivation of endosomal VPS34 and lack of PI3P at 
endosomal membranes leads to the delocalization and the increased activity of LKB1 [358]. 
In mammals, LKB1 is one of the two kinases that activate AMPK by phosphorylation of 
threonine 172 (T172) within the activation loop. LKB1 phosphorylates and activates AMPK at 
the late endosome, which in turn negatively regulates mTORC1. The activity of LKB1 is 
regulated by WDFY2, a protein that is recruited to the endosome through the interaction 
between its FYVE domain and PI3P [358]. Therefore, interrupting endosomal maturation 
through the loss of VPS34 and PI3P might lead to a reduction in the recruitment of WDFY2, 
thereby increasing LKB1 signalling and resulting in higher p-AMPK/AMPK ratio. Furthermore, 
unbound LKB1 might be more prone to degradation, providing a possible explanation for the 




reduced level of LKB1 in VPS34-deficient Treg cells. AMPK is a central mediator of cellular 
energy homeostasis and its activation of AMPK leads to selective regulation of a subset of 
genes involved in metabolism, autophagy and lysosomal function. I therefore aim to monitor 
the phosphorylation status of AMPK1 in VPS34-deficient Treg cells.  
 
6.2.3 Analysis of the phosphoproteomic of Treg cells 
Using proteomic profiling, I can only determine the total protein amount, but cannot draw 
any conclusions on the location of a given protein. Therefore, should the total protein content 
remain the same, it is impossible to determine whether VPS34-deficiency leads to a blockage 
in the transport of the given protein. This limitation might lead to incorrect conclusions about 
which pathways or cellular processes rely on VPS34-kinase activity and will have to be taken 
into account and addressed when designing further experiments.  
Since results from the proteomic profiling could not provide me with a definite clue 
about the mechanism leading to the observed phenotype in mice with VPS34-deficient Treg 
cells, the next step will be to analyse the phosphoproteome of VPS34-deficient Treg cells. 
Phosphorylation of proteins is an extensively employed mode of signal transduction, 
frequently involving cascades of phosphorylation events among kinases [359]. In the past 
decade, technological advances have made quantitative phosphoproteomics a method of 
choice for studying protein phosphorylation in an unbiased manner [360]. This methodology 
has been applied to characterize the system-wide regulation of phosphorylation in many 
different settings and processes, thereby providing valuable information about crucial 
regulatory events [361]. Hence, in order to characterize the impact of VPS34-deficiency on 
the early and late temporal dynamics of the phosphoproteome, I aim to assess global changes 
in phosphorylation after short-term (15 min) and long-term (4h) stimulation of VPS34- 
deficient Treg cell before and after activation with anti-CD3, anti-CD28, and IL-2. We have 
already established collaborations with Pedro Cutillas (University College London) and Doreen 
Cantrell (University of Dundee), with whom we aim to carry out this analysis. Considering the 
reduced percentage of activated Treg cells (based on the expression levels of CD44, CD69, 
KLRG1, and LAG3 as shown in Chapter 3), it is worth considering further the activation status 
on VPS34-deficient Treg cells after activation, since the differential expression of 




(phospho)proteins involved in the pathway(s) responsible for the fatal phenotype observed 
in FoxP3Cre Pik3c3fl/fl mice might only be detectable upon activation of Treg cells. 
 
6.2.4 Knock-down of PI3P-binding proteins with CRISPR/Cas9 gene editing 
In collaboration with Kristopher Johansen (another PhD student in Klaus Okkenhaug’s 
laboratory), I will evaluate the role of different VPS34 effector proteins in Treg cells using 
CRISPR/Cas9 gene editing. Treg cells do not grow vigorously in culture, but it is possible to 
induce iTreg cells from naive CD4+ T cell precursors in the presence of IL-2 and TGF-β in vitro, 
during which genes can be knocked out by CRISPR/Cas9 using retroviral transduction of Treg 
cells isolated from Cas9 transgenic mice [362]. We have generated a list of all (potential) PI3P-
binding proteins, proteins with PX domains, FYVE domains as well as other proteins containing 
BAR domains, A/ENTH domains, C2 domains, and PDZ domains, resulting in a list of 757 genes. 
We used Benchling (Benchling [Biology Software] (2019)) to design guide RNAs (gRNAs) (3 
guides per target gene, leading to a total of 3028 gRNAs).  
We routinely achieve up to 80% knockout efficiency in primary CD8+ T cells and 
anticipate that we can adopt this technology for Treg cells. As an alternative approach, genes 
of candidate proteins will be knocked out in bone marrow cells in vitro, using another recently 
described protocol [363], and used to reconstitute Treg cell-deficient hosts, allowing to 
evaluate whether the lack of the candidate protein is recapitulating the observed phenotype 
of FoxP3YFP-Cre Pik3c3flox mice and its effect on Treg cell function. Eventually, should we find 
evidence for the role of a particular protein being responsible for VPS34-dependent Treg cell 
suppression, we will generate or acquire mice with the corresponding floxed gene and use 
FoxP3YFP-Cre mice or inducible FoxP3Cre-ERT2 mice to test its function in vivo.  
 
6.2.5 Investigating the cell cycle progression of antigen-specific CD8+ T cells in vivo 
In order to investigate the role of VPS34 during the activation and effector function of antigen-
specific CD8+ T cells in vivo, I will use different experimental strategies to analyse the numbers 
and phenotype of antigen-specific CD8+ T cells responding to an antigenic stimulus in vivo.  




Currently, I am implanting GzmBYFP-Cre Pik3c3fl/fl mice subcutaneously with the murine 
melanoma cell line B78ChOVA-mCherry. I observed that the tumour growth is less well 
controlled in GzmBYFP-Cre Pik3c3fl/fl mice, but the mouse group size was not sufficient to 
provide definite results about the phenotype of infiltrating immune cells.  
In the realm of the tumour experiments, I am still facing some technical issues, such 
as the divergent efficacy of the mice to form tumours upon inoculation. I am currently 
optimizing the culturing method of the cancer cells. Furthermore, I aim to move towards a 
tumour cell line that does not express a fluorescent tag, as this will facilitate the design of the 
panels for flow cytometry and the ensuing analysis of the data. I am considering the MC-38 
cell line, derived from the C57BL6 murine colon adenocarcinoma, as a suitable choice for my 
purpose.  
Once these technical issues have been solved, I will inoculate GzmBYFP-Cre Pik3c3fl/fl 
mice with cancer cells and analyse tumour-infiltrating CD8+ T cells as well as antigen-specific 
CD8+ T cells within the tumour mass and migrating to the draining lymph node. I will perform 
cell cycle analysis by injecting mice with BrdU two to four hours before sacrificing them and 
analyse CD8+ T cells in the tumour, draining lymph nodes and spleen by flow cytometry. This 
approach will allow to assess whether in vivo-activated Pik3c3Δ21 CD8+ T cells also display a 
defect in cell cycle progression, and if so, in which stage. I will also assess the proliferation 
capacity of antigen-specific CD8+ T cells using the proliferation marker Ki67, and enumerate 
the proportion of cells undergoing apoptosis using Annexin V staining. Obtained results aim 
to provide a better understanding of why antigen-specific CD8+ T cells are reduced in GzmBYFP-
Cre Pik3c3fl/fl mice, and the reason for their reduced effector functions.  
 
6.2.6 Determine whether endosomal vesicular trafficking is required for the function of 
activated CD8+ T cells 
Based on the observations from FoxP3YFP-Cre x Pik3c3fl/fl mice (presented in Chapter 3.2.8) and 
the reduced levels of CD107a (results presented in Chapter 5.2.7), I aim to assess whether 
endosomal dynamics are affected by the loss of VPS34-kinase activity in CD8+ T cells and to 
which extend intact endosomal vesicular trafficking is required in the context of activated 
CD8+ T cells. As cytokine production and release is key to effector functions of CD8+ T cells, 




and I observed that both the production of IFN-γ and TNF-α, as well as levels of LAMP-1 
(CD107a) on the surface of splenocytes seven days after the primary infections was reduced 
in activated Pik3c3Δ21 CD8+ T cells, it lies close to assume a defect in vesicular trafficking. To 
the end, I will at first bulk-activate splenocytes with αCD3 and αCD28 for 48 hours followed 
by a five day-expansion phase in hrIL-2 and assess endosomal dynamics by flow cytometry 
and fluorescence microscopy using markers for early endosomes (EEA1 or APPL1), late 
endosomes (Rab7), and lysosomes (LAMP-1).   





In conclusion, this work revealed a fundamental and novel role for the class III PI 3-kinase 
VPS34 in the maintenance of Treg cell suppressive mechanisms, and has drawn a link between 
VPS34 and Treg cell metabolism. Also, it reinforced the complexity of VPS34 signalling in 
mammalian cells, and thus the need to further define the upstream and downstream 
pathways involved. These results in turn could profoundly affect our understanding of how 
immunological tolerance is maintained by Treg cells. 
In addition, the data presented in this thesis demonstrated that VPS34 is important 
for activated CD8+ T cells. Based on the requirement of VPS34 for the induction of autophagy 
and the described role of autophagy for memory formation of CD8+ T cells, I had hypothesised 
that loss of VPS34 would recapitulate the phenotype of mice with autophagy-deficient CD8+ 
T cells. Rather, VPS34 resulted in decreased proportions of antigen-specific CD8+ T cells and 
reduced effector functions, i.e. cytokine production and degranulation, while memory 
formation was intact. Therefore, it would be of great interest to delineate the molecular 
process(es) required for the formation of effector CD8+ T cells that depend on VPS34, and 
understand better why VPS34-deletion does not affect memory formation, despite its role in 
autophagy. Therefore, future experiments will aim at delineating the role of VPS34 in the 
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